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ABSTRACT 
In the post-genomic era, X-ray crystallography has emerged as the workhorse of large-scale 
structural biology initiatives that seek to understand protein function and interaction at the 
atomic scale.  Despite impressive technological advances in X-ray sources, phasing 
techniques, and computing power, the determination of protein structure has been severely 
hampered by the difficulties in obtaining high-quality protein crystals.  Emergent 
technologies utilizing microfluidics now have the potential to solve these problems on 
several levels, both by allowing researchers to conduct efficient assays in nanoliter reaction 
volumes, and by exploiting the properties of mass-transport at the micron scale to improve 
the crystallization process.  The technique of Multilayer Soft Lithography (MSL) has been 
used to developed a set of microfluidic tools suitable for all stages of protein 
crystallogenesis, including protein solubility phase-space mapping, crystallization 
screening, harvesting, and in silicone diffraction studies.  These tools represent the state of 
the art in on-chip fluid handling functionality and have been demonstrated to dramatically 
improve protein crystallization. 
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C h a p t e r  1  
OVERVIEW 
Introduction 
The industrialization of DNA sequencing and completion of numerous genome projects has 
set the stage for the next great endeavor, illuminating the cellular proteomes.  Just as the 
invention of the microscope helped to bring about an understanding of life at the cellular 
scale (1), X-ray crystallography has allowed scientists to observe proteins at the atomic 
level, causing a structural revolution in the biological and medical sciences.  A 
conservative estimate is that through alternative splicing, the 30 000 genes that have been 
identified in the human proteome will give rise to over 100 000 proteins whose structures 
and functions are largely unknown.  The diversity of proteomes across species, the need to 
elucidate complex protein/protein interactions, and the visualization of ligand and drug 
binding, imply an effectively limitless number of crystallization targets (2).   
 
Technological advances in synchotron X-ray sources, phasing techniques, and computing 
power have revolutionized data collection and model building techniques (3-5).  These 
innovations have not however been matched by the development of techniques to rapidly 
obtain high-quality crystals.  Major bottlenecks in the expression, purification, and 
crystallization of macromolecule targets continue to thwart high-throughput structural 
biology initiatives (6).  As structure determination efforts begin to focus less on the most 
tractable crystallization targets (typically small soluble proteins), and instead on more 
challenging macromolecules, including large protein complexes and membrane proteins, 
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the need to develop novel and enabling technologies has become urgent (7-9).  The 
bottlenecks associated with generating diffraction quality crystals are further exacerbated 
by the fact that many of the most interesting crystallization targets are difficult to express 
and purify in large amounts.   
 
Microfluidic technologies have the potential to provide unprecedented economies of scale 
and massively parallel sample processing, making them ideal candidates for applications 
where the screening and processing of precious reagents is required (10-12).  The fluid 
handling functionality necessary for realizing diverse and complex biological assays on a 
chip requires the integration of active valves.  A recent breakthrough in fabrication 
techniques, Multilayer Soft Lithography (MSL) (13), uses non-conventional soft materials 
to fabricate true sealing valves.  As a fundamental building block, these valves may be used 
to build up higher level fluidic components such as pumps, mixers, and injectors (13, 14).   
 
Beyond reduction in sample consumption, the reduced length scale of microfluidic 
structures allows access to unique regimes of mixing and fluid flow that are not manifested 
in macroscopic devices.  Realizing the true potential of microfluidic technologies therefore 
requires an understanding of the fluid physics that dominate at the micron scale.  Exploiting 
the physical behaviors that are characteristic to the micro-environment thereby allows for 
the implementation of assays with increased sensitivity and higher efficiencies than are 
achievable by conventional techniques.   
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The focus of this thesis is the application of Multilayer Soft Lithography to the 
development of microfluidic tools that accelerate and improve protein crystallogenesis.  
The emphasis of this work is on realizing the highest possible scientific impact by enabling 
science that has hereto been intractable, and the marriage of engineering and science is a 
central theme in this work.  The utility of a technology depends not only on sound scientific 
principals, but further on maximal robustness, reliability, and accessibility.  These 
engineering principals must be present from the inception of design, and are inextricably 
coupled to the underlying science.   
 
Furthermore, effective technology development requires intimate familiarity with the 
current methodologies and problems.  Only once the inventor is immersed in the field and 
able to consolidate this experience with his technical expertise do the most elegant and 
simple solutions present themselves.  Throughout this work a large effort has therefore 
been directed towards validating the technology through application to outstanding 
crystallization problems.                    
 
Context    
This work builds upon the Multilayer Soft Lithography (MSL) technology developed by 
previously in our lab by Unger et al. (13).  At the time the author began his work on protein 
crystallization in microfluidic devices, MSL was an emerging technology with enormous 
potential and obvious advantages over existing methodologies.  It was still however in a 
nascent form, and technical issues severely limited the complexity of devices that could be 
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realized.  The author has had a major role in resolving these issues and establishing MSL as 
a robust and reliable technology platform. 
 
This thesis describes the first application of microfluidics to protein crystallization.  In this 
work the development of a variety of microfluidic devices suitable for all aspects of protein 
crystallogenesis is described.  The most mature of these technologies is a device for ultra-
small volume screening of crystallization conditions by microfluidic free interface 
diffusion.  This screening device has advanced past the prototype stage and has been 
extensively tested in the crystallization of diverse and challenging macromolecule targets.  
The screening device has been developed into a commercial product by Fluidigm Corp., 
and is being successfully used in structure determination projects at major pharmaceutical 
companies in the United States and Great Britain.     
 
A microfluidic formulator device has been developed for the systematic characterization of 
protein solubility over a broad range of chemical conditions.  This device allows for the 
first practical implementation of high-throughput solubility characterization in nanoliter 
volume reactions.  Additionally, this device has enabled the first implementation of true 
combinatorial mixing on chip and represents the state of the art in microfluidic 
functionality and precision.  The formulator device is currently in the 10th prototype version 
and is being refined for routine use an instrument for rational protein crystallization.  
 
A diffraction device has been developed to allow for successful chip-based crystallization 
conditions to be exported with high correspondence to larger volume formats.  
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Additionally, this device allows for the rapid harvesting and mounting of crystals, and for 
in silicone diffraction studies both at cryogenic and at room temperatures.  The 
diffraction device is in a early prototype stage and is currently being developed both at 
Caltech and at Fluidigm Corp. for commercialization.   
 
Organization and Collaborations 
Chapter 2 discusses the extension of MLS technology to the development of robust and 
scaleable methods for metering and dispensing reagents on chip, a fundamental 
requirement for all liquid handling systems.  The Chapter begins by introducing the method 
of pressurized outgas priming.  This technique is central in solving problems of device 
priming, small-volume sample loading, suppressing bubble formation, and maintaining 
sample hydration.  Pressurized outgas priming allows for the simple implementation of 
robust metering scheme called geometric metering, which is used in the protein 
crystallization screening device.  A second metering technique, positive displacement 
cross-injection (PCI) metering is also presented.  This technique is used in the formulator 
device to realize precise and robust programmable metering on chip.  
 
Chapter 3 begins with an introduction to the characteristic energies of protein 
crystallization and growth.  Simple physical models are presented to provide a framework 
for later discussions of mixing kinetics and crystal nucleation.  In particular, the concept of 
“crystallization phase-space” is presented.  The properties of mass transport that are 
manifested in microfluidic devices allow for the efficient sampling of crystallization phase-
space by a technique called microfluidic free interface diffusion.   
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Chapter 4 describes a protein crystallization screening device that uses geometric metering 
to realize a parallel implementation of microfluidic free interface diffusion.  The 
effectiveness of this device is evaluated in the context of both well-characterized 
crystallization standards and challenging real-world crystallization targets.  Protein samples 
used in these trials were generously provided by a number of academic collaborators: most 
notably the labs of J. Berger, P. Bjorkman, D. Rees, F. Arnold, and D. Eisenberg.   
 
Chapter 5 describes a microfluidic formulator device designed for the systematic 
exploration of protein phase-space behavior.  This device integrates valves, pumps, 
multiplexers, and a mixer to achieve programmable combinatorial mixing on chip.  
Characterization of chip reliability, metering precision and robustness are presented.  
Additionally, issues of cross-contamination and i/o interfacing are discussed.  This work 
was done in equal collaboration with M. Sommer. 
 
Chapter 6 discusses achieving fast mixing in the formulator device through mixer 
optimization.  The application of simple fluid mechanics is used to determine the scaling 
laws that govern mixing times in a rotary mixer.  This discussion follows work done by T. 
Squires.  The behavior of the mixer is further investigated through numerical simulations 
done in equal collaboration with M. Sommer.  Finally, the optimization of valve response 
time for achieving high flow rates in the rotary mixer is discussed.   
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Chapter 7 describes the use of the formulator device in the systematic study of the 
solubility behavior of Endo-1,4-β-xylanase (xylanase) from Trichoderma reesei.  Solubility 
fingerprinting and phase-space mapping are used to characterize xylanase in a variety of 
precipitating agents.  Information gained from these studies is used to design an optimal 
crystallization screen that dramatically enhances the chance of crystallization when 
compared to commercial sparse matrix screens (15).  This work was done in equal 
collaboration with M. Sommer. 
 
Chapter 8 describes a diffraction device that allows successful crystallization conditions 
identified in the screening device to be transported with high correspondence to a larger 
volume format.  A technique for rapid harvesting and mounting of crystals for in silicone 
diffraction studies at cryogenic and room temperatures is presented.  By minimizing crystal 
manipulations and providing a harvesting format amenable to automation this device 
establishes a clear path from crystals to structure.  
 
Chapter 9 begins with an overview of multilayer soft lithography (MSL) as developed by 
Unger et al.  The goal of the remainder of the Chapter is to highlight various technical 
issues related to MSL technology, and to document some useful solutions that have been 
realized throughout the course of this work.  It is the author’s hope that this section will 
provide a useful resource to students new to the field.  Practical considerations and design 
problems that previously limited the reliability and achievable complexity of devices are 
discussed.  Other issues related to fabrication and component design are presented.  In 
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cases where the author had a major contribution only in the conception of solutions, with 
the implementation carried out by other students, appropriate references are made.   
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C h a p t e r  2  
ROBUST AND SCALEABLE MICROFLUIDIC METERING 
Introduction 
In the same way that miniaturization has impacted the electronics industry, microfluidic 
technologies promise to spark a revolution in the biological sciences by integrating ultra 
small-volume sample processing within a chip format.  The use of nanoliter reaction 
volumes and highly scaleable parallel sample processing makes microfluidic technologies 
ideally suited to protein crystallography, where the screening and processing of precious 
reagents is required.  Beyond reduction in sample consumption, the unique properties of 
mixing and fluid flow at the micron scale also allow for the implementation of assays that 
are highly efficient at detecting crystallization conditions (16).    Despite this enormous 
potential, several technical problems have prevented the realization of the full potential of 
microfluidic devices for protein crystallization.   
 
Central to the realization chip-based protein crystallization and other lab-on-chip 
technologies is achieving the fundamental fluid handling capability of precisely metering 
and mixing fluids at the sub-nanoliter scale.  In order to be scaleable and to have general 
applicability, such a system must further be insensitive to both the surrounding fluidic 
architecture and to the properties of the working fluids.  In the case of protein 
crystallography, this latter requirement is particularly important since the solutions used in 
crystal trials cover a large range of chemistries, viscosities, ionic strengths, and pH.   
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The early work in microfluidics was focused on the development of glass microchips that 
exploited electrokinetic manipulation of fluids for applications such as enzymatic assays 
and molecular separations.  This work demonstrated that microfabricated fluidic structures 
may be used to accurately meter and mix fluids on the picoliter scale (17-22).  Although 
these systems have proven useful in niche applications such as capillary electrophoresis, 
they have not proven to be scaleable, and have fundamental limitations that prevent there 
universal application.  For example, the electrokinetic force used in these devices depends 
strongly on both the properties of the working fluid and on its interaction with the channel 
walls.  Small changes in pH or salt concentration, that result from ion drift over time, can 
lead to more than a tenfold variation in injected volume (23, 24).  These systems are also 
dependent on the viscosity and on the fluidic resistance due the surrounding channel 
architecture.  As a result, electrokinetic devices must be recalibrated for every fluid, and are 
not suitable for high-throughput screening applications with a diverse ensemble of 
unrelated reagents.   
 
Moreover, since electrokinetic systems have no active valves, reagents diffuse through 
junctions and channels over time.  This leaking dilutes and contaminates samples over 
time, restricting the maximally achievable incubation times and the density at which 
assays may be integrated on chip.  The problem of reagent storage is particularly acute 
for crystallization applications where assays may be required to incubate for several days 
or weeks.  
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All of these problems may be addressed by using MEMS (micro-electro-mechanical 
systems) fabrication techniques to incorporate active mechanical valves on chip.  
Traditional MEMS techniques, using “hard” materials such as glass or silicon, may be 
used to fabricate true, leak-proof mechanical valves.  However, MEMS fabrication 
techniques are expensive and require many processing steps, rendering the integration of 
many valves on a chip a difficult and expensive process.  Furthermore, since these valves 
are fabricated from hard materials, a large actuator area is needed to achieve valve 
closure at attainable actuation forces.  The large actuators of each valve and the low yield 
of the fabrication process impose practical constraints on the degree of integration that is 
possible in microfluidic devices made from traditional MEMS techniques.   
 
While there is a thriving MEMS community making silicon-based valves and 
microfluidic devices, alternative fabrication techniques using non-traditional materials, 
including hydrogels (25), plastics, and elastomers (26, 27), are gaining popularity and 
have been developed for the quick and inexpensive fabrication of passive and active 
microfluidic devices.  In particular a technique developed by Unger et al., Multilayer Soft 
Lithography (MSL), enables facile and inexpensive large-scale integration of valves on 
chip (27).  MSL uses consecutive soft lithography molding and bonding steps to generate 
complex multilayer fluidic devices.  In this way, planar channel structures separated by 
only a thin flexible elastomeric membrane may be integrated into a monolithic polymer 
chip.  The orthogonal crossing of channel structures in two adjacent layers creates a 
deflectable membrane valve.  A hermetic seal of the channel structure may be easily 
achieved at by application of modest hydraulic or pneumatic pressure to the control 
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structure.  The low Young’s modulus of the elastomer ( ~1 MPa compared to ~100 GPa  
for crystalline silicon) allows for the large deflection of membranes with small active 
areas (typically 10000 µm2), thereby enabling the large-scale integration of valves on a 
chip (27).  Moreover, the softness of the channel and valve structure ensures the 
formation of a robust seal even in the presence of particulates or fabrication 
imperfections.     
 
This Chapter describes the extension of MSL technology to the development of two 
metering techniques that are both scaleable and robust to the properties of the working 
fluid.  The first of these techniques, geometric metering, relies on the ability to easily prime 
arbitrary connected fluidic structures via the pressurized outgas priming (POP) method.  
Geometric metering is a static technique whereby the final aliquot volumes and mixing 
ratios are defined by the fluidic structure.  This robust technique is extremely powerful by 
virtue of its simplicity of operation and scalability to massively parallel architectures, and is 
central to the implementation of a protein crystallization screening device (Chapter 4).  An 
extension of this technique, in the form of variable volume nanopipettes, allows for a 
degree of programmability to be achieved through the analogue or discrete tuning of cavity 
volumes.  A second technique, positive displacement cross-injection (PCI) metering, is a 
dynamic technique that allows for the programmable serial dispensing of an arbitrary 
number of reagents.  This versatile method is used to realize the first demonstration of true 
combinatorial mixing on chip (Chapter 5).    
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Pressurized Outgas Priming 
The realization of highly integrated and complex fluidic devices requires that the problem 
of priming, or initially filling the device with fluid, be addressed.  For microfluidic devices 
made from conventional hard materials such as silicon or glass, this requirement may 
prevent the use of multiply crossing, highly complex fluidic architectures.  Such devices 
must be primed using a flow-through method, which requires an outlet through which 
displaced gas may be vented.  The introduction of the priming fluid through a complex 
fluidic structure may trap air bubbles at junctions and other channel features.  Surface 
tension effects at the liquid-gas interfaces of these bubbles result in large pressure drops so 
that bubbles can not be easily removed and adversely affect the performance of the device.  
Furthermore, since a single priming fluid must pass through the entire device, it may 
subsequently contaminate or dilute sample solutions.  These difficulties can be surmounted 
in silicone devices by exploiting the gas permeability of a soft silicone polymer (28, 29).  
The permeability of silicone rubber to a variety of gases is listed in Table 1 (30).   
 
   Penetrant  Permeability (Barrer) 
   H2   890 ± 30 
   O2   800 ± 20 
   N2   400 ± 10 
   CO2   3800 ± 30 
 
Table 1:  Permeability of poly(dimethylsiloxane) to various gases.  1 Barrer = 10-10 
cm3(STP)·cm/cm2·s·cm Hg. 
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Arbitrarily complex, connected fluidic structures may be filled in minutes by a technique 
called Pressurized Outgas Priming (POP).  Using the POP technique, a fluid is injected into 
a closed channel structure, causing the gas ahead of it to be pressurized.  Due to the 
permeability of the elastomer, the pressurized gas quickly diffuses into the bulk material, 
allowing the priming fluid to completely fill the flow structure.  Figure 1 shows a time 
sequence of a 7 nL well being dead-end filled at 8 psi loading pressure.  Despite the low 
surface energy of PDMS (22 mJ/m2), aqueous solutions may be easily introduced, at 
moderate pressures (1-8 psi), into channels having a minimum dimension of 1 µm, 
eliminating the need for surface modification protocols.  Since no outlet is needed for the 
venting of gas, dead-end reaction chambers and channels may be used, allowing significant 
design flexibility.  Furthermore, since the priming is selective and integrated valves may be 
used to direct flow of the fluid, a device can be primed with many different fluids in 
different channels or chambers.  This latter property is the basis of the geometric metering 
scheme described below.  A more comprehensive introduction to MSL technology and 
various relevant technical issues is provided in Chapter 9.  
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Figure 1:  Opical micrographs showing the dead-end filling of a 7.5 nL reaction chamber 
at 8 psi using the pressurized outgas priming (POP) method.  Scale bar is 100 µm. 
 
Geometric Metering 
The ability to fill a device with many different fluids in different channels and chambers 
using the POP technique allows for the implementation of a simple and robust geometric 
method of metering solutions.  The principle behind this scheme is to set up a geometry in 
which interface valves are used to partition a continuous microfluidic reactor into sections 
of well-defined volume.  Each section may be separately filled with different solutions 
through separate inlet channels.  Once filling is complete, the inlet channels are sealed by 
actuation of containment valves, thereby isolating the reactor from the rest of the device.  
De-actuation of selected interface valves allows for adjacent sections of the reactor 
containing different reagents to be combined.   
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A simple fluidic structure for the geometric metering of two reagents at three different 
mixing ratios is shown in Figure 2A.  With a central interface valve closed, the chambers 
on either side of the interface are first dead-end filled with two different solutions using the 
POP technique (Figure 2B).  Once both chambers have been completely filled, the 
containment valves are actuated, thereby isolating the chambers from the rest of the chip 
and defining the total volume of the reactor.  The interface valve is then opened to create 
fluidic connection between the chambers, allowing them to mix by diffusion.  Figure 2C 
shows the complete diffusive mixing of an organic dye with water, creating a set of three 
distinct concentrations in separate reaction chambers.   
 
 
 
 
 17
Figure 2:  Geometric metering.  (A) Three pairs of coupled microwells.  Control 
channels are filled with 20 mM Orange G (Aldrich Chemical Company).  (B) Loading of 
reagents using POP method.  The interface valve (center) is actuated and reagents are 
loaded into adjacent sides of compound wells.  The bottom wells are being dead-end 
loaded with water, and the top wells have been loaded with 13 mM bromophenol blue 
sodium salt (Aldrich Chemical Company).  (C) A gradient of dye concentration.  The 
containment valves (top and bottom) isolate compound wells, and the interface valve is 
released to allow diffusive mixing.  Image shows complete mixing after 2 hours.  (D) 
Histogram showing the insensitivity of BIM to fluid viscosity.  BIM was used to combine 
7 mM bromophenol blue sodium salt with water (η ≅ 1 cP) or 34% m/m sucrose (η ≅ 4 
cP) tens times each at mixing ratios of (Dye:water/sucrose) 1:4, 1:1, and 4:1.  Water 
measurements are shown in blue, and sucrose is shown in red. The variations in the 
concentration measurements (~ 10%) are comparable to those taken on solutions of 
known concentrations.   
 
In this way the chambers effectively act as microfluidic measuring cups, precisely 
determining the mixing ratio by the relative chamber volumes.  Since the metering depends 
only on the volume of the chambers it is an inherently robust technique that is insensitive to 
resident fluid properties.  Figure 2D shows a histogram of mixing ratios achieved in 20 sets 
of 3 reaction chambers using two fluids of varying viscosity.  Similar experiments using 
solutions of sodium chloride ranging from 0 M to 2 M have shown that metering is 
independent of ionic concentration (data not shown). 
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In this simple configuration, mixing is dominated by diffusion of the reagents, which 
takes on the order of an hour for small molecules in an aqueous solution.  This purely 
diffusive mixing is sometimes advantageous in that it removes the confounding effects of 
convection, thereby allowing for slow equilibration of the various reagents.  In cases for 
which speed is an issue, it is straightforward to implement the BIM scheme in alternative 
geometries, such as a ring, and then accelerate mixing by dispersion induced through 
active pumping around the ring (see Chapter 6).  This scheme has found applications in 
single-cell gene expression analysis and large-scale multiplexed PCR reactions (31, 32). 
 
A major advantage of this technique lies in its simplicity of control and scalability.  The 
volume of the reaction chambers is precisely defined during lithography and molding so 
that there is no need to calibrate the system.  Each of the steps in the metering and mixing 
process (interface actuation, filling, containment, and diffusive equilibration) proceeds to 
completion prior to the initiation of the next step, so that there is no requirement of 
precise valve actuation timing.  Hence, thousands of reactions can be implemented in 
parallel using only two control lines irregardless of differences in the length of loading 
channels or in the fluid properties.  Figure 3 shows a section of a device designed to 
implement 144 simultaneous metering and mixing experiments.  The ability to implement 
large-scale parallel metering and mixing of reagents without increasing control 
complexity has been exploited in a variety of applications including protein 
crystallography (29, 33), multiplexed PCR reactions (32), and cell-library screening (27).  
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Figure 3:  Parallel implementation of geometric metering.  Section of a device designed 
for the simultaneous mixing and metering of a single sample (blue) with 48 unique 
reagents (clear) using only two control lines (orange). 
 
Geometric metering is primarily a static technique in which the final dispensed volumes are 
“hard-wired” into the fluidic structure.  Nevertheless a degree of programmability may be 
achieved by the inclusion of redundant valves and/or channels.  Figure 4 shows a channel 
and valve geometry designed to allow for 10 alternate mixing ratios to be achieved by 
selection of one of many possible interface valves (I1 – I10) located at different locations 
along a reaction chamber defined by two containment valves (C).  Additionally, a series of 
channel inlets could be included between each of the 12 valves to allow for many different 
numbers of reagents and mixing ratios to be implemented.  Although this allows a large 
number of alternative configurations, such geometries greatly increase the control 
complexity of the device and may introduce severe routing problems that make them no 
longer scaleable to parallel implementations.     
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Figure 4:  Channel architecture for programmable geometric metering.  Selection of 
specific interface channel (I1 – I10) determines mixing ratio of fluids introduced at the 
channel inlets. 
 
Alternatively, the geometric metering scheme may be extended to structures in which the 
total volume of the reaction chamber may be tuned in a continuous or discrete fashion by 
deflection of a membrane.  Figure 5 shows a column of a microfluidic chip with an array of 
1 nanoliter fixed-volume nanopipettes.  Each column of nanopipettes is addressed by a 
separate input channel (clear).  Each nanopipette has a containment valve at the inlet and a 
deflectable membrane.  The size of each membrane defines the metered volume and is 
varied across the row.   
 
The simple two-component metering of solutions at a variety of fixed mixing ratios is 
implemented as follows.  The first fluids to be mixed are introduced into separate columns 
of the array via a multiplexing structure (not shown).  The chip outlet is then closed and the 
nanopipette containment valves are opened to allow for the dead-end filling of each 
reaction chamber by the POP method.  Once filled, the reaction chambers are sealed by 
actuation of the containment lines, and the next fluids to be mixed are flushed down the 
columns.  Figure 5A shows 3 nanopipettes filled with an organic dye (20 mM bromophenol 
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blue sodium salt, TRIS·HCl pH 8.0).  To execute the metering task the containment valves 
are opened and the membranes are inflated, ejecting a well-defined volume from each 
pipette (Figure 5B).  The ejected volume is flushed from the column and replaced with the 
second solution (Figure 5C).  The membranes are then deflated, causing a well-defined 
volume of the second reagent to enter the nanopipette (Figure 5D).   
 
 
 
Figure 5:  Parallel operation of fixed volume nanopipette.  (A) Nanopipettes are filled 
first reagent (blue), containment valves are actuated, and inlet channel is flushed.  (B)  
Membranes are inflated to expel a well-defined volume of first reagent.  (C)  Inlet 
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channel is flushed and loaded with second reagent.  (D)  Relaxation of membranes results 
in aspiration of a well-defined volume of second reagent.        
 
 
In this setup the mixing ratio is determined by the membrane geometry and is therefore 
hard-wired into the device.  Since a separate reagent is introduced to each column of the 
array and each nanopipette is designed to achieve a specific mixing ratio, this strategy 
allows for the parallel screening of different reagents at different mixing ratios.  Figure 6 
shows the mixing of two organic dyes (orange G and bromophenol blue sodium salt) at 0:1 
(A), 1:3 (B), 1:1 (C), and 2:1 (D) ratios.  In cases where parallel architectures are not 
required the nanopipette may be used to meter fluids in an analogue fashion.  Varying the 
actuation pressure applied to deflect the membrane allows for continuous tuning of the 
nanopipette volume.   
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Figure 6:  Parallel mixing at variable mixing ratios using an array of 1 nL nanopipettes.  
(A)  1 blue : 0 orange.  (B)  3 blue : 1 orange.  (C)  1 blue : 1 orange.  (D)  1 blue : 2 
orange. 
 
Positive Displacement Cross-Injection Metering 
Formulation applications require arbitrary combinations and concentrations of a large 
number of distinct reagents to be mixed on chip.  This “mix-on-command” requirement 
necessitates a robust and programmable metering scheme that can accommodate a large 
number of input solutions.  Positive displacement cross-injection metering allows for the 
sequential injection of precise sample aliquots from a single microfluidic channel into 
reaction chambers through a positive-displacement cross-injection (PCI) junction (Figure 
7).  
  
The PCI junction is formed by the combination of a three-valve peristaltic pump (13) and a 
four-port cross-injection junction with integrated valves on each port (Figure 7A).  Two 
sets of valves at the junction inlets are actuated to direct the flow either horizontally or 
vertically.  Prior to metering the flow is switched vertically through the junction, charging 
the cross-injector with the sample fluid (Figure 7B).  The flow is then directed horizontally 
through the junction and the three valves forming the peristaltic pump are actuated in a five 
state peristaltic sequence to advance the fluid in the horizontal direction (Figure 7C).  Each 
cycle of the peristaltic pump injects a well-defined volume of sample (approximately 80 
pL) determined by the dead volume under the middle valve of the peristaltic pump.  The 
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deflection of the valve membranes when not actuated is determined by the pressure 
difference across the membrane.  The volume injected during each cycle therefore may be 
tuned continuously, allowing for variable positive displacement metering.  By repeating the 
injection sequence, the volume of injected solution may be increased in 80 pL increments, 
allowing for the programmable quantized control of the final downstream sample 
concentration.  After each injection sequence the junction is flushed and recharged 
allowing for the sequential introduction of different reagents down the line (Figure 7D).   
 
 
 
Figure 7:  Positive displacement cross-injection (PCI) for robust and programmable 
high-precision dispensing on chip.  (A)  Schematic of a four port PCI junction.  The split-
channel architecture creates a larger volume injector region, thereby allowing for an 
increased number of injections before recharging.  (B)  Charging of the injector region of 
the pci junction.  Junction valves are actuated to direct the flow vertically through the 
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junction, filling the injector region.  (C)  Precise positive displacement metering by 
actuation of peristaltic pump valves in pumping sequence.  (D)  PCI junction is 
sequentially charged with different solutions to create complex multi-component 
mixtures.   
 
Certain applications may require the parallel injection of reagents into an array of reaction 
chambers containing different reagents/cells/bacteria.  An array of five PCI junctions is 
shown in Figure 8A.  The corresponding junction valves of all gated cross-injection 
junctions are interconnected, allowing an entire injection array, potentially of hundreds of 
junctions, to be controlled using only two control lines.  The channel sections contained 
between the rightmost horizontal gate valves, and the peristaltic pump, define 5 reaction 
chambers, each having a volume of 2.6 nL.  To execute the metering task the flow is first 
directed vertically, charging the junctions (Figure 8B).  The flow is then directed 
horizontally through the junctions, and the peristaltic pump advances the fluid in the 
horizontal direction, injecting an even aliquot of sample into each reaction chamber.  By 
operating the peristaltic pump at low frequency so that the response is linear, the amount of 
injected fluid is independent of the fluidic resistance of the channels.  Figure 8C shows the 
even injection of sample solution into 5 reaction chambers of unequal fluidic resistance, 
and containing fluids of differing viscosity.  For a similar pressure-driven injection, shown 
in Figure 8D, the flow through middle chamber leads that of the adjacent chambers due to 
the lower fluidic resistance and viscosity.  
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Figure 8:  Parallel array of PCI junctions.  (A)  5 PCI junctions controlled in parallel by 
5 control lines.  (B)  Flow is directed vertically to charge PCI junctions with blue dye (10 
mM bromophenol blue sodium salt).  (C)  Even injection of dye down 5 channels of 
varying fluidic impendence using peristaltic pump.  Length of channels to outlet is (top to 
bottom) 2.5 mm, 1.5 mm, 1 mm, 1.5 mm, 2.5 mm.  (D)  Uneven pressure-driven injection 
of dye down channels due to varying fluidic impedence.  Scale bars are 2mm.       
 
Repeating the injection sequence allows for the volume of injected solution may be 
increased in discrete steps, so that programmable and quantized control of the final sample 
concentration is realized.  Once the correct volume has been dispensed, the fluids are 
contained, and allowed to mix by diffusion.  Absorption measurements for five adjacent 
reaction chambers of varying fluidic resistance and viscosity are shown in Figure 9.  All 
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five data sets show excellent linearity, having r2 values between .980 and .996.  The 
average slope was determined to be 103 pL / injection, with a standard deviation of 6%, 
and a maximum deviation of 9%.    
 
 
 
Figure 9:  Absorption measurements of parallel metering using and array of 5 PCI 
junctions.  Volume of injected dye (10 mM bromophenol blue sodium salt, TRIS·HCl 
pH8.0) is insensitive to changes in solution viscosity and fluidic impendence.     
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C h a p t e r  3  
MICROFLUIDIC FREE INTERFACE DIFFUSION: OPTIMAL MIXING 
Introduction 
The crystallization of a biological macromolecule is realized by the manipulation of one or 
more chemical and thermodynamic variables such that the solubility of a target molecule in 
a concentrated solution is reduced, thereby promoting a transition to the solid phase in the 
form of a well-ordered crystal.  In principal a stable protein solution may be brought to a 
state of supersaturation through the manipulation of any physical parameter that appears in 
the thermodynamic equation of state of the protein.  This is typically accomplished through 
the addition of precipitating agents that lower the solubility of the protein (often 
accompanied by a slow concentration of the solution).  Traditional precipitating agents 
include salts, polymers, organic solvents, buffers, and various additives.  When successful, 
these reagents promote specific protein-protein interactions by modifying solution 
properties such as pH, dielectric constant and ionic strength.   
 
Natural macromolecule targets for crystallography are both large and extremely varied.  
Proteins, for example, are complicated polymers of amino acids with polar, non-polar, 
charged, and aromatic residues that interact with each other and with the external 
environment.  These complicated interactions result in a highly varied and complicated 
phase-space diagram that cannot be deduced a priori.  Consequently, macromolecular 
crystallization requires a brute force approach in which as large a volume of chemical 
phase-space as possible must be explored.  The vastness of phase-space that must be 
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explored implies that a thorough investigation by conventional techniques is impractical. 
The initial search is therefore typically directed towards a sparse matrix or incomplete 
factorial sampling of likely crystallization agents (15, 34). 
 
For macromolecules possessing a large volume of phase-space that is conducive to 
crystallization, there is a good chance that one of the randomly screened conditions will 
result in crystal formation.  Since the first ‘hit’ is not likely to be optimal, initial successes 
are usually of poor quality, and may consist of spherulites (Figure 10A), phase separation 
(Figure 10B), micro-crystals (Figure 10B), needles, needle clusters, thin plates (Figure 
10C), plate stacks (Figure 10D), or  small single crystals (Figure 10E).   These starting 
conditions can be used to initiate focused and refined screening, eventually producing 
diffraction quality crystals (Figure 10F).  If only a very narrow range of conditions is 
conducive to crystallization, initial screens may be too coarse to uncover promising 
conditions and further screening may be required.   For macromolecules that require very 
specific crystallization conditions, almost invariably the ones of greatest interest to the 
investigator, many thousands of experiments may be required before a hit is detected, if at 
all.   
 
 
 30
 
 
Figure 10:  Examples of initial crystallization hits from a single on-chip screening 
experiment of a type II topoisomerase ATPase domain/ADP; 12 mg/mL.  (A)  Irregular 
spherulite.  (B) Phase separation and spherulites with nucleating microcrystals.  (C) Thin 
plate clusters.  (D) Thick plate stacks.  (E)  Well-formed microcrystals.  (F) Large single 
crystals.  All scale bars are 100 µm. 
 
Moreover, many important crystallization targets are only available in very small 
quantities.  The large number of experiments required to uncover successful crystallization 
conditions therefore is what represents the most formidable obstacle to determining the 
structure of many important biological macromolecules.  For example, membrane proteins 
play a central role in cell signaling and are often excellent targets for small molecule 
therapeutics.  Unfortunately, the structures of only a very few (approximately 50) have 
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been determined to date, primarily because of the difficulties associated with expressing, 
solubilizing and stabilizing these molecules in the large quantities required for 
crystallization trials (> 1 mg) (35-37).  Similarly, many proteins work in the cell as large 
complexes.  Structural information of these targets provides invaluable information 
regarding complex biochemical reactions and protein/protein interactions.  As with 
membrane proteins these assemblies are exceedingly difficult to purify in large amounts, 
and at times must even be purified by processing kilogram quantities of native sources (38, 
39).  
 
Traditional techniques for the crystallization of macromolecules include concentration 
through slow dehydration (vapor diffusion), batch and dialysis methods, and both liquid-
liquid and liquid-gel diffusion experiments (For review see [40]).  Practical limitations of 
traditional fluid handling approaches require that the minimum volume per assay for these 
techniques ranges from 0.2 µL to 1 µL for vapor diffusion and microbatch methods, and up 
to 50 µL for micro-dialysis.  Since protein samples may only be available in milligram 
quantities, and target molecule concentrations are generally required in excess of 10 
mg/mL, the ability to routinely perform nanoliter scale assays using microfluidics not only 
helps to promote a more comprehensive screening strategy, but further allows for 
experimentation with ultra-low-abundance macromolecules. 
 
The probability of success in a crystallization screening experiment is proportional both to 
the number of independent trials, and to the chance of success of each trial.  An optimal 
screening methodology must therefore maximize not only the number of independent trials 
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through small volume sample processing, but also the efficiency of each assay.  Although 
the appropriate chemical variables cannot be ascertained in advance, it is possible to use the 
universal phase properties of the precipitant-protein interaction to systematically design 
experiments with optimal mixing kinetics, and thereby enhance the chance of crystal 
growth.  In addition to the impressive economy of scale provided by microfluidic devices, 
the physical properties of fluid flow at the micron scale allow for the implementation of 
highly efficient crystallization assays.   
 
Characteristic Energies of Nucleation and Growth 
The successful crystallization of a macromolecule is determined both by thermodynamic 
and kinetic considerations.  A concentrated solution of the target molecule must first be 
brought to a state in which the crystal phase is energetically favorable, and then kept in this 
state to allow crystal nucleation and growth to occur.  An essential feature of crystal 
nucleation and growth is that it is necessarily a non-equilibrium process.  A measure of 
how far out of equilibrium a system is, and therefore of the tendency towards 
crystallization, is the saturation defined as C/C0, where C is the concentration of protein 
and C0 is the maximum concentration of protein in thermodynamic equilibrium.  By 
definition, saturation below unity describes a stable protein solution in which no phase 
change will be observed.  All supersaturated solutions (S > 1) are unstable and will 
ultimately exhibit a phase transition to an amorphous or crystalline state.  An emerging 
crystalline phase will continue to grow at the expense of the soluble phase until the 
concentration of soluble protein is reduced to C0 and the chemical potentials of both phases 
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are equal.  In equilibrium, the probability of observing a solution with concentration C is 
given by the Boltzman distribution as 
 
    ⎟⎠
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where ∆G is the Gibbs free energy of the solution relative to that of the solution in 
equilibrium with the crystalline phase.  The chemical potential is identically the number 
specific Gibbs free energy of an ensemble so that taking the log of this expression gives the 
chemical potential of the crystalline phase relative to equilibrium as (41) 
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Thus, if the protein concentration in solution is greater than C0,the crystal is energetically 
favored and will continue to grow.   
 
Favorable interactions with neighboring molecules compensate for the net loss of entropy 
associated with incorporating a protein molecule into the growing lattice.  On the surface of 
a growing crystal these interactions are incomplete, giving rise to an unfavorable surface 
term.  The net free energy of a crystalline aggregate is therefore given by 
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where S is the surface area of the growing aggregate, σ is the surface energy crystal/solvent 
interface, V is the volume of the aggregate, and υ is the volume occupied by a protein 
molecule in the crystal.  A hypothetical plot of the free energy of a growing nucleus as a 
function of radius is shown in Figure 11.  The competition between the surface and volume 
terms gives rise to a finite activation barrier.  Only after an aggregate achieves a critical 
radius does it become stable.   
 
 
 
Figure 11:  Activation barrier to crystal nucleation.  Competition between favorable 
volume interactions and unfavorable surface interactions results in a minimum critical 
nucleus radius R* that is stable.  
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If the critical radius is large compared to the size of each protein molecule, the growth of 
the nucleus can be well approximated as a continuous process.  In this limit the nucleation 
process can be modeled as thermal activation of a quasiparticle over an energy barrier of 
height G*, with a rate given by Kramer’s relation (42): 
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where J is the expected number of nucleation events per second per unit volume.  The 
prefactor Κ0 may be loosely interpreted as the escape attempt rate of a quasi-particle 
oscillating in the potential well near the activation barrier, and is therefore determined by 
the curvature potential in the vicinity of the soluble state minimum, the curvature near the 
transition state (critical nucleus), and is proportional to the concentration of molecules in 
solution.  
 
An expression for the activation barrier, and hence the dependence of the nucleation rate on 
the degree of solution saturation may be deduced if an assumption is made as to the shape 
of the growing aggregate.  For the case of a spherical aggregate the activation barrier may 
be expressed as (43) 
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The very strong dependence of the nucleation rate on saturation is illustrated in Figure 12.  
By defining a characteristic reaction volume Vexp, and a relevant experimental timescale τ, 
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the rate of nucleation may be used to classify a supersaturated solution into one of two 
regimes.  An average time to nucleation 1/(J Vexp) that is much longer than τ defines the 
metastable regime.  In this regime the growth of large, high-quality crystals is supported 
but nucleation events are rare, requiring impractically long incubation times.  Experiments 
that stay in this region will likely appear as clear drops and will be unremarkable.  It is 
worth noting that since the average time to nucleation scales with the volume of the 
reaction, small volume crystallization formats must achieve higher levels of supersaturation 
for crystals to be observed in reasonable times. 
 
 
Figure 12:  Nucleation rate of a spherical aggregate as a function of solution saturation.  
 
Systems in which the average time to nucleation 1/(J ν) is much shorter than τ are said to be 
in the labile regime.  In this regime multiple nucleation events will be observed in time τ.  
Polycrystalline aggregates and high levels of defect incorporation are characteristic of rapid 
crystal growth in the labile regime (44).  Furthermore, very high levels of supersaturation 
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often result in showers of microcrystals that may be too small to distinguish from 
amorphous precipitate, a problem that can cause promising conditions to be overlooked.   
 
In conventional macromolecular crystallization a stable protein sample is brought into a 
state of supersaturation through the addition of a crystallizing agent.  This process is 
represented as a deformation of a free energy landscape defining a crystalline and a soluble 
phase (Figure 13), where the aggregate radius has been replaced by a generalized reaction 
coordinate that encompasses all degrees of freedom in the system.  Initially the protein 
sample is stable in the soluble form, having a free energy below that of the crystalline 
phase (Figure 13A).  Perturbation of the system through the addition of a precipitating 
agent that lowers the solubility of the protein induces a state of supersaturation in which the 
energy of the soluble phase rises above that of the crystalline phase.  If the degree of 
supersaturation is small this will result in a metastable state characterized by a large 
activation barrier (Figure 13B).  If a higher degree of supersaturation is achieved, say 
through the addition of more precipitating agent, a labile state conducive to crystal 
nucleation is achieved in which the activation barrier has been substantially reduced 
(Figure 13C).     
 
The three-dimensional aggregation of target molecules into a critical nucleus from which 
crystal growth may proceed is a process that requires a higher activation energy, and hence 
higher supersaturation, than the subsequent one- or two- dimensional nucleation needed for 
crystal facet growth.  For this reason, an optimal crystal growth scheme should allow for 
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initial nucleation by transiently high levels of supersaturation followed by passage into 
lower supersaturation levels that support high-quality crystal growth (Figure 13D) (44, 45). 
 
 
 
Figure 13:  Hypothetical free energy diagrams characteristic of different regimes of 
solution saturation.  (A) Stable regime.  The soluble phase “S” has lower free energy and 
is stable.  (B)  Metastable regime.  Growth of crystalline phase “C” is favored but 
nucleation events are rare due to large activation barrier.   (C)  Labile regime.  A small 
activation barrier leads to rapid nucleation events and poor quality growth.  (D)  
Metastable regime after nucleation.  Activation barrier is reduced due to the presence of a 
critical nuclei in solution.  High-quality crystal growth is supported.   
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Mixing at Low Grashoff Number 
In the thermodynamic limit of infinite equilibration time, and with other thermodynamic 
variables held constant (i.e. pressure and temperature), the phase of the protein solution will 
be uniquely determined by the concentration of protein and precipitating agent in solution.  
This behavior may be represented by a hypothetical two-dimensional phase-space having 
concentration of protein and concentration of precipitating agent as variables.  This phase-
space represents the interaction of a given protein with a specific precipitating solution, and 
is therefore unique to that solution.  Complex phase-space behavior arising from 
interactions such as specific protein/ligand interactions, protonation/deprotonation of amino 
acids, detergent micelle formation, and protein denaturation, results in highly varied and 
unpredictable phase behavior.  The different phases that may exist within a single phase 
diagram include monomeric soluble phase, aggregate soluble phase, condensed liquid 
phase, amorphous aggregate, denatured protein, and various crystalline forms. 
 
In the simplest non-trivial case there will exist at least two distinguishable phases: a soluble 
phase and a solid phase.  At low protein and low precipitant concentrations the soluble 
phase is stable.  This region is bounded by a solubility curve that determines the maximum 
stable concentration C0(Cprec) of protein as a function of the precipitating agent 
concentration, which by definition must be single valued.  For precipitating agents that 
have the potential to induce crystallization there exists a metastable region located just 
above the solubility curve.  In this region the protein solution is out of equilibrium, and 
given sufficient time, will undergo a phase transition to a crystalline solid.  Beyond the 
 
 40
metastable region, at higher protein and precipitant concentrations, lies the labile region 
where the nucleation of crystalline or amorphous aggregates is a rapid process.  The 
boundary between these regions, which depends on the relevant timescale of the 
experiment, is referred to as the precipitation curve.      
 
The equilibration of a crystallization assay can thus be represented as a parametric plot 
through phase-space, having time as the independent variable.  It is instructive to examine 
the phase-space evolution of the two most commonly used crystallization screening 
formats, microbatch and vapor diffusion (Figure 14).  In microbatch crystallization the 
protein is mixed at a one to one ratio with a precipitating agent and then incubated under a 
layer of immiscible oil.  The immiscible oil prevents dehydration/concentration of the drop 
so that a microbatch experiment samples only a point of phase-space.   
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Figure 14:  Schematic diagram of the evolution of hanging drop and microbatch 
experiments through a two-dimensional phase-space having macromolecule 
concentration and precipitating agent concentration as variables.  The phase-space is 
divided into Stable, Metastable, and Labile regions.  In microbatch experiments incubated 
under an immiscible oil (1:1 mixing ration) are represented as a single point (red) on the 
bisection of a tie-line connecting the initial protein concentration (Po) and precipitant 
concentration (Co).  Hanging drop experiments allow post-mixing equilibration through 
vapor diffusion with a large reservoir of precipitating agent, slowly concentrating the 
reagents, and driving the sample into the super-saturation region (orange).  Depletion of 
protein due to precipitation or crystal growth is not included in the figure.     
 
In vapor diffusion experiments the protein and precipitant solutions are initially mixed at a 
one to one ratio, and are then suspended over a large reservoir of the concentrated 
precipitant solution.  The drop subsequently equilibrates with the reservoir through a 
process of vapor diffusion until the vapor pressures of the drop and the reservoir are equal.  
This results in a monatomic concentration of the drop over time.  This evolution is 
represented by an upward arrow in phase-space (orange).   
 
Microbatch and vapor diffusion methods exhibit phase trajectories that are stagnant or 
monotonically increasing in supersaturation.  The point sampling behavior of microbatch 
experiments results in an inefficient sampling of phase-space when compared to vapor 
diffusion which allows for a continuum of conditions to be explored through drop 
evaporation.  However, the monatomic increase in both protein and precipitant 
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concentration does not provide the desired transiently high levels of supersaturation for 
nucleation followed by regression to the metastable regime for high-quality crystal growth.  
Furthermore, in microbatch or hanging-drop experiments, the sudden addition of the 
precipitating agent to the protein sample induces rapid convective mixing resulting large 
transient concentration gradients throughout the drop.  The corresponding high levels of 
supersaturation that occur at the fluid/fluid interface often result in the immediate and 
irreversible precipitation of the protein.  
 
As an alternative to microbatch and vapor diffusion formats, the technique of free interface 
diffusion (FID) allows for both slow and controlled mixing and efficient phase-space 
evolution.  In conventional FID experiments a liquid/liquid interface is established between 
the protein and precipitant solutions in a capillary tube (top of Figure 15).   
 
As the reaction begins, a slow equilibration of the molecular species across the interface 
occurs by diffusion.  Each species present in the reaction equilibrates at a rate determined 
by its diffusion constant.  The diffusion constant of a particle may be approximated through 
the Stokes-Einstein relation: 
 
    
r
KTD πη6=  ,    (6) 
 
where η is the solution viscosity in kg/ms, and r is the hydrodynamic radius of the particle.  
The inverse dependence of the diffusivity on radius implies that small molecule 
precipitating agents will equilibrate much faster than larger protein molecules.  For 
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example, a salt ion with a radius of 1 Ǻ has a diffusion constant in water of approximately 
1000 µ2/s.  By comparison a typical protein molecule of radius 10 nm will have a diffusion 
constant of 10 µ2/s.  The counter-diffusion of analytes with different diffusion constants 
along a capillary of constant cross section results in a complex spatial-temporal evolution 
of the concentration profiles (Figure 15) (46, 47). 
  
 
 
Figure 15:  Conventional FID reaction.  (top)  Protein (blue) and salt (red) solutions are 
brought into intimate contact at a fluid-fluid interface within a capillary of constant cross 
section.  (bottom)  Evolution of protein (blue) and salt (red) concentration profiles due to 
counter-diffusion of species across the interface.  Diffusion constants of salt and protein 
are taken to be 1000 µ2/s and 10 µ2/s respectively.  Concentration profiles are shown at 
even 1 day time intervals from t = 0 days (step function) to t = 10 days.    
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Let us consider two observation points, A and B, located some fixed distance on either side 
of the interface (Figure 15).  Shortly after the reaction commences the protein concentration 
at point A changes very little, while that of the precipitating agent, which typically has a 
much larger diffusion constant, increases towards the final concentration determined by 
initial the mixing ratio.  Subsequently, over a larger timescale, the protein concentration 
equilibrates, decreasing towards the final protein concentration that is again determined by 
the mixing ratio.  The concentration profile at point A therefore travels a curved path 
through phase-space, potentially sampling efficient crystal nucleation conditions in the 
labile region prior to settling into a high-quality growth regime in the metastable region.  
As the solutions homogenize, the evolution at point B follows a complementary trajectory 
to A, ultimately converging to the same final state (Figure 16). 
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Figure 16:  Phase-space evolution of FID reaction at two observation points (Figure 15) 
equidistant from the fluid-fluid interface.  Points represent even 1 hour time steps from t 
= 0 hours to t = 240 hours.   
 
Free interface diffusion has long been recognized as an efficient means of detecting 
crystallization conditions that has distinct advantages over microbatch or vapor diffusion 
techniques (45).  Despite the favorable kinetics of conventional free interface diffusion, this 
method has not been widely adopted in the protein crystallography community for a 
number of reasons.  For example, conventional FID setups require that solutions be 
carefully introduced into opposite ends of the capillary using a thin needle.  This is a 
delicate and labor-intensive technique making it illsuited to high-throughput screening.  
Moreover, the diameter of the capillary must be of substantial size (typically 1mm), 
necessitating the use of relatively large sample volumes (generally > 5 µL).  Furthermore, 
the introduction of the second fluid causes transient convection, resulting in a poorly-
defined interface which may only be reduced by cumbersome procedures such as the 
introduction of hydro-gels or the prior freezing of the first solution.  The intrinsic 
drawbacks of large required volume, delicate dispensing, and poorly-defined interface have 
thus prohibited the use of FID as either a routine or large-scale automated screening 
technique. 
 
Even when a well-defined fluidic interface can be created, buoyancy-driven convection, 
due to density differences in the solutions causes complex mixing at the interface.  To 
avoid unwanted mixing, capillaries must be stored with the long axis parallel to gravity, 
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and with the more dense solution on the bottom.  This configuration creates a stable fluidic 
interface, but often causes nucleated crystals to fall away from the interface and out of the 
optimal growth conditions.  It has thus been proposed that free interface diffusion would 
only realize its practical advantages in microgravity environments were gravity-induced 
convection is eliminated (40, 48).  However, the unusual properties of fluid flow in 
microfluidic devices make it both possible and practical to implement nearly ideal free 
interface diffusion conditions in terrestrial devices.  The relevant non-dimensional number 
that governs the onset of convection in a closed fluidic system is the Grashof number 
(which measures the ratio of buoyant to viscous forces): 
 
Gr
cgL= α ν
∆ 3
2
 ,    (7)   
 
where α is the solutal expansivity (cm3/mg), ∆c is the difference in solute concentration 
(mg/cm3), g is the acceleration of gravity (cm/s2), L is the characteristic dimension of the 
container (cm), and ν is the kinematic viscosity (cm2/s). 
 
At low Grashof number the interface between two distinct solutions brought into intimate 
fluidic contact is stable.  Inspection of Equation 7 suggests that this condition may be 
achieved at high solution viscosity (49), in microgravity environments (50) or at small 
characteristic length scales.  Space-born free interface diffusion experiments have been 
conducted in microgravity environments.  These investigations have shown that stable 
fluidic interfaces are achievable and further suggest that crystals of increased perfection 
may be grown in microgravity (50, 51).  However, the enormous expense of conducting 
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space-born experiments prohibits its use as a screening technique, so that investigation has 
been limited to well-characterized model proteins.   
 
Artificially increasing the solutal viscosity through the addition of polymerizing hydrogels 
has been investigated as a technique for achieving low Grashof number mixing in terrestrial 
devices (49, 52).  In particular, the gel-acupuncture method has been advanced as a method 
of realizing purely diffusive mass transport in crystallization assays.  This method has been 
successful over a broad range of crystallization targets and has been used to produce high-
quality crystals of novel crystallization targets.  Despite this success, several limitations 
have prevented general use of this technique.  In particular, this technique has not proved 
amenable to small volume, large-scale crystallization screening.  Additionally, the 
requirement of including a polymerizing gel into the crystallization reagents presents an 
undesirable constraint on the chemistry.  An optimal crystallization technique should allow 
for independent control over both the chemical composition and mixing kinetics.  
 
The third power dependence of the Grashof number on the characteristic length suggests 
reducing the critical dimension of the reactor as a means to suppress convection and 
achieve purely diffusive mass transport.  Five microfluidic reactors designed to provides 
exactly this property are shown in Figure 17.  Microfluidic free-interface diffusion (µFID) 
through a constricted channel connecting two microwells allows for the slow counter-
diffusion of the precipitant and protein solutions.   
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Figure 17:  Microfluidic free interface diffusion (µFID) reactors.  5 pairs of microwells 
are designed to implement 5 simultaneous FID reactions at mixing ratios 4:1, 2:1, 1:1, 
1:2, and 1:4.  Total volume of each reactor is 10 nL. 
 
In this configuration the final concentration of each reactor is determined by the relative 
volume of the coupled microwells.  Opening the interface valve that separates the protein 
from the precipitating solution creates a well-defined fluidic interface that allows for 
diffusive equilibration of the coupled microwells.  Due to the different mixing ratios the 
individual trajectories of each reactor fan out in phase-space, thereby providing efficient 
coverage of potential crystallization zones (Figure 18).  
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Figure 18:  The evolution of 3 µFID reactions having mixing ratios 3:1, 1:1 and 1:3.  
Curves represent the average state of both the sample side (top) and precipitating agent 
side (bottom) of each compound well.  The curves are representative of a counter-
diffusion between Lysosyme and sodium chloride and agree qualitatively with numerical 
finite element simulations.  A decrease in protein concentration due to precipitation or 
crystal growth is not included in the figure.   
 
A further advantage of the constricted channel between the two wells is that only a very 
small fraction of the protein sample is exposed to large transient gradients that occur 
shortly after the interface is established.  More concentrated precipitating solutions may 
therefore be used with negligible immediate precipitation so that higher levels of 
supersaturation may ultimately be achieved. 
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C h a p t e r  4  
MICROFLUIDIC FREE INTERFACE DIFFUSION: SCREENING DEVICE 
Parallel Implementation of µFID 
The simple geometric metering architecture (Figure 17) allows for the facile 
implementation of nanoliter µFID crystallization assays in which the endpoint, and hence 
the trajectory through phase-space, may be accurately controlled.  Furthermore, since this 
technique is robust to the properties of the resident fluid and does not require precise valve 
timing it is scaleable to massively parallel architectures.  The robust and precise metering, 
simplicity of control, and highly efficient mixing kinetics of this technique have been used 
to implement a microfluidic screening device for protein crystallization in ultra-small 
volume reactions (Figure 19) (29).  The current version of this device implements 240 
simultaneous metering and mixing reactions while consuming only 3.0 µL of protein 
solution; this represents a reduction of approximately 100-fold in sample consumption 
when compared to traditional crystallization techniques.   
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Figure 19:  Microfluidic protein crystallization screening device. 
 
A layout of the chip showing 48 reaction centers, each consisting of 5 µFID reactors with 
mixing ratios of 1:4, 1:2, 1:1, 2:1 and 4:1 is shown in Figure 20.  Each pair of chambers is 
connected to the protein sample and one of 48 crystallization solution inlets.  Parallel 
control of 720 integrated valves is achieved through two control lines that separately 
address 240 interface valves and 480 containment valves.  By virtue of this parallel 
architecture the device may be used to simultaneously mix and meter 48 solutions of 
varying viscosity, surface tension, pH, and ionic strength at five different mixing ratios 
using only two hydraulic control lines.   
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Figure 20:  Layout of crystallization screening device.  Flow layer is molded from a 
multilevel negative master having both 13 µm high flow channels fabricated from 5740 
photoresist (blue), and 45-micron-high microwells and inlet channels fabricated from 
SU8 2050 resist (black).  The high SU8 inlet structures prevent channel collapse during 
loading. Control structure (red) consists of two separately addressable networks for 
actuation of interface and containment valves.  Forty-eight 4 µL reagent wells allow for 
direct loading of the crystallization reagents.     
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The chip is contained within a carrier device (Figure 21) that facilitates loading, storage, 
and interfacing with the control lines.  The chip is secured in the base of the carrier with the 
interface line directly connected to one of two carrier interface pins that are externally 
accessible.  The containment line interface pin is connected to the chip through a pressure 
accumulator.  Once charged, this accumulator acts as an on-board pressure source to 
maintain actuation of the containment valves for several weeks, thereby allowing the chip 
to be stored and transported without the need for any external connections.   
 
 
 
Figure 21:  Crystallization chip inside carrier device.  Pressure reservoir (right) allows 
for free transport and storage of chip.  Interface pins (front) allow for easy loading and 
control of chip valves. 
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The top of the carrier has two cavities with a raised lip around their periphery and stainless 
steel input ports for pressurization.  The cavities mate with the 48 reagent wells, creating a 
seal against the compliant elastomer chip when the plates are pressed together.   3 µL of 
each of the 48 crystallizing agents is introduced into the reagent wells of the chip using gel 
loading pipette tips (Figure 22).  Since the crystallization reagents are loaded directly onto 
the chip there is no need for connecting 48 separate tubing connectors, greatly simplifying 
operation.  Once the carrier is assembled the cavities are pressurized, simultaneously 
injecting the 48 crystallizing agents into the chip.  The protein sample is then loaded 
through a single port located in the center of the chip.  4 µL of protein sample are aspirated 
into a pipette tip, and the tip is inserted into the protein port.  The tip is then pressurized 
through an adapter, injecting the protein into the 240 reaction chambers.  Since the sample 
is introduced through a single port, there is very little lost at the interface, and a true 
economy of scale is realized with more than two thirds of the sample being used in the 
crystallization assays.   
 
 
Figure 22:  Loading of crystallization agents directly into reagent wells. 
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This device represents the first scaleable implementation of free interface diffusion in a 
format suitable for high-throughput structural biology initiatives.  The ability to efficiently 
screen crystallization conditions in a small-volume format represents an enormous savings 
in the costs associated with upstream expression and purification processing.  The modest 
requirements in peripheral fluidic hardware, small footprint, and simple operation make 
this device practical for use in both high-throughput crystallization facilities and in 
specialized academic labs.  Furthermore, the inexpensive fabrication of these devices 
should be possible once adequate production technology is in place, making chip-based 
crystallization economical when compared to commercial liquid handling robots.  It is 
hoped that this will democratize the field of structural biology, making small volume 
crystallization accessible to small academic laboratories.  
 
Crystallization Results 
An initial validation study of on-chip protein crystallization by µFID was conducted on 8 
model macromolecules including 7 commercially available crystallization standards, 
(Lysosyme, Glucose Isomerase, Xylanase, Thaumatin, Protease K, Bovine Trypsin, and 
Beef Liver Catalase), and 1 protein with unpublished structure (bacterial primase catalytic 
core domain).  The bacterial primase catalytic core domain was chosen since it had 
previously been extensively screened, and was known to be difficult to crystallize.  Each 
protein was tested against two or more commercially available standard sparse matrices of 
precipitants. To compare crystallization in chip against standard crystallization methods, 
crystallization experiments were repeated for 9 of the model macromolecules using the 
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conventional microbatch and hanging-drop techniques; this allowed the precipitant 
chemistries to be kept constant while varying the kinetic scheme for crystal growth. 
 
Crystal growth was observed in the chips for all model macromolecules tested, and showed 
an excellent degree of correlation with successful conditions revealed by more standard 
screening techniques.   Crystals of 6 different protein models grown in chips are shown in 
Figure 23.  A histogram comparing the number of successful experiments obtained by each 
method for 8 model proteins (Figure 24) shows enhanced crystallization success in the 
chip-based experiments.  Sparse matrix screens led to crystal growth more often in the chip 
than by conventional techniques in all but two cases (protease K and bovine trypsin).  The 
large number of crystallization hits obtained for Protease K in microbatch experiments is 
difficult to explain on the basis of mixing kinetics since microbatch should be the least 
efficient assay format.  Subsequent experimentation with a broad range of crystallization 
targets has shown this result to be anomalous – chip based crystallization screening has 
been found to generally produce more hits than conventional techniques. 
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Figure 23:  Optical micrographs of macromolecule crystals grown in chip.  (A) Chicken 
Egg White Lysosyme  (Sigma-Aldrich); 50 mg/mL in 0.2 M sodium acetate pH 4.7.  
Mixing ratio of 4:1 with 0.2 M Magnesium Chloride hexahydrate, 30% w/v iso-propanol, 
0.1 M Hepes-Na pH 7.5.  (B) Bacterial Primase catalytic core domain; 15 mg/mL in 
50mM sodium chloride, 20mM TRIS-HCl pH 8.0, 1mM DTT.  Mixing ratio of 4:1 with 
1.4 M potassium/Sodium Phosphate pH 6.8.  (C)  Type II Topoisomerase ATPase 
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Domain / ADP; 12 mg/mL in 100mM sodium chloride, 20 mM TRIS pH 7.0.  Mixing 
ration of 1:1 with 0.2 M ammonium fluoride, 20% w/v polyethylene glycol 3350, pH 6.2.  
(D) Thaumatin (Sigma-Aldrich); 50 mg/mL in 0.1 M ADA (Sigma Aldrich) pH 6.5.  
Mixing ration of 1:1 with 0.8 M potassium sodium tartrate tetrahydrate, 0.1 M HEPES 
pH 7.5.  (E)  Xylanase (Hampton Research); 43% w/v glycerol, 180 mM Na/K phosphate  
pH 7.0.  Mixing ratio of 4:1 with 0.2 M calcium chloride dihydrate, 28% v/v polyethelene 
glycol 400, 0.1 M HEPES pH 7.5.  (F)  Glucose Isomerase (Hampton Research) 31 
mg/mL in 10 mM ammonium sulfate.  Mixing ratio of 1:1 with 0.2 M calcium chloride 
dihydrate, 28% polyethelene glycol 400, 0.1 M HEPES pH 7.5.  Scale bars are 100 µm.  
All scale bars are 100 µm.  
 
 
 
Figure 24:  Histogram of crystallization hits for sparse matrix screens of model proteins.  
Number of screens tested on each protein are Lysosyme (Lys) = 2, Glucose Isomerase (GI) 
= 2, Protease K (PK) = 1, Bovine Liver Catalase (BLC) = 1, Xylanase (Xy) = 2, Bacterial 
Primase catalytic core domain (BPC) = 3, Bovine Pancreas Trypsin (BPT) = 1, Thaumatin 
(Th) = 1, mycobacterial RNase (MBR) = 3.  
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In the case of the bacterial primase catalytic core domain the chip-based experiments 
showed a dramatic improvement in success rate.  µFID experiments identified 11 
conditions that produced needle crystals of dimensions greater than 100 µm while no hits 
were observed in either macroscopic method.  An additional on-chip experiment 
optimizing around the crystallization conditions identified from the initial screen produced 
crystals whose largest dimension exceeded 400 µm (Figure 23B).  These conditions were 
subsequently transported to microbatch format.  This example suggests that optimized on-
chip crystallization conditions may be successfully exported to macroscopic techniques. 
 
Finally, crystal growth in µFID experiments was generally observed to be faster than in 
microbatch or hanging-drop formats.  For the type II topoisomerase ATPase domain crystal 
growth in microbatch required 2 weeks while crystals grown on chip with the same 
conditions appeared after only 4 hours of incubation.  When crystals grew on chip in less 
than 12 hours, they were always observed on the protein side of the compound well, 
suggesting that the short crystallization times are due to the high degree of supersaturation 
achieved in the initial phase of diffusive equilibration.   
 
In conventional screening formats reagents are generally mixed in a one-to-one ratio so that 
the influence of mixing ratio is rarely investigated.  In chip based experiments different 
mixing ratios are set in parallel with no increase in setup time or complexity.  In many 
cases protein/precipitant mixing ratio was found to be an important screening parameter, 
influencing both the success and morphology of crystallization.  Figure 25 shows the 
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dependence of mixing ratio on the crystallization of a type II topoisomerase ATPase 
domain and of DNA B/C helicase complex. 
 
 
 
Figure 25:  Variability in crystallization behavior due to different protein/precipitant 
mixing ratios.  (A) Crystals of DNA B/C helicase; 14 mg/mL grown at 4:1 (left), 1:1 
(center), and 1:4 (right) mixing ratios of protein sample with 2.0 M (NH4)2SO4, 
phosphate-citrate pH 4.5.  (B)  Crystals of Type II Topoisomerase ATPase Domain / 
ADP; 12 mg/mL in 100mM sodium chloride, 20 mM TRIS pH 7.0.  Mixing ratio of 4:1 
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(left), 1:1 (center), and 1:4 (right) with 0.2 M ammonium fluoride, 20% w/v polyethylene 
glycol 3350, pH 6.2.  All scale bars are 100 µm. 
  
Consistent with the localization of large initial concentration gradients to the relatively 
small volume of the connecting channel, µFID-based chip experiments resulted in reduced 
protein precipitation.  It was observed that the mixing ratios and concentration of 
crystallization agents that lead to crystallization on chip often caused the protein to 
immediately precipitate in hanging drop and microbatch experiments.  In the case of a type 
II topoisomerase ATPase domain, the final concentration of precipitating agent achievable 
in chip was 4 times greater than that possible for microbatch.    
 
Beyond experimentation with well-characterized crystallization standards the present 
technique has proven useful in the crystallization of outstanding and challenging 
macromolecule targets.  During these trials, chip-based µFID reactions have been used to 
crystallize membrane proteins, large macromolecule complexes, and targets that had failed 
to produce crystals by conventional screening techniques.   
 
The crystallization device has been used for the de novo crystallization of 3 targets (a type 
II topoisomerase, a transferring receptor heterodimer complexed with HFE (hdTfR/HFE), 
and 10 MDa vault protein assembly) that had not previously been successfully screened by 
conventional methods.   A single device was used to screen the topoisomerase protein 
against a commercially available sparse matrix screen (Hampton Crystal Screen I; 
Hampton Research).  After 24 hours of incubation this screen identified 18 conditions that 
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gave crystals exhibiting varied quality and morphologies including some large single 
crystals (Figure 23C).  Crystals obtained from 10 of these conditions were reproduced in 
microbatch format and were ultimately used to collect data at a resolution of 2 Ǻ (53).   
 
hdTfR/HFE is a complex of an engineering heterodimer of transferrin receptor mutants 
(hdTfR) and HFE, a protein implicated in hereditary hemochromatosis (54).  The 
hdTfR/HFE complex was screened against 4 commercially available sparse matrix screens 
(Hampton Crystal Screen I, Hampton Crystal Screen II; Hampton Research, Wizard I, 
Wizard II; Emerald Biostructures), resulting in the identification of 3 conditions that gave 
rise to small (approximately 5 micron) plate clusters.  Two rounds of subsequent 
optimization using systematic grid screens resulted in plate clusters and some single plates 
having maximum dimensions of approximately 50 microns (Figure 26A).  It was 
determined that hdTfR/HFE crystallized only in a very narrow range of conditions, and in a 
specific protein/precipitant mixing ratio.  Changing the concentration of precipitant (PEG 
MME 750) by as little as 1% from the successful condition (17% v/v PEG MME 750, 100 
mM TRIS·HCl pH 7.6, 250 mM NaCl) did not produce crystals.   Efforts to export these 
conditions to microbatch and hanging drop formats have thus far been unsuccessful despite 
highly resolved screening of precipitant and salt concentrations. 
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Figure 26:  Optical micrographs of macromolecule crystals grown in chip.  (A)  Needle 
clusters of hdTfR/HFE complex.  13 mg/mL sample mixed at 1:1 ratio with precipitant 
(17% v/v PEG MME 750, 250 mM sodium chloride, 100 mM TRIS·HCl pH 7.6).  (B)  
Rod cluster of P450 Alkane Hydroxylase  MUT 139-3.  30 mg/mL sample mixed at 1:1 
ratio with precipitant (30% w/v PEG 8000, 0.2 M sodium acetate, 50 mm sodium citrate 
pH 5.5).  (C)  Rod crystals of DNA helicase B/C complex.  15 mg/mL sample mixed at 
1:1 ratio with precipitant (1.26 M (NH4)2SO4, sodium cacodylate pH 6.5)  (D)  Crystals 
of Vault.  3 mg/mL protein sample mixed 1:1 with precipitant (15% PEG 400, 0.2 M 
sodium citrate, TRIS·HCl pH 8.5)  (E)  Crystals of E. coli aquaporin AqpZ.  20 mg/mL 
sample mixed at 3:1 ratio with precipitant (28% v/v PEG MME 2000, 200 mM , 4% 
isopropanol 100 mM magnesium chloride, 100 mM sodium cacodylate pH 6.5 ) (55)  (F)  
Crystal of Probable ribonuclease III (RNASE III) from mycobacterium tuberculosis 
Rv2925.  7 mg/mL sample mixed at 1:3 ratio with precipitant (20% (w/v) PEG-8000, 
Ca(OAc)2, MES pH 6.0)  (G)  Crystal of 70s ribosome.  Approximately 5 mg/mL sample 
mixed at 1:1 ratio with precipitant (18% w/v PEG 8000, 0.2 M calcium acetate, 100 mM 
sodium cacodylate pH 6.5)  (H)  Crystals of mechanosensitive ion channel of large 
conductance (MscL) from E. coli.  20 mg/mL sample mixed at 1:4 ratio with precipitant 
(35 % PEG 600, 100 mM ammonium sulfate, 100 mM sodium cacodylate pH 6.5).  (I)  
Crystals of DNA condensin complex cndD/G/H.  20 mg/mL sample mixed at 4:1 with 
precipitant (10 % w/v PEG 8000, 8% v/v ethelyne glycol, 0.1 M HEPES pH 7.5)  
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Vault is an extremely large (13-MDa) ribonucleoprotein assembly, composed of three 
proteins (TEP1, 240 kDa; VPARP, 193 kDa; and MVP, 100 kDa) that are highly 
conserved in eukaryotes and an untranslated RNA (vRNA).  This complex is of interest 
to nanotechnology as a potential vehicle for drug delivery and has also been implicated in 
the multidrug resistance in cancer cells (56).  Although two-dimensional crystals were 
reported during cryo-electron microscopy studies, severe limitations in sample 
availability had prevented conventional crystal screening, making it an ideal target for 
chip-based experimentation.  Vault was screened in the µFID format against (3) 
commercial sparse matrix screens (Crystal Screen; Hampton Research, Wizard I and 
Wizard II; Emerald Biostructures).  Large single plate crystals having largest dimensions 
of approximately 100 microns were detected in three conditions (Figure 26D).  These 
conditions were successfully exported directly to hanging drop format.  Preliminary 
diffraction data at low resolution has been collected from these crystals (D. Eisenberg, 
personal communication).      
 
Different crystal forms of a macromolecule can exhibit large variations in robustness, 
size, shape, and perfection.  Since not all crystal forms will be suitable for high-quality 
diffraction studies, it is often of interest to detect new crystallization conditions.  The 
greater efficiency of µFID crystallization screening allows for novel conditions to be 
identified which were missed by traditional screening.  A previously unidentified crystal 
form of the bacterial 70S ribosome was obtained (Figure 26G) in three conditions of a 
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sparse matrix of precipitants (Hampton Crystal Screen I), demonstrating that large 
protein/nucleic acid complexes may be crystallized in chip (C. Hansen, A. Vila-Sanjurjo, 
and J. Cate, personal communication).   
 
P450 139-3 is refers to the heme domain of a mutant of P450 BM-3 from Bacillus 
megaterium (P450 BM-3).  P450 139-3 is a highly efficient catalyst for the conversion of 
alkanes to alcohols (57).  P450 139-3 had failed to produce crystals from initial screens in 
vapor diffusion format.  Subsequent broad-based screening gave rise to very thin 
(minimum dimension less than 1 micron) needle crystals.  A single round of chip-based 
screening using standard sparse matrix screens resulted in the identification of novel 
conditions giving rise to single three-dimensional rod-shaped crystals (Figure 26B).  
Crystals were scaled up and harvested using larger-volume µFID format (see Chapter 8), 
and subjected to diffraction studies.  Initial diffraction produced reflections out to 
approximately 10 Ǻ resolution.  The low resolution diffraction was likely in part due to 
poorly optimized cryo-protection and mechanical damage during harvesting; crystals 
showed visible cracking and melting during harvesting process.  Subsequent protein 
preparations gave rise to markedly different behavior, failing to produce crystals.  This 
study was ultimately abandoned due to difficulties in obtaining protein samples of 
consistent quality from our collaborators.   
 
Chip-based µFID has further proved applicable to the crystallization of integral membrane 
proteins.  In one study (performed at Fluidigm Corporation in collaboration with B. Stroud) 
a successful condition for the crystallization of an ion channel (aquaporin AqpZ from E. 
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coli) identified in hanging drop, and transported directly to chip resulted in large single 
crystals; demonstrating that membrane proteins can be crystallized in nanoliter volume 
silicone µFID reactors (Figure 26E).   
 
In a second study a previously crystallized mechanosensitive ion channel (MscL) was 
screened against 5 sparse matrix screens (Hampton Crystal Screen I, Hampton Crystal 
Screen II, Hampton Peg Ion Screen, Emerald Biostructures Wizard I, Emerald 
Biostructures Wizard II) at 20 °C and 4 °C.  MscL refers here to the mechanosensitive ion 
channel of large conductance from E. coli.  MscL is a member of a large family of 
mechanosensitive channels implicated in the regulation of osmotic pressure in prokaryotes 
(58).  10 successful conditions were identified in the experiments performed at 4 °C; room 
temperature screening produced only phase separation.  The chip-based crystallization 
conditions showed excellent agreement with those identified in hanging drop experiments, 
and included an additional crystallization condition.  This novel condition was optimized 
and transported to larger volume µFID format (see Chapter 8) to grow large crystals that 
diffracted to low resolution (approximately 9 Ǻ).  Attempts to improve resolution by 
screening cryo-protectants were unsuccessful.  The low resolution diffraction is consistent 
with data collected from crystals optimized from hanging drop formats and suggests low 
intrinsic crystal order.  One possible source of crystal disorder that has been suggested is 
the incomplete cleavage of HIS tags from the protein subunits, resulting in a heterogeneous 
protein sample (S. Steinbacher, personal communication).   
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For target macromolecules that exhibit a very narrow crystallization slot, the growth of 
high-quality crystals is dependent on achieving optimal mixing kinetics.  In some cases, 
such as the hdTfR/HFE complex, crystallization may require very specific mixing kinetics 
and conditions which are difficult to acheive in microbatch or vapor diffusion formats.  In 
other cases, the highly efficient mixing kinetics realized in µFID reactions may be used to 
change the habit and improve the quality of crystals grown using conventional techniques.  
One such example is the crystallization of a 450 KDa DNA B/C helicase loader complex.  
DNA B is the bacterial hexameric replicative helicase and DNA C is the accessory protein 
that mediates DnaB loading at replication initiation sites.  In this study hanging drop 
conditions based on sulfate salts were found that produced very small (maximum 
dimensions of 5 µm, minimum dimensions < 1 µm) poorly formed needles.  No 
improvement in the size or morphology of these crystals was achieved despite attempts at 
optimization through extensive grid and additive screening.   Independent screening of this 
complex against standard sparse matrix screens identified similar crystallization conditions 
based on ammonium and lithium sulfate salts.  Chip-based crystals were however of much 
higher quality, exhibiting three-dimensional hexagonal rod morphology with maximum 
dimensions of 200 microns, and minimum dimension of 25 microns (Figure 26C).  
Although harvesting of these chip-grown crystals has been problematic, initial diffraction 
studies from a single crystal that was grown in hanging drop (and could not be reproduced) 
showed reflections to 3 Ǻ resolution.  Indexing data from chip-grown crystals confirmed 
that the space group and lattice constants (space group P3; unit cell dimensions a=b=174.5 
Ǻ, c=87.98 Ǻ, α=β=90° γ=120°) were the same, suggesting that the crystals are 
intrinsically well ordered.  
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Perhaps the most striking result of these studies has been the rapid identification of 
crystallization conditions for novel targets that had been exhaustively screened without 
success.   In one instance, crystals of a mycobacterial RNase were obtained from a single 
experimental condition on chip (Figure 26F), whereas no crystals had been observed for 
this sample despite extensive prior trials using traditional methods.  Subsequent broad-
based screening efforts around this condition using hanging-drop vapor diffusion setups 
proved successful, but only after the protein concentration was increased from 7 mg/mL to 
> 40 mg/ml.  Crystals grown by vapor diffusion diffracted to 2 Ǻ resolution and were used 
to solve the structure of this protein (D. Aiky, personal communication).   
 
In another striking example a 750 KDa ternary complex (DNA D/G/H) (59), that had been 
in crystallization trials for over two years without success, was screened against 4 sparse 
matrix screens in chip.  DNA D/G/H refers here to a subassembly of the S. cerevisiae 
condensin complex comprised of the CndD, CndG, and CndH subunits.  It lacks the two 
ATP-binding subunits of condensin, Smc2 and Smc4.  After 2 days of incubation at 20 °C 
single three-dimensional crystals with rounded edges (maximum dimension 20 microns) 
were observed at a mixing ratio of 3:1 (precipitant : protein) in two related chemical 
conditions based on PEG 3350 and sodium acetate.  This condition was reproduced in a 
subsequent chip-based experiment performed at 4 °C, resulting in three-dimensional 
polyhedron-shaped crystals (maximum dimension 20 microns) with well-defined edges.  A 
systematic grid screening strategy varying precipitant concentration, salt concentration, and 
pH was used to successfully transfer this condition to hanging drop.  Initial diffraction 
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studies of these crystals gave very poor diffraction (highest-order reflections at 
approximately 20 Ǻ).  Subsequent protein preparations failed to produce crystals despite 
repeated trials over a period of approximately 4 months.  Crystals were finally recovered in 
chip-based trials by conducting a partial proteolytic digest of c-terminal residues (Figure 
26I).  Initial diffraction studies of chip-grown crystals displayed reflections to 
approximately 5.5 Ǻ resolution.  The crystals were in space group P3 with unit cell 
dimensions a = 223.11 Å, b = 223.11 Å, c = 265.56 Å,  α = β = 90.0°, γ = 120° (S. Gradia, 
personal communication).  Attempts to transfer this condition to hanging drop vapor 
diffusion format by systematic screening based on the chip condition were unsuccessful 
until a detergent additive was used.  The condition that ultimately gave crystals in hanging 
drop format included a detergent additive, had higher salt concentration, and lower peg 
concentration when compared with the successful chip condition.  These crystals showed 
diffraction to 5.5 Ǻ.  Unfortunately, subsequent protein preparations have again failed to 
crystallize despite meticulous reproduction of the initial expression, purification, and 
crystallization protocols.  Continued crystallization trials attempting to reproduce this 
success are currently underway.  Additionally, orthologues of this complex derived from a 
variety of organisms are being investigated as potentially more tractable crystallization 
targets (J. Berger, personal communication). 
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C h a p t e r  5  
SYSTEMATIC SOLUBILITY STUDIES: FORMULATOR DEVICE 
Introduction 
Understanding the phase behavior of proteins is an essential part of the crystallization 
process.  The growth of crystals from a protein solution requires the existence of a 
nontrivial phase diagram which allows the protein state to be manipulated between at least 
two thermodynamic phases: soluble and precipitated.  The processes of crystal nucleation 
and growth arise on the boundary between these two phases, and are governed by subtle 
effects in physical chemistry.  There are a variety of schemes that manipulate the kinetics 
of the crystallization process, and all take advantage of generic features of these phase 
diagrams (44).  However, in practice the phase behavior of very few proteins has been 
studied in detail (60-68), and solubility information for a specific protein is rarely available 
for crystallization and optimization experiments (69, 70). 
 
Furthermore, it is often an arduous process to find the right combination of chemicals that 
yields appropriate phase behavior for a given protein.  Every protein is different, and even a 
modest subset of stock precipitating solutions comprise a vast chemical phase-space that 
must be explored.  The large amounts of sample required make systematic exploration by 
conventional techniques infeasible, and screening is typically directed towards random 
sampling using an incomplete factorial or sparse-matrix approach, which is a brute-force 
process requiring large numbers of experiments (15, 34).  There have been numerous 
attempts to rationalize this procedure, for example by using computational approaches to 
 
 72
predict phase behavior (71, 72) or by trying to correlate measurements of osmotic 2nd virial 
coefficients (73, 74) with crystallization conditions.  Practical limitations have thus far 
prevented these techniques from being generally applicable. 
 
Although the small-scale characterization of protein solubility by a pre-crystallization 
solubility assay has been reported (15, 75, 76), this technique has not been widely adopted 
since the large required sample volumes make it unsuitable for targets that cannot be 
expressed and purified in large quantities.  Microfluidic technologies enable ultra-small 
volume processing and hence are ideally suited to address these problems.  Previously 
microfabricated dispensers have been used to reduce sample consumption in cases where 
the sequential addition of reagents to a levitated drop of microliter volume is sufficient to 
explore a restricted chemical space (76).  This Chapter describes the development of a 
microfluidic device that allows for the practical and systematic exploration of protein 
phase-space behavior. 
 
Combinatorial Mixing on Chip 
Thorough characterization of protein solubility behavior requires accessing a vast chemical 
space through the combinatorial mixing of a limited number of stock reagents.  The layout 
of a microfluidic formulator device that combines precise and robust PCI metering with 
microfluidic mixing (14) and multiplexing elements (27) is shown in Figure 27.  This 
design allows for unprecedented fluid handling capability and represents the first 
implementation of true combinatorial mixing on chip.   
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Figure 27:  Microfluidic formulator device.  Device allows programmable combinatorial 
mixing of 32 stock solutions (top), 8 buffer solutions (left) and a sample solution (center).  
27 pneumatic and hydraulic control lines are interfaced to external solenoid actuators 
through an array of control ports (bottom).  The control layer mold is patterned from a 
single mask shown in blue.  A multilevel flow layer is patterned from three separate 
lithography steps; 50 µm SU8 2075 for low impedance inlets and outlets (pink), 13 µm 
5740 for rounded channel structures compatible with integrated valves (green), and 10 
µm SU8 2015 for observation windows of rectangular cross section (yellow).   
 
The active region of an earlier version of the microfluidic formulation chip that allows for 
the arbitrary combinatorial mixing of 16 stock reagents into one of 16 buffer solutions is 
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shown in Figure 28A.  Two 16-solution multiplexer arrays, actuated by 8 control lines, 
allow for the selection of buffers (left) and reagents (bottom).  A PCI junction, formed by a 
3-valve peristaltic injection pump (red) and cross-injection valves (center green) dispenses 
directly into a 5 nL ring reactor.  Once the reactor has been flushed, a reagent line is 
selected and the cross-injection sequence is executed.  The extended split channel region 
increases the volume of the cross-injection junction, thereby allowing for up to 15 
injections.  The maximum number of consecutive injections that may be executed before 
the junction needs to be recharged depends on the Taylor dispersion (77) of the injected 
fluid as it is pumped down the channel, and is therefore a function of the analyte diffusivity 
and the flow rate.  Figure 28B shows the injection of 4 slugs, each having a volume of 80 
pL, into the ring reactor.  Arbitrary combinations of 16 reagents may be produced in the 
reactor by sequential flushing and injection steps.  Figure 28C shows a color gradient 
formed from the sequential injections of water, blue dye, green dye, yellow dye, and red 
dye.  In screening applications that require the interrogation of a precious sample against 
many pre-mixed reagent formulations, the cross-injection flushing step is wasteful and is 
circumvented by the injection of sample through a separate sample injection site (Figure 
28D).  After the ring is filled with the desired reagents, they are mixed by active pumping 
around the ring (14).   
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Figure 28:  Combinatorial mixing using a microfluidic formulator.  (A)  Integration of 
multiplexer (dark blue), peristaltic pumps (red), rotary mixer (yellow), and PCI junction 
(center green) components for on-chip combinatorial formulation.  The parallel 
multiplexer shown has been replaced with a binary tree multiplexer in more recent 
designs.  (B)  Injection of approximately 250 pL (4 injection cycles) of blue dye into 
rotary mixer.  (C)  Color gradient formed by consecutive injections into mixing ring (8 
injections blue, 8 injections green, 8 injections yellow, 8 injections red).  (D)  Pumping 
around ring for 3 seconds results in complete mixing of dye.  Blue dye is added to 
mixture through sample injection inlet (bottom right).   
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Robust and Precise Picoliter Metering 
The reagents used in crystallization exhibit a large variation in physical properties such as 
viscosity, surface tension, ionic strength, and pH.  This variation presents a formidable 
challenge for fluid handling systems that must allow for arbitrary fluid combinations and 
proportioning.  The positive displacement cross-injection metering method overcomes this 
obstacle, allowing for variable dispensing to be dynamically programmed by the user in 80 
picoliter increments with less than 5% variation over a broad range of fluid properties.   
 
The precision of metering was evaluated by injecting variable amounts of dye 
(bromophenol blue sodium salt; Sigma) into a reactor, mixing, and performing absorption 
measurements.  Measurements were taken to determine the concentration of bromophenol 
blue sodium salt (absorption peak at 590 nm).  A 9 µm high segment of the mixing ring 
(approximately 300 µm by 80 µm) having rectangular cross section was illuminated with a 
590-nm diode (AND180HYP; Newark Electronics) and imaged through a stereoscope 
(SMZ 1500; Nikon) onto a charge coupled device camera.  Pixel intensities were averaged 
and compared to an identical adjacent reference channel containing the undiluted dye (2 
mM bromophenol blue sodium salt, 100 mM TRIS-HCl pH 8.0).  In some experiments 
glycerol was added to the injected dye to vary the viscosity.  Dye concentrations were 
calculated using the Beer-Lambart relation as 
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where I0 is the intensity measured prior to injections, Iback is the background ccd intensity, 
Iref is the intensity measured in the reference channel, and Idata is the intensity measured in 
the ring.  The injected volume was then calculated from the measured concentration 
assuming a nominal ring volume of 5 nL determined by the measured height and geometry 
of the master mold. 
 
A set of 900 sequential titration experiments (Figure 29A) shows the metering to be both 
precise and reproducible, with a slope of 83.4 pL per injection cycle and a coefficient of 
correlation of 0.996.  The standard deviation of the injected slug volume was determined to 
be approximately 0.6 pL.  Although the positive displacement metering ensures that the 
injected volume is robust to changes in the fluid viscosity, the viscosity of the working 
fluid does however reduce the bandwidth of the injector.  It was found that for a solution 
having viscosity of 400 cP the frequency response of the injector began to roll off at 10 Hz.  
When operating at an injection frequency of 5 Hz all solutions having viscosities below 
400 cP produced even injection volumes.  Since the metering mechanism is completely 
mechanical, there is no dependence on the pH or ionic strength of the injected fluid.  
Additionally, since the fluid is not dispensed from the chip, there is no phase interface, and 
therefore little dependence on surface tension, so that the metering technique is truly robust 
to the physical properties of the injected fluid.  Titration experiments with fluids of varying 
glycerol concentration show the injection volume to vary by less than 5% over a viscosity 
range of 1 cP to 400 cP without any modification to the injection sequence (Figure 29B). 
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Figure 29:  Precise and robust microfluidic metering.  (A)  Absorption measurements 
showing high precision and reproducibility of PCI injections.  Each of the 9 clusters 
represents 100 identical injection sequences.  (B)  Absorption measurements of 4 sets of 
20 injection and mixing sequences showing metering to be robust to the viscosity of the 
injected fluid.  Fluids contain varying amounts of glycerol and have viscosity ranging 
from 1 cP to 400 cP (black = cP, blue = 40, red = 100 cP, green = 400 cP).   
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Cross-Contamination Issues 
The cross-contamination of reagents is a concern in formulation experiments that are 
sensitive to residual amounts of various chemicals that are present in the stock solutions.  
Within the formulator device cross-contamination may occur by three mechanisms: carry-
over within the PCI junction, adsorption to the elastomer walls, and unwanted mixing 
within the multiplexer structure.      
 
Carry-over within the PCI junction may be minimized by proper fluidic design and 
sufficient flushing protocols.  To ensure the complete exchange of reagents within the PCI 
junction during a flushing cycle it is necessary to minimize the dead volume of the 
junction.  This is accomplished by ensuring that the inlet of the junction is, within 
fabrication tolerances, directly adjacent to the mixing ring inlet.  A comparison between a 
poorly designed injector and a low dead volume injector is shown in Figure 30.  In the 
poorly designed injector (Figure 30A) a significant volume of fluid is caught in a stagnation 
region adjacent to the ring inlet and therefore is not efficiently exchanged by convection.  
In this case the complete exchange of fluids within the injector is limited by the 
characteristic time for diffusion of species out of the stagnation region.  In the low dead 
volume injector (Figure 30B) there is no appreciable stagnation region near the inlet so that 
convection can rapidly exchange the fluids.  In this case the flushing speed is only limited 
by the diffusion of species across the gradient of the flow profile (width of the channel) and 
is therefore much faster.  It should be noted that incomplete flushing at the stagnation area 
near the outlet of the injector does not contribute to contamination.  Absorption 
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measurements were used to quantify the injector carry-over during a flush cycle of 1.5 
seconds.  Using a low viscosity solution and standard operating pressure the carry-over 
(residual concentration of dye) was determined to be less than 5 parts in 10,000 (the limit 
of detection).     
 
 
 
Figure 30:  Comparison of injector designs.  (A)  Poorly designed injector having 
substantial dead volume.  (B)  Low dead volume injector. 
 
Possible contamination due to nonspecific adsorption of molecules to the walls of the 
container has not been thoroughly investigated.  The highly hydrophobic surface of the 
PDMS makes the adsorption of soluble small molecules unlikely.  However, due to their 
amphiphilic properties, the adsorption protein molecules to the elastomer surface is a 
concern.  For applications in which modest protein concentrations are employed this effect 
can be significant due to the large surface to volume ratio that is characteristic of 
microfluidic structures.  In the case of protein crystallization, this effect can safely be 
ignored due to the very high protein concentrations.  Considering a section of low aspect 
ratio channel of width 100 µm and height 10 µm, the surface area per unit length is 220 
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µm2.  The adsorption of a densely packed monolayer of protein having a characteristic 
dimension of 5 nm to this surface would require 8.8 x 106 molecules per unit length.  
Assuming a molecular mass of 40,000 Da, the total mass of protein adsorbed from a 1 km 
section of channel (1 mL) is approximately 0.5 mg.  Since protein concentrations used in 
crystallization are typically 10 mg/mL or more this represents only 5% of the total protein 
in solution. 
 
The parallel multiplexing structure (27) reported by Thorsen et al. consists of an array of 
parallel channels which are connected to a single cross-channel and addressed via an array 
of valves.  The large dead volume at the downstream end of each channel within this 
parallel multiplexing structure makes a certain degree of reagent cross-contamination 
unavoidable (Figure 31).  Although this contamination can be reduced to acceptable levels 
at the PCI junction by sufficient flushing it causes serious problems in the vicinity of the 
multiplexer due to unwanted reactions between reagents.  In the case of protein 
crystallization the stock solutions include various salts, polymers, buffers, and organic 
solvents.  The inadvertent mixing of certain combinations of these reagents can lead to 
phase separation, aggregation, or the formation of insoluble salts.  For instance, the mixture 
of phosphate salts with salts containing magnesium or calcium anions results in the 
instantaneous formation of insoluble magnesium/calcium phosphate salts.  Once insoluble 
salts are formed they quickly clog the microchannels and ultimately lead to device failure.  
This reagent incompatibility imposes very stringent demands on the fluidic design and 
flushing protocols.   
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Figure 31:  Contamination in parallel multiplexing structure.  (A)  Selection of reagent 
causes contamination in dead volumes at the inlets of remaining channels and at 
multiplexer outlet.  (B)  Sequential selection of reagents causes unwanted mixing within 
multiplexer.  
 
Initial attempts to eliminate this problem used an additional flush channel through which 
the front of the multiplexer could be flushed after every injection step.  A protocol of 
successive flushing and peristaltic pumping was used to prevent the unwanted mixing of 
reagents within the multiplexer.  Initially the multiplexer is filled with dionized water 
through the flush channel.  A reagent is selected and used to charge the PCI junction.  Once 
the reagent flush step is complete the multiplexer valves are closed and the front of the 
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multiplexer is flushed through the flush channel.  The valves of the multiplexer are then 
actuated in a peristaltic sequence to expel any contaminated reagent from the multiplexer.  
The front of the multiplexer is then flushed again and the multiplexer valves are pumped in 
the reverse peristaltic sequence to refill the multiplexer with dionized water.  In this way a 
“buffer” of water is used to maintain separation between the reagents and prevent unwanted 
mixing.  This protocol was successful in eliminating the formation of insoluble salts over a 
two week period of operation; in the absence of this protocol insoluble salt formation was 
observed within a minute of device operation.    
 
Although the protocol of successive flushing and pumping steps is effective at eliminating 
unwanted reagent mixing it adds considerable control complexity and has two undesirable 
drawbacks.  Firstly, the additional flushing and pumping steps are very time consuming and 
account for nearly half of the experiment time.  Secondly, it was found that in order to 
avoid unwanted mixing it was necessary to have more reverse pumping steps than forward 
pumping steps, leading to the growth of the dionized water “buffer” region over time.  
Charging of the PCI junction with a selected reagent requires that this buffer region be 
completely expelled and therefore requires that the flush time be increased.  Since the size 
of the “buffer” is determined by the history of the flushing sequence it is difficult to 
ascertain the appropriate length of each flush cycle.  Additionally, if a reagent is not used 
for extended periods of time the “buffer” becomes impractically large extending off the 
chip and into the connecting tubing.      
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In order to eliminate reagent cross-contamination and avoid cumbersome flushing 
protocols a low dead volume multiplexing structure was designed.  A binary tree flow 
channel structure that allows for low dead volume multiplexing of reagents is shown in 
Figure 32 (personal communication S. Maerkl).  N consecutive bifurcations originating at a 
single channel allow for the 2N inlet channels to be connected through equivalent fluidic 
paths.  Each level of the binary tree has pairs of valves at the bifurcations which allow for 
flow to be directed either to the left or right.  At the final level of the binary tree every 
second channel is a flush channel connected in parallel to a common flush inlet containing 
dionized water (Figure 27).  Operation of the device is as follows.  The reagent with which 
the PCI junction will be charged is selected and flushed through a path of the binary tree.  
Once the injection sequence is complete the least significant valves on the binary tree are 
reversed, causing water to be flushed through the tree by the same path that the previous 
reagent followed.  The binary tree is thereby restored to its original state and is ready for 
the next injection sequence.  Provided that the flushing step is complete this protocol 
completely eliminates the possibility of unwanted mixing within the multiplexer.  
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Figure 32:  Binary tree multiplexing structure.  Low dead-volume junctions and 
interleaved flush lines (blue) allow for zero reagent cross-contamination.  (A)  Selected 
reagent (green) is flushed through unique path of binary tree.  (B)  Reversing logic of 
least significant valves (top) restores the multiplexer to its original state.   
 
I/O Interfacing 
The utility of a technology depends ultimately on the ease with which it can be used.  
Invariably, time spent optimizing the robustness of a device, and engineering practical 
interfaces, results in increased productivity.  The large number of solution and control 
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inlets used in the formulator device presents a significant challenge for chip i/o interfacing.  
Individually connecting the 78 required fluidic connections that must be made is very time 
consuming and introduces the risk of incorrect connections being made.  Additionally, 
since the formulator uses extensive flushing protocols, and can operate for weeks at a time 
it is necessary that there be a sufficient reservoir of flushing, buffer, and stock reagents. 
 
In the case of the screening device the problem of introducing 49 separate solutions into the 
chip was solved by introducing each reagent into a separate inlet well using a pipette and 
then applying pressure to all reagents simultaneously via a seal with the top of the device.  
In the case of the formulator device, the footprint of the wells required to supply a 
sufficient volume of stock solutions (approximately 100 µL) is impractical.  To address this 
issue a manifold was designed that allows for 1 mL reservoirs of reagents to be interfaced 
to the device.  The base of the manifold consists of a Delrin® block into which an array 
circular holes has been machined to accommodate 1 mL Nalgene® centrifuge tubes (Figure 
33A).  The holes are designed such that, when inserted, the tops of the tubes are just below 
the surface of the block.  The block has a cover plate with an array of tapped 10-32 through 
holes that are aligned with the tubes (Figure 33B).  Fittings with 20 gauge stainless steal 
pins are screwed into each hole of the plate (Figure 33C).  O-ring seals at each fitting make 
an air-tight seal with the plate.  An O-ring seal between the plate and the block creates a 
closed chamber that may be pressurized through a single inlet located on the side of the 
block.  When assembled (Figure 33D) the end of each pin is immersed a separate reagent 
tube so that pressurizing the chamber causes the reagent to flow through the tube.  A thin 
layer of paraffin oil is added to the top of each tube to ensure minimal evaporation during 
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the course of an experiment.  The large volume of reagent in each tube (1 mL) is sufficient 
for continuous operation of the formulator over several weeks.      
 
 
 
Figure 33:  Reagent manifold for formulator device.  (A)  Delrin block with 
pressurization port (bottom left).  One reagent tube in inserted in hole array.  (B)  Top 
plate of manifold.  (C)  Fitting with o-ring and pin.  (D)  Assembled manifold shown with 
8 of 16 wells connected to tubing.  Remaining ports are occupied by plugs. 
 
In order to quickly and correctly establish the large number of connections required for the 
formulator operation, a standard one-touch connector was designed.  The connector 
consists of an aluminum piece with two rows of 16 through-holes bored at a 0.1˝ pitch.  
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The rows are separated by a distance of 0.1˝ and offset by 0.05˝.  Each hole accommodates 
a 1˝ long 20 gauge stainless steal pin that extends ¼ ˝ from the surface of the connector that 
mates with the chip (bottom).  The pins on the top of the connector are bent 90° and 
interface with microbore Taigon® tubing that is connected to the reagent manifold.  This 
32 pin connector is easily inserted and removed from the device to make quick 
connections.  The connection of a formulator device to 32 reagent lines and 32 control 
inputs via two one-touch connectors is shown in Figure 34. 
 
 
 
Figure 34: Microfluidic formulator device with one-touch 32 pin fluidic connectors.  
Stock reagents are introduced from manifold through a 32 pin one-touch connector (top).  
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Pneumatic and hydraulic control lines are interfaced through a separate 32 pin connector 
that interfaces with solenoid manifolds. 
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C h a p t e r  6  
MICROFLUIDIC MIXING: SCALING LAWS AND OPTIMIZATION 
Introduction 
Rapid microfluidic mixing is necessary for conducting the large number of experiments 
required for systematic phase-space mapping in a pratical time.  This Chapter discusses 
how the basic physics of microfluidic fluid flow and mass transport affect the design and 
optimization of the rotary mixer used in the formulator device.   
 
Achieving efficient mixing in the microfluidic environment is problematic due to the 
characteristic laminar flow that is manifested in these devices.  At the small length scales 
that are characteristic of microfluidic devices viscosity becomes dominant over inertial 
effects in mass transport phenomena.  Put simply, this implies that the fluid has no memory 
and that the flow field is instantaneously determined by the imposed boundary conditions.  
In particular the advection of momentum, which leads to turbulent mixing in macroscopic 
systems, is suppressed so that the flow is laminar.  The relative importance of viscous and 
inertial forces, and hence the onset of turbulence, is determined by the Reynolds number:  
 
Re = ρµ
UL
 ,    (9)  
    
 
where ρ is the fluid density (g/cm3), U is the characteristic velocity (cm/s), L is the 
characteristic channel dimension (cm) and µ is the viscosity of the fluid (g/cm·s).  For most 
flows in small channels the Reynolds number is small so that the flow is laminar and the 
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familiar turbulent mixing of macroscopic devices vanishes.  The transition from laminar to 
turbulent flow occurs at Reynolds numbers of approximately 2000.  By comparison, the 
flow of water at 1 cm/s down a 10 µm high channel has a Reynolds number of 10-1, and is 
therefore completely laminar.    
 
All mixing is ultimately accomplished by diffusion.  Accelerated mixing may therefore be 
accomplished by generating convective flows to increase interface areas, decrease 
characteristic diffusion lengths, and enhance concentration gradients.  In the case of 
macroscopic fluidic devices (like a coffee cup) this may be readily achieved through 
turbulent mixing.  Turbulent mixing gives rise to exponential reduction in characteristic 
separations, thereby causing rapid and efficient mixing.  For example, pulling a spoon 
through a coffee cup causes complete mixing within seconds.   
 
Turbulent mixing cannot be accessed in microfluidic devices that operate in the regime of 
low Reynolds number.  It is nevertheless possible to achieve exponential mixing by the 
process of chaotic advection.  The implementation of chaotic advection for efficient 
microfluidic mixing has been reported using three-dimensional flows created by spiral 
mixers (78), herringbone mixers (79), and reverse-micelle mixers (80).  All of these 
strategies achieve chaotic advection by means of a three-dimensional flow field.   
 
Generally, steady two-dimensional flows are integrable and cannot access exponential 
mixing by means of chaotic advection.  However, geometric mixing can be accomplished 
by the repeated “folding” or “kneading” of a fluid onto itself.  A rotary mixer based on this 
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principal was proposed by Chou et al. (14).  In this mixer two or more fluids occupying 
different sections of a ring-shaped channel structure are homogenized by active pumping 
around the ring.  Unlike the herringbone and spiral flow-through mixers which accelerate 
mixing between laminate streams of fluids flowing in juxtaposition along a channel, the 
rotary mixer is a batch mixer that homogenizes fluids that are serially introduced into the 
ring.  Fluids pumped around the ring are subject to a transverse gradient in the flow 
velocity due to the non-slip boundary conditions at the channel walls, resulting in the axial 
dispersion of analytes.  Mixing in this structure is accelerated through the combination of 
this axial dispersion and the periodic boundary conditions imposed by the ring structure.       
 
During mixing, molecules are subject to the combined effects of convection and diffusion.  
As molecules diffuse transversely across the channel they sample different flow rates.  The 
net dispersion, and hence the time required to homogenize different reagents, therefore 
depends on the relative contributions of convection and diffusion.  A comparison of the 
importance of these two effects is given by the non-dimensional Peclet number: 
 
    
D
ULPe = ,      (10) 
 
where U is the fluid flow velocity, L is the characteristic spatial dimension (say the width 
of the channel), and D is the diffusion constant of the analyte.   
 
The dispersion of an analyte due to pressure-driven flow down a channel of circular cross 
section was first described by G.I. Taylor in 1953 (77).  A thin slug of tracer particles 
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flowing down a channel is stretched by the non-uniform velocity profile.  The non-slip 
boundary condition imposed at the channel wall implies that a line of tracer particles is 
stretched to a thickness Umaxt in time t.  Therefore, in the absence of diffusion, the 
dispersion of the plug is generally linear in time.   
 
Diffusion of the molecules within the flow stream acts to significantly reduce dispersion.  
As the plug is stretched by the flow a transverse concentration gradient is established, 
thereby causing molecules to diffuse across streamlines from regions of high velocity to 
regions of low velocity and vice versa.  The characteristic time for a molecule to diffuse the 
width of the channel is τ = h2/D.  At the end of this time interval the molecule will be 
located somewhere within the slug that has stretched to a length of Umaxτ.  Therefore, at 
time t the net progress of the molecule down the channel can be approximated as a random 
walk of t/τ steps having an average step size of Umaxh2/D.  The dispersion of the molecules 
is therefore diffusive in nature with an effective diffusivity proportional to Umax2h2/D.  At 
long times a collection of molecules initially defined within a thin slug will evolve into a 
Gaussian distribution centered at Uavgt having mean squared displacement proportional to 
Umax2 h2/(Dt).  Figure 35 shows a finite difference time domain simulation of the dispersion 
of a line of tracer molecules in a two-dimensional parabolic flow profile.  Concentration 
profiles are shown after 10 seconds of dispersion for a maximum flow velocity of 100 
µm/s, and an analyte diffusivity of 100 µm2/s.  The Peclet number is varied by changing the 
channel width in each simulation to illustrate the qualitatively different behavior.  The 
Taylor dispersion description is only valid at long times when the molecules have sampled 
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the entire flow profile and large transverse gradients are relaxed.  In the simulation this 
condition is achieved in the case of Pe = 10. 
 
 
Figure 35:  Finite difference time domain simulation of dispersion of tracer particles in 
parabolic flow profile at varying Peclet number.  Diffusion constant is 100 µm2/s and 
maximum velocity is 100 µm/s  so that Peclet number is equal to the channel width in 
microns. 
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Dispersion in Low Aspect Ratio Channels 
The distribution of analyte along the stretched plug is determined by the gradient of the 
flow profile and hence depends on the exact geometry of the channel.  The viscous flow of 
an incompressible Newtonian fluid through a static structure satisfies the Navier-Stokes 
equation subject to non-slip boundary conditions.  For steady-state flow within a channel of 
constant cross section, and in the absence of body forces, this reduces to the one-
dimensional Poisson equation subject to Dirichlet boundary conditions, 
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The form of solutions to this equation is completely determined by channel geometry and is 
proportional to the ratio of the pressure gradient to the viscosity, which by similarity 
arguments must be constant along the channel.  In the previous discussion the Peclet 
number determining the Taylor diffusivity was based on the width of the channel.  As 
discussed below, this is appropriate for channels of semi-ellipsoidal (rounded) cross section 
but not for channels of rectangular cross section.   
 
Flow through low aspect ratio channels of rectangular cross section is described by Hele-
Shaw flow.  In general, viscous drag effects in low aspect ratio structures with constant 
height are dominated by the constricted dimension (height), so that lateral features 
(obstacles) only have significant effect on length scales comparable to the height.  In 
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situations where Re << h/w << 1, flow lines reproduce those of two-dimensional potential 
flow (flow at infinite Reynolds number) with a thin boundary layer.   
 
In the case of low Reynolds number flow through a shallow rectangular channel viscous 
drag is dominated by the height dimension so that only within a distance comparable to the 
height of the channel is there a significant effect of the wall.   This results in a velocity 
profile that is essentially constant across the width of the channel (Figure 36A).  In the 
vertical direction the flow profile is parabolic, resulting in large velocity gradients.  Since 
the channel height is much smaller than the channel width, gradients due to the wall no-slip 
condition do not significantly contribute to Taylor dispersion.  The relevant Peclet number 
for determining the Taylor dispersion in a shallow channel of rectangular cross section is 
therefore based on the channel height.  The nearly constant velocity profile across the 
largest dimension of the channel results in a dramatic reduction in Taylor dispersion when 
compared to flow through a channel of equal circular cross section.  The effective “Taylor 
diffusivity” in a rectangular 1:10 aspect ratio channel is U2A/(2100D) compared to 
U2A/(48πD) for a circular channel of equal cross sectional area A.    
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Figure 36:  False color plots of normalized flow velocity profiles down a 10 µm high, 
100 µm wide rectangular channel (top A) and a 13 µm high, 100 µm wide semi-
ellipsoidal channel (top B).  Average velocity profiles across channels obtained by 
integrating out height dependence (bottom A and B).  Curve fit to average flow profile in 
B is y = 1 – x2.       
 
Annealing flow molds to generate a rounded channel cross section has a dramatic effect on 
the flow profile and the magnitude of Taylor dispersion.  A common standard MSL flow-
channel geometry is a width of 100 µm and a 13 µm high semi-ellipsoidal cross section.  
The tapering of the height of channel away from the centerline results in a greatly enhanced 
fluid drag at the edges.  This drag generates large transverse velocity gradients and hence 
enhances dispersion.  Figure 36B shows a finite difference simulation of the flow profile 
through a 1:10 aspect ratio channel with semi-ellipsoidal cross section.  Integrating out the 
height dependence yields a flow profile that is nearly perfectly parabolic.  This profile is 
observed in experiments (Figure 37).  The flow profile in the vertical direction is also 
essentially parabolic due to the small curvature of the channel.  However, since the 
characteristic diffusion time across the width of the channel is much greater than that across 
the height (by a factor of 100 for 1:10 aspect ratio), the dispersion arising from the velocity 
gradient across the width dominates.  The appropriate Peclet number for channels of semi-
ellipsoidal cross section is therefore based on the width. 
 
 
 98
 
 
Figure 37:  Parabolic flow profile observed across width of semi-ellipsoidal channels. 
 
It is interesting that the thermal reflow of flow channels necessary for complete valve 
sealing results in the nearly perfect parabolic flow profile that is the two-dimensional 
analogue of Poiseuille flow through circular capillaries (the geometry treated in Taylor’s 
original paper).  The dispersion in the channel case is however greater than that of the 
capillary case.  In the capillary geometry the velocity is a function of the radius so that the 
occupancy of molecules is biased towards low velocities.  The parabolic flow profile 
combined with opposing linear occupancy results in a constant average concentration along 
the dispersing slug in the limit of very high Peclet number.   In the semi-ellipsoidal channel 
geometry the occupancy is biased towards high velocities due to the varying channel 
height, creating a more dispersive flow.   
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Rotary Mixing: Scaling Laws and Simulation 
In the rotary mixer the dispersion of analytes due to the combination of diffusion and 
convective dispersion is exploited to accelerate mixing.  As the Peclet number at which the 
rotary mixer is operated increases, the dominant mechanism of mixing changes.  The 
scaling laws that determine the mixing time as a function of Peclet number may be 
determined for three separate regimes of mixer operation.   
 
Very low Peclet number defines a regime of mixing that is dominated by diffusion.  In this 
regime a molecule has ample time to diffuse the full width of the channel before convection 
can impart any significant downstream displacement.  The molecules thus sample the entire 
flow velocity profile and therefore do not undergo appreciable flow-induced dispersion.  
The dispersion of a line of tracer particles will therefore be dominated by diffusion and will 
spread out into a Gaussian distribution centered at Uavgt: 
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where strict equality holds in the limit of Pe ? 0, and Uavg is the average flow velocity over 
the channel cross section.  The mixing time at low Peclet number is therefore approximated 
by the time for a molecule to diffuse the circumference of the ring:  
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where R is the radius of the mixing ring.  Assuming a ring radius of 1 mm, the time require 
for a salt solution ( D ≈ 1000 µm2/s) to be completely mixed is approximately 10 hours.  
 
At intermediate Peclet numbers the dispersion of a slug of tracer molecules is determined 
by the interplay of diffusion and convection in mass transport as described by Taylor 
dispersion.  The required mixing time at intermediate Peclet number therefore has the 
dependence 
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A flow of salt solution ( D ≈ 1000 µm2/s)  at 100 µm/s  down a channel having a width of 
100 µm corresponds to a Peclet number of 10 which is an intermediate value.  Once again 
assuming a ring radius of 1 mm, the time required for complete mixing of this solution is 
on the order of several minutes. 
 
As mentioned previously, the Taylor dispersion analysis is only valid once the molecules 
have had sufficient time to sample the entire flow profile so that significant transverse 
gradients have been eliminated.  The periodic boundary conditions imposed in the rotary 
mixer structure imply that at high Peclet number this condition will not be achieved the 
ring and mixing is accomplished by a mechanism of “convective stirring.”  At flow rates 
where h2/D >> πR/U tracers will be stretched around the ring before they have a chance to 
diffuse across the channel.  Each circuit of the ring wraps the line of tracer particles back 
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onto itself in thin interlaced streams.  The characteristic distance between these streams 
decreases linearly with the number of cycles and is given by d*=h/2N, where N is the 
number of cycles.  The mixing time can therefore be approximated as the required time to 
ensure that the separation distance between streams becomes comparable to the diffusion 
length.  Equating d*=(Dt)1/2 and substituting N = Ut/2πR gives (T. Squires and S.R. Quake; 
Review of Modern Physics, in press) 
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A flow of salt solution ( D ≈ 1000 µm2/s)  at 5000 µm/s  down a channel having a width of 
100 µm corresponds to a Peclet number of 1000.  Assuming a ring radius of 1 mm, a line of 
salt tracer molecules will make approximately 10 circuits of the loop in the time required to 
diffuse the full width of the channel.  The time for mixing in this situation will therefore be 
on the order of a second.  
 
The scaling of mixing time with Peclet number is shown in Figure 38.  Mixing time may be 
monotonically decreased by raising the Peclet number within the system.  Since the 
diffusivity is a material property of the particular reagents being mixed, achieving rapid 
mixing requires either modifying the channel geometry or increasing the flow velocity.  
The size of the channel directly influences the Peclet number by scaling the appropriate 
length dimension.  Generally, larger channels have higher effective dispersivity.  However, 
at high Peclet number the mixing time has an explicit dependence on the channel critical 
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dimension.  This reflects the fact that the dispersion of molecules is only enhanced in the 
axial direction.   
 
 
 
Figure 38:  Scaling of mixing time as a function of Peclet number.   
 
Figure 39 shows finite time difference simulations of the evolution of tracer molecules 
originally occupying half the volume of a rotary mixer.  Simulations were performed in 
MatLab® using a first-order finite time difference algorithm.  The script used for these 
calculations is included in Appendix B.  The simulations are carried out for flow velocities 
(10 ≤ Pe ≥ 10 000) chosen to illustrate the transition from the Taylor diffusion regime (Pe = 
10) to the “convective stirring” regime (Pe = 10 000).  The simulations show the dramatic 
enhancement in mixing efficiency as the flow velocity is increased.  Also of interest is the 
delayed mixing within the center of the channel at high Peclet numbers.  This effect is due 
to the direct dependence of mixing time on width and is accentuated by the small velocity 
gradients present near the channel center. 
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Figure 39:  Finite difference time domain simulations of rotary mixer.  Evolution of 
concentration profiles are shown at various times T (seconds).  Periodic boundary 
conditions are imposed at ends of 1000 µm channel to simulate dispersion in ring.  
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Channel width is 100 µm and diffusion constant is 100 µm2/s so that the Peclet number is 
equal to maximum flow velocity (A: Pe=10, B: Pe=100, C: Pe=1000, D: Pe=10000).     
 
Fast Valve for Fast Mixing 
Regardless of the specific channel geometry, optimal mixing requires that the flow rate be 
maximized.  When operated in the linear regime, the speed of flow driven by a peristaltic 
pump is proportional to the pump cycle rate so that achieving rapid mixing requires that the 
valve response be optimized.  Actuation of a pneumatic or hydraulic valve requires that a 
volume of fluid be displaced down the control line to deflect the valve membrane (Figure 
40).  The valve response is therefore dependent on the speed at which fluid can be pushed 
in and out to displace the membrane.  For low aspect ratio control channels of rectangular 
cross section the flow rate determining the time constant of actuation can be approximated 
as (81), 
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where Q is the volume flow rate, h is the channel height, w is the channel width, L is the 
channel length, ∆P is the driving pressure, and µ is the fluid viscosity.   
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Figure 40:  Valve actuation.  Opening (top) and closing (bottom) of valve requires 
transport of finite volume ∆V through control structure.   
 
In order to optimize pumping speed, the control channel height was changed from 10 µm to 
25 µm, and ∆P was raised by increasing both the actuation pressure and the fluid pressure 
by 5 psi.  As an added benefit, raising the back-pressure of the fluid was found to suppress 
the nucleation of air bubbles.  This enabled the control line fluid to be changed from water 
(viscosity 1cP) to air (viscosity 0.01 cP).   
 
Although the use of a compressible fluid (air) in the control lines adds capacitance to the 
control structure, the greater reduction in fluidic resistance results in a net improvement in 
response time.  The response of the control structure to a pressure input can be modeled as 
an exponential rise having an RC time constant, with the channel resistance defined by 
Equation 18 and the channel capacitance defined as the ratio of control volume input to 
change in pressure.  As a first approximation the capacitance of the control structure can be 
written as the sum of the intrinsic capacitance of the channel structure due to the 
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compliance of the elastomer (82), the fluid capacitance due to the compressibility of the 
fluid, and the capacitance due to the expansion of the membrane. 
 
It was determined using absorption measurements that the height of the channel increases 
by approximately 40% when pressurized to 15 psi.  The capacitance of the channel is 
therefore approximately 0.4 times the channel volume per atmosphere pressure.  The 
capacitance of the membrane is approximately 100 pL per atmosphere and is negligible in 
comparison.  Pressurizing air to 15 psi results in approximately a 50% volume reduction so 
that the fluid capacitance is approximately the channel volume per atmosphere pressure.  
The relative increase in capacitance associated with using a compressible fluid instead of 
water is therefore of order 1 (approximately 3 fold).  Therefore, since the viscosity of air is 
100 times smaller, the net reduction in the actuation time constant should be on the order of 
30 fold.  This argument does not include corrections for air permeation into the elastomer 
which would further slow the response.  
 
The combined effects of changing the fluid control height, changing the actuation fluid, and 
increasing the back pressure allowed for the pump frequency to be increased from 10 Hz to 
100 Hz.  At this frequency the valve actuation speed is limited by the maximum frequency 
of off-chip solenoid actuation.  100 Hz pumping frequency resulted in a maximum flow 
velocity of approximately 2 cm/s; this represents a 10 fold improvement over previously 
reported work using similar channel geometries (13, 14).  At these flow rates complete 
mixing of non-viscous reagents is achieved in less then 3 seconds, and solutions with 
viscosities of approximately 100 cP may be mixed less than 9 seconds.   
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C h a p t e r  7  
SYSTEMATIC SOLUBILITY CHARACTERIZATION: CASE STUDY 
The flexibility, precision, fast mixing, and small volume requirements of the formulator 
device make feasible the systematic mapping of crystallization phase-space.  In order to 
demonstrate the utility of ab initio solubility characterization prior to crystallization trials 
we exhaustively explored the solubility behavior of a commercially available crystallization 
standard, Endo-1,4-β-xylanase (xylanase) from Trichoderma reesei (83, 84).  Xylanase is a 
21 KDa member of the gluconase enzyme family of industrial interest in the processing of 
pulp and paper due to its ability to break down xylans.  Xylanase was chosen for solubility 
studies since it is stable for long periods of time at room temperature, and is known to be 
more challenging to crystallize than other crystallization standards. 
  
Endo-1,4-β-xylanase (xylanase) from Trichoderma reesei (Hampton Research) was 
prepared in deionized water from stock (36 mg/mL protein, 43% wt/vol glycerol, 0.18 M 
sodium/potassium phosphate pH 7.0) by repeated buffer exchange at 4 C using a 
centrifugal filter with a molecular weight cutoff of 10,000 Da (Micon Bioseparations).  
Protein concentration was measured by absorption at 280 nm and adjusted to 120 mg/mL.  
10 µL aliquots were flash frozen in liquid nitrogen and stored at –80 °C.  To avoid sample-
sample variations, a single sample preparation was used for all solubility screening, phase-
space mapping and corresponding crystallization experiments.   
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Automation and Data Aquisition 
Automation of metering, mixing and data acquisition allows for thousands of solubility 
experiments to be executed without the need for user intervention.  In each solubility 
experiment a unique mixture of the 32 reagents and the protein sample is produced.  All 
device control and data acquisition was implemented using a custom software driver 
developed in LabView (National Instruments).  Mixing recipes were generated using a 
spread-sheet program and translated into valve actuation sequences by the software driver.  
Off-chip solonoid valves (Lee Products Ltd.), controlled using a digital input output card 
(DIO-32HS; National Instruments), were used to generate square-wave pressure signals at 
the device control ports.  A frame-grabber card (Imagenation PXC200A; CyberOptics) was 
used to automate image acquisition from a charge coupled device camera. 
 
Precipitation Detection 
Precipitation of the protein was automatically detected by imaging a portion of the mixing 
ring, calculating the standard deviation of the pixel intensities and comparing this value to 
the background (no protein added).  To ensure even illumination, images were taken at 112 
times magnification at a 9 µm high section of the mixing ring having rectangular cross 
section.  As a metric of precipitation, the standard deviation of imaged pixels not only 
allows for distinction between precipitated and soluble conditions, but further allows for a 
rough quantitative measure of the degree of precipitation.  Beyond the precipitation limit, 
the pixel standard deviation increases linearly with the protein concentration, and therefore 
is proportional to the concentration of precipitated protein present in the solution (Figure 
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41).  A video of on-chip protein titration and precipitation is included as supporting 
information. 
 
 
 
Figure 41:  Precipitation measurements at varying concentration of xylanase in 0.6 M 
potassium phosphate with 0.1 M TRIS/HCl pH 6.5.  Standard deviation of pixels 
provides a quantitative metric of protein precipitation.  Below the precipitation limit 
standard deviation shows constant background level with low variation.  Above 12 
mg/mL solution is in the precipitation regime where the pixel standard deviation exhibits 
an approximately linear dependence on protein concentration.  All points represent the 
mean of 5 identical experiments with error bars indicating standard deviation of 
measurements.   
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Solubility Fingerprinting 
A two-step protocol was used to map out the solubility space.  An initial coarse search was 
used to identify reagents that have a strong precipitating effect on the target 
macromolecule.  In this step concentrated protein sample is combined with a wide range of 
potential precipitating agents (chemical conditions) at high concentrations.  This generates 
a solubility fingerprint of the crystallization target.  Each precipitation peak in this 
fingerprint represents a chemical condition that exerts a pronounced effect on solubility.  
Chemical conditions that do not result in protein aggregation even at high concentrations 
are dismissed as unlikely crystallizing agents and are not explored further.   
 
The solubility fingerprint of xylanase generated by 4 independent runs, each consisting of 
approximately 4000 titration experiments, is shown in Figure 42.  This fingerprint is highly 
reproducible and is characteristic of the protein studied.  The chemical conditions tested in 
Figure 42 were grouped by the identity of the major precipitating agent so that each peak 
represents the effect of this reagent over a range of pH values and concentrations.  The 
large width of these peaks indicates a high level of experimental redundancy, suggesting 
that a more efficient search could be conducted using less related chemical conditions.       
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Figure 42:  Solubility fingerprints of xylanase over approximately 4200 chemical 
conditions.  Each data series represents a separate fingerprinting experiment using the 
same basis of chemical conditions.  The top solubility fingerprint (blue), generated using 
a sample having elevated protein concentration (90 mg/mL), exhibits both higher signal 
to noise and additional peaks not present in the other data series (70 mg/mL).  The two 
center solubility fingerprints were generated sequentially on a single device (first orange, 
then green) with the same loaded sample, demonstrating the stability of the protein over 
the time of the experiment (approximately 20 hours).  The bottom solubility fingerprint 
(red) was generated using the same sample as orange on a separate device, showing 
reproducibility across devices.   
 
The solubility fingerprint of xylanase revealed 5 salts (sodium citrate, di-potassium 
phosphate, ammonium sulfate, and sodium/potassium tartrate) as likely crystallizing 
agents.  A high molecular weight polymer (polyethelyne glycol 8,000) in combination with 
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various salt additives was also identified to be a strong precipitating agent at high pH 
values.  The high isoelectric point of xylanase suggests that the reduced effectiveness of 
this precipitant at low pH values is due two-body electrostatic repulsion.  A smaller 
molecular weight polymer (polyethelyne glycol 3,350) was found to be a much weaker 
precipitating agent and was not investigated further in phase-space mapping experiments.          
 
Protein Phase-space Mapping 
The identified xylanase precipitating conditions were expanded in 24 systematic grid 
searches over all accessible protein and precipitant concentrations.  Each grid consists of 72 
separate mixing experiments, creating a two-dimensional phase-space with protein 
concentration and precipitant concentration as variables.  All 24 phase-spaces were 
generated sequentially on a single device using less than 3 uL of protein sample 
(approximately 100 nL per phase-space) and are included in Appendix C.  A comparison of 
precipitation phase-spaces measured for xylanase in chip (5 nL reactions) and in 
microbatch format under paraffin oil (5 µL reactions) shows good agreement in detecting 
the precipitation boundary (Figure 43).  Since measurements of precipitation are made 
immediately after mixing (within 3 seconds), the locus of points that separate the 
precipitated and soluble regions of the graph generate a precipitation curve that is distinct 
from the thermodynamic solubility curve.  Conditions that reside just below the 
precipitated region may be in a metastable state conducive to crystallization.   
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Figure 43:  Comparison of phase mapping done on chip (small yellow circles) and in 
microbatch (large red circles) experiments.  Microbatch experiments were set at a final 
volume of 2 µL and actively mixed under oil by repeated aspiration with a pipette.    
 
Solubility Hysteresis 
The formulator has been used to make a direct observation of the supersaturation region of 
chicken egg white lysozyme.  The concentrations of salt and lysosyme were manipulated 
while keeping the buffer concentration constant in order to evolve the chemical state of the 
mixing ring radially out from the origin and then back again.   Measurements of 
precipitation were taken at approximately 1 minute intervals.  The addition of a family of 
such radial titrations was used to generate two phase-space diagrams for chicken egg white 
lysosyme; one for the outward titrations and one for the return titrations (Figure 44).  The 
first observation of protein precipitation appears at higher salt and protein concentration 
during the outward trajectory than on the return path, thereby exhibiting solubility 
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hysteresis.  The intersection of the soluble region of the outward phase-space with the 
precipitated region of the return path phase-space provides a direct observation of a 
metastable regime in which the aggregate phase is thermodynamically stable but not 
observed at short times.  The observation of the reversible formation of a protein aggregate 
may be used to distinguish between denatured and well-folded protein aggregates.  
Additionally, identified metastable regions in phase-space provide likely candidates for 
crystal seeding and growth experiments.   
 
 
 
Figure 44:  Overlay of two phase-space diagrams generated by outward and return 
titrations.  Observed hysteresis in precipitation threshold identifies metastable region of 
phase-space.  
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Optimal Crystallization Screening 
A detailed knowledge of protein solubility behavior provides an empirical basis for the 
design of maximum likelihood crystallization trials.  The 24 phase-spaces generated for 
xylanase were used to design an optimal crystallization screen consisting of 48 reagents.  A 
single batch crystallization trial using the optimal screen was set by combining relative 
amounts of protein and precipitant stock so that the final condition was located on the 
boundary of the precipitation region.  The efficiency of this screen was evaluated by 
comparison with standard commercially available sparse matrix screens (Crystal Screen I, 
Crystal Screen II; Hampton Research, Wizard I, Wizard II; Emerald Biostructures).  2 
batch crystallization trials of 48 unique conditions were prepared for each of the 4 sparse 
matrix screens for a total of 384 individual assays.  For each commercial screen final 
protein concentrations of 12.5 mg/mL and 25 mg/mL were used; the recommended 
concentration range for the crystallization of xylanase is 10 mg/mL to 40 mg/mL.  All 
batch crystallization trials were actively mixed by repeated aspiration and incubated under 
paraffin oil.  Crystallization trials were inspected daily for a period of two weeks.  
Observed crystals were confirmed to be protein crystals by staining (IZIT dye; Hampton 
Research) and were recorded as crystallization hits.  The optimal screen formulations and 
crystallization results are listed in Appendix D. 
 
Twenty-seven crystallization conditions were observed in the optimal screen compared to a 
total of 3 crystallization conditions in the 8 standard sparse matrix screens.  The use of ab 
initio solubility information therefore resulted in a 72-fold enrichment in crystallization 
success (Figure 45).  A surprising result was that xylanase crystals were observed in the 
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optimal screen for all the precipitants identified in coarse screening.  These results suggest 
that achieving optimal levels of supersaturation is more important in the crystallization of 
xylanase than is the broad sampling of chemical space.  Additionally, crystallization 
conditions were identified in the optimal screen that gave large single three-dimensional 
crystals (Figure 45B); flat plate clusters were observed in the standard screens.   
 
 
 
Figure 45:  Comparison of microbatch crystallization experiments using commercially 
available sparse matrix screens to an optimal crystallization screen based on solubility 
phase-spaces.  (A)  Histogram showing number of successful crystallization conditions 
identified with sparse matrix screens (each at protein concentrations of 12 mg/mL and 23 
mg/mL) and optimal screen.  (B) Polarized micrograph of large single crystals grown 
directly from optimal screen (16% polyethelyne glycol 8000, 65 mM sodium chloride, 65 
mM TRIS-HCl pH 8.2, 42 mg/mL xylanase).  Scale bar is 100 µm.   
 
 
 117
Crystallization Variability 
Subsequent crystallization experiments based on the optimal screen were repeated using 
different protein sample obtained from the same vendor and prepared in the same way as 
the original sample.  14 of 17 polyethelyne glycol conditions that gave crystals in the 
original experiment were reproduced using the second sample, compared to 1 of 10 for the 
salt based conditions.  To determine if this discrepancy was due to variations in phase-
space behavior a complete phase-space of one condition (sodium/potassium tartrate, 
TRIS·HCl pH 8.5) was measured in microbatch format for both samples (Figure 46).  It 
was discovered that although both samples exhibited comparable phase-space behavior 
they produced vastly different crystallization results.  The reason for this difference in 
behavior is unclear but may be due to slight sample-sample variations or trace amounts of 
chemical contaminants introduced during purification or concentration steps.  It is 
interesting that some crystallization conditions (those based on PEG 8000) may be more 
robust to batch-dependent perturbations.    
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Figure 46:  Crystallization variability.  Two phase-space mapping and crystallization 
experiments with different batches of Xylanase.  All experiments were set in microbatch 
format under paraffin oil with a final volume of 2 µL.  Active mixing by repeated 
aspiration through a pipette was used.  Location of soluble (green circles) and 
precipitation (black circles) conditions correspond well between batches.  Crystallization 
conditions (blue diamonds) were observed after one week of incubation.   
 
Another application of protein solubility phase-space mapping is in transporting successful 
crystallization conditions from one experimental format to another.  The successful 
crystallization of a protein is determined both by the established thermodynamic variables 
and the kinetic trajectory of an experiment.  For this reason experiments conducted with 
different crystallization kinetics (e.g., Hanging drop vapor diffusion, microbatch, free-
interface diffusion) using the same precipitating agents will not necessarily produce similar 
results.   For example, the hydroxylase domain of a cytochrome p450 alkane hydroxylase 
(Mutant 139-3 of BM-3) did not produce crystals in initial hanging drop trials, but was 
found to crystallize readily by microfluidic free interface diffusion (29) (1 part protein 20 
mg/mL, 1 part 30% m/v polyethelyne glycol 8000, 0.2 M sodium acetate, 0.1 M TRIS-HCl 
pH 7.0).  This condition was unsuccessful when set in hanging drop vapor diffusion format, 
resulting only in amorphous precipitate.  The microfluidic formulator was used to generate 
a phase-space at constant buffer and salt concentration (100 mM TRIS-HCl pH 7.3; 200 
mM sodium acetate) with polyethelene glycol concentration and protein concentration as 
variables.  Two hanging drop experiments were designed to equilibrate near the solubility 
limit determined from the phase-space map.  One condition (8 µL of 35 mg/mL protein 
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sample mixed with 6.7 µL of 10% polyethelene glycol, 100 mM sodium acetate, 50 mM 
TRIS-HCl pH 7.3, and equilibrated at 20 °C against 1 mM of  20% polyethelene glycol, 
200 mm sodium acetate, 100 mM TRIS-HCl pH 7.3) produced crystals within 3 days.  This 
success demonstrates the usefulness of solubility mapping in transporting conditions across 
crystallization formats.  
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C h a p t e r  8  
CLEAR PATH TO STRUCTURE 
Introduction 
Nanoliter-scale protein crystallization screening in µFID reactors has proven a powerful 
technique for identifying protein crystallization conditions over a broad range of 
challenging crystallization targets.  In particular, the ability to screen very small sample 
volumes and the number of successful crystallization studies with targets that have proven 
intractable by conventional screening techniques highlights the potential of this technology 
to have a large impact on structural biology.  The realization of this potential however 
depends crucially on establishing a clear path from chip-based crystallization to structure.  
This Chapter discusses the ongoing development of general methods for growing high-
quality crystals of sufficient size for diffraction studies, and harvesting these crystals 
without damaging them.       
 
Direct Harvesting from Screening Devices 
Once crystallization conditions giving rise to high-quality crystals are determined in chip-
based screening experiments a method must exist for getting crystals into the x-ray beam.  
The most direct of these methods is the extraction of crystals from screening devices.    
Despite the small volumes, crystals of sufficient size for crystallographic structure 
determination may be grown and harvested directly from the chip.  Figure 47 shows a high-
resolution diffraction pattern for a single thaumatin crystal grown from only 5nL of protein 
solution (29).  Crystals were exposed by separating the microfluidic device from a glass 
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substrate containing microfabricated reaction chambers, cryo-protectant was dispensed on 
the reaction wells, and the crystals were harvested using conventional cryo-loops.   
 
 
 
Figure 47:  X-ray diffraction pattern (resolution < 1.35 A°) from a single thaumatin 
crystal grown from 5 nL of sample in chip. The inset shows a clean reflection at 1.35 A° 
resolution.   Diffraction data was collected at station 8.3.1 of the Advanced Light Source 
(ALS) at an incident wavelength of 1 Å, with a 20 s exposure and 1° oscillation. 
 
The high-resolution data obtained from chip-grown thaumatin crystals exceeds that 
reported of crystals grown by conventional ground-based techniques, and is comparable to 
that obtained from thaumatin crystals grown in space (85).  In general crystallization 
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experiments in space have suggested that microgravity environments may be well suited 
for the growth of large, high-quality crystals (48, 85-87).  The mechanism for the increased 
order of space-grown crystals is not completely known but is largely attributed the lack of 
buoyancy-driven convection during crystal growth, an effect also present in terrestrial 
microfluidic devices. (88-90).   
 
High-resolution diffraction data has been collected from crystals of several protein models 
extracted directly from chip (lysozyme, glucose isomerase, ferritin, bovine liver catalase).  
Despite this success, the direct extraction of protein crystals from screening devices is a 
delicate and time-consuming procedure that has not proven to be generally applicable.  For 
instance, large single crystals of a type II topoisomerase ATPase domain extracted from a 
screening device diffracted to only 3.5 Ǻ; crystals grown from the same condition in 
hanging drop experiments diffracted to 2.0 Ǻ (personal communication with K. Corbett).  
Several technical problems make this method prone to damaging crystals, thereby 
compromising their diffracting power.       
 
Chemical variations and osmotic shock introduced during harvesting can severely reduce 
the diffracting power of a crystal.  This mechanism is particularly important in nanoliter 
volume screening devices due to the large surface to volume ratio of the reactors and the 
permeability of the elastomer material.  
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Permeability Effects  
In addition to equilibration by free interface diffusion, chip-based reactions are subject to 
slow hydration/dehydration due to vapor diffusion through the elastomer chip.  The 
magnitude of this effect is determined by a complicated interplay of chemical, material, 
geometric, and environmental factors.  The transport of water vapor through the elastomer 
device is governed by the diffusion equation : 
 
    PK
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 ,    (17)  
  
where P is the partial pressure of water vapor, and KP is the permeability of the elastomer 
to water vapor.  This equation is valid within the bulk of the elastomer device.   An exact 
solution to this equation is made difficult due to the three-dimensional geometry and the 
complex time-varying boundary conditions.  The problem is directly analogous to a heat-
flux problem and is illustrated in Figure 48 below.   
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Figure 48:  Schematic showing boundary conditions influencing the transport of water 
vapor through the bulk elastomer.  The control lines (blue) are filled with dionized water 
and serve as sources of water vapor.  The vapor pressures of the reagents (orange and 
green) and control fluids are a strong function of temperature.  Additionally, the vapor 
pressure of the reagents is a function of the concentration of species and hence changes 
due to both counter-diffusion and hydration/dehydration.  The underlying glass substrate 
(black) imposes a no-flux condition.   
 
The partial pressure at the chip surface is determined by the ambient room conditions and 
hence may be time-varying.  A no-flux condition is present at the bottom of the chip due to 
the low permeability of the glass substrate.  Additional boundary conditions at the flow 
channel, control channel, and microwell surfaces are determined by the vapor pressure of 
the various reagents and control fluids.  The vapor pressure of the reagents within the flow 
 
 125
structure is a function of the identity and concentration of reagents, and hence is time 
varying due to diffusive mixing and concentration/dilution effects.  The vapor pressure of a 
solution is approximated by Raoult’s law: 
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where P is the vapor pressure of the solution, P0 is the vapor pressure of the pure solvent, Ni 
is the molarity of the solute, and N0 is the molarity of the solvent (55.346 mol/L for water). 
 
In normal chip operation the control fluid is chosen to be dionized water and is constantly 
replenished through the control line port.  The control lines therefore define the boundary 
condition of maximal partial pressure and provide a constant source of water vapor.  This 
ensures a constant flux of water vapor from the control lines into the reagent wells and out 
of the chip.  As the system evolves towards steady state the reagents within the wells will 
asymptotically approach a vapor pressure that gives rise to zero net vapor flux.  This 
implies that at long times the final vapor pressure of each reaction, and hence the level of 
dehydration, will be determined solely by the ambient conditions and the device geometry.  
An important point is that the samples do not dehydrate completely, but rather converge to 
a condition of dynamic equilibrium in which all the reactors assume the same osmotic 
strength irrespective of the mixing ratio or chemistry.  For example, screening devices with 
crystals of MscL and hdTfR/HFE have been incubated for several months with no apparent 
change in hydration and no observed degradation of crystals.    
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It is worth noting that the vapor pressure of an aqueous solution is a strong function of 
temperature, varying over four-fold from 5 °C (Pvap = 6.54 mmHg) to 25 °C (Pvap = 27.76 
mmHg).  This effect results in dramatically different rates and final levels of dehydration 
between devices incubated at 4 °C and 20 °C.  The rate of evaporation from the control 
structure of a screening device was measured by tracking the meniscus of the control input 
line over time.  Dehydration rates of approximately 8 µL/day were typical of devices 
incubated at 20 °C compared to rates of 1 ± 1 µL/day in devices incubated at 4 °C.     
 
In the screening device the timescale for evaporative equilibration is on the order of one to 
several days, making it comparable to or slower than the diffusive equilibration of 
precipitating agents between wells.  This process therefore results a continued slow 
evolution of the conditions through chemical phase-space after diffusive equilibration is 
complete.  This continual sampling of phase-space is likely a major factor in the 
observation of crystallization events that occur at long incubation times, and hence 
increases the number of detected hits.  However, since the rate and final extent of 
evaporation depends in a complex way on the chip geometry, reagent chemistry, and 
ambient conditions, it is not easily characterized over the large number of unique screening 
conditions used in chip.  For this reason it may be difficult to ascertain the precise chemical 
condition that gave rise to crystallization events in screening devices at long incubation 
times.  This uncertainty complicates both the transport of chip-based conditions to 
alternative formats and the harvesting of crystals.   
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The transport of water vapor during the crystallization process results in a richer phase-
space evolution, giving rise to more crystallization hits, but also introduces uncertainty in 
the exact chemical state of each reactor.  Uncertainty in the concentration of chemical 
species is particularly problematic in the formulation of an appropriate cryo-protectant for 
harvesting.  This problem is further exasperated by the very small volume of the reagent 
wells since the addition of a microliter of mother liquor or cryo-protectant to a nanoliter 
volume crystallization mixture results in an abrupt change in the concentration of the 
reagents.   
 
Mechanical damage is another cause of reduced crystal diffracting power.  Physical 
manipulations during the looping of delicate crystals from solution (common practice in 
conventional harvesting) can fracture or crack fragile crystals (especially for thin rods or 
plates).  The degree of mechanical damage that occurs during the conventional harvesting 
of crystals is not well characterized but is thought to be tolerable for all but the most fragile 
of crystals.  The additional manipulations required to extract crystals from screening 
devices present more severe risks.  Peeling away the elastomer to expose the crystallization 
wells can result in crystals being carried away with the fluid or crushed between the chip 
and the substrate.  Furthermore, crystals that adhere to the walls of the chip or the substrate 
are difficult to remove without cracking or crushing them.   
 
Finally, harvesting crystals from screening chips necessitates peeling off the entire device 
or cutting the control lines.  This imposes impractical constraints on harvesting since the 
entire device must be sacrificed for the harvesting of a single well; crystals can not be 
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harvested from different reactors at optimal times.  The potential for inducing chemical and 
mechanical damage along with the aforementioned technical complications therefore make 
direct extraction from the screening device suitable for only the most robust of crystals.   
   
Transporting Conditions to Conventional Formats 
In cases where crystal growth occurs at low supersaturation levels, or where the absolute 
concentration of protein is low, it may be necessary to transfer conditions to larger volume 
formats in order to produce crystals of sufficient size for diffraction studies.  Additionally, 
once crystallization conditions are transported to conventional microbatch or vapor 
diffusion formats harvesting may be accomplished by well-established conventional 
techniques.  Since the success and quality of crystal growth is governed both by the 
chemistry and the mixing kinetics of an experiment, transferring chip-based crystallization 
conditions to conventional formats may not be straightforward.  Furthermore the transport 
of water vapor through the elastomer may introduce uncertainty in the exact concentration 
of reagents that gave rise to crystallization 
 
The success rate of directly transferring crystallization conditions form the chip to hanging 
drop vapor diffusion or microbatch techniques was investigated using 4 crystallization 
standards (beef liver catalase, proteinase K, glucose isomerase, and bovine pancreas 
trypsin) (experiments conducted at Fluidigm corporation).  All four proteins were tested in 
crystallization trials using a commercially available sparse matrix screen (Crystal Screen; 
Hampton Research).  The results of these experiments are displayed in Venne diagrams in 
Figure 49.  In these experiments the rate of successfully transferring conditions directly 
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from the chip to hanging drop vapor diffusion format was 66 %.  The rate of transferring to 
microbatch format was comparable at 56 %.  This high success rate reflects the ease with 
which these model proteins can be crystallized.  Although no systematic study has been 
done, the success rate of transferring conditions directly from chip to conventional formats 
is estimated by the author to be much lower for more challenging crystallization targets 
(approximately 20 %).   
 
 
Bovine Pancreas Trypsin     Protease K 
 
  Glucose Isomerase    Beef Liver Catalase   
 
Figure 49:  Venne diagrams showing correspondence between chip, microbatch, and 
hanging drop vapor diffusion formats. 
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If directly transporting conditions is not successful, identified chip-based crystallization 
conditions nevertheless provide valuable information that can be leveraged for conducting 
efficient crystallization trials in conventional formats.  Firstly, chip-based experiments 
provide an excellent way to efficiently evaluate the crystallizability of a target using small 
amounts of sample.  This is particularly useful in cases were many othologues or constructs 
of a target are being pursued in parallel.  Secondly, identifying successful precipitating 
agents dramatically reduces the chemical space that must be explored in crystal trials.  This 
allows for a more refined search of the relevant parameters, greatly increasing the chance 
of success.  Highly resolved and systematic screening based on crystallization conditions 
optimized in chip has been used to successfully transport conditions to microbatch or vapor 
diffusion formats.  In experiments conducted at UC Berkeley 5 of 6 target proteins that 
were initially crystallized in chip were transported to conventional formats (JM Berger, 
personal communication).  It is expected that current efforts directed towards more 
thorough characterization and modeling of chip equilibration will allow for the 
development of systematic protocols for transporting conditions between chip and standard 
formats.     
 
Scaling up µFID Reactions 
In cases were systematic screening fails to identify crystallization conditions in 
conventional formats the success of crystallization may depend on the unique equilibration 
kinetics achieved in chip.  The slow diffusive mixing achieved in chip provides both a 
continuous sampling of chemical phase-space and eliminates rapid initial precipitation.  
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Preserving the mixing kinetics achieved in chip is therefore crucial in attempts to scale up 
µFID crystallization reactions with high correspondence.   
 
Conventional free interface diffusion achieves high transient levels of supersaturation but 
has a complicated spatial/temporal gradient due to the constant cross section of the 
capillary.  This gradient couples the kinetics and thermodynamics of traditional free 
interface diffusion assays in a way that µFID does not.  In the µFID assay, the fluidic 
interface is established between the two wells in a constricted channel where the cross 
section is 10 µm x 100 µm.  In contrast, the cross section of a well is approximately 300 µm 
x 100 µm.  This constriction acts as a high-impedance connection between the two 
channels, localizing the concentration gradient only to the length of the connecting channel.  
Figure 50 shows a finite difference time domain simulation of the diffusive equilibration of 
a low molecular weight dye in two microwells coupled by a constricted channel (PDE 
Toolbox, MATLAB®; The MathWorks Inc. of Natick, Mass.).  With the exception of the 
region in close proximity to the inlet, no appreciable concentration gradient forms in the 
microwell itself.  In a protein crystallization experiment, this implies that as the wells 
equilibrate, the vast majority of the sample evolves simultaneously through a continuum of 
thermodynamic conditions.   
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Figure 50:  Two-dimensional finite element modeling of diffusion of an organic dye in 
aqueous solution between two microwells connected by a constricted channel.  
Simulation shows the bulk of the concentration drop occurring along the channel with no 
appreciable gradient within the microwells.  For modeling purposes, constriction of the 
channel in the vertical dimension has been represented by a lateral constriction.  
Concentrations are normalized to a maximum of 1 (arbitrary units). 
 
In the optimization of crystallization conditions, it is often desirable to slow down the 
equilibration process so that favorable conditions are approached more slowly to produce 
fewer nucleation events and larger crystals.  In vapor diffusion experiments, this can be 
achieved by methods such as placing a thin layer of semi-permeable oil over the 
precipitant, increasing the size of the crystallization drop to slow equilibration, or by 
inclusion of a chemical additive such as glycerol to the crystallization drop in order to 
reduce the vapor pressure.  While these techniques are effective in slowing down the 
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equilibration of the drop with the reservoir, they allow for only coarse control of the 
equilibration kinetics.  Conversely, microfluidic free interface diffusion allows for precise 
and straightforward control of the equilibration rate while decoupling the kinetics and 
thermodynamics of crystallization.   
 
The absence of any spatial gradient within the microwells allows for a simple analytical 
solution of the time-dependent evolution of the concentration in each chamber.  The net 
transport of a diffusing species along the channel is equal to the product of the diffusive 
current density and the channel cross sectional area.  Since the channel is constricted in 
both height and width, the problem is one-dimensional and the gradient along the channel 
is given by the difference in concentration divided by the channel length.  The equation 
governing the change of concentration in a well of volume V1 and concentration C1(t) that 
is coupled to a second well of volume V2 at concentration C2(t) is therefore given by 
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where D is the diffusion constant of the species.  Integration of this equation and 
application of the initial conditions C1(0) = C0 , C2(0) = 0, gives 
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From this equation, it can be seen that for a given diffusion constant and relative well 
volume, the rate of equilibration depends only on two characteristic lengths: the length of 
the connecting channel, and the ratio of the well volume to channel cross sectional area. 
Thus, modifying the channel geometry allows for intuitive and accurate control over the 
kinetics of diffusive equilibration without changing the chemistry of the solutions.  For 
example, by making the channel twice as long the reaction proceeds at one half the rate, 
whereas reducing the channel cross sectional area by a factor of two increases the 
equilibration time by the same factor.  Furthermore, since these length scales only scale 
time in the exponent, the locus of concentrations (path through phase-space) achieved 
during a complete equilibration depends only on the diffusion constants of the species and 
the relative volume of the wells, and is independent of the channel geometry.  The 
decoupling of the kinetics and thermodynamics of diffusive equilibration has important 
implications in crystal optimization where it is often desirable to slowly approach 
crystallization conditions while conserving the successful thermodynamic variables. 
 
Growth Device 
The analysis above suggests that a simple scaling of the reaction well volumes will provide 
a high-correspondence method by which screening chip crystallization hits can be 
transported to larger volume formats.  To test this hypothesis a growth chip device was 
designed having larger-volume wells and a variety of connecting channel lengths designed 
to explore the effect of varying mixing kinetics on crystallization.  The device features 8 
reaction sites having 5 different mixing ratios and 4 different connecting channel lengths 
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(Figure 51).  The volume of each well is designed to be approximately 300 nL, 
approximately a 30 fold increase over the screening chip format.   
 
 
 
Figure 51:  Layout of growth device featuring different mixing ratios and connecting 
channel geometries. 
 
A series of crystallization experiments were conducted using 7 model proteins that had 
been successfully crystallized in the small-volume screening device.  These models 
included DNA B/C, Rho, hdTfR/HFE, P450 1-12G (hydroxylase domain), P450 139-3 
(hydroxylase domain), DNA D/G/H and MscL.  Of these models, four (DNA B/C, 
hdTfR/HFE, P450 1-12G) had resisted attempts at transferring to hanging-drop vapor 
diffusion by screening around chip-based conditions.  In the case of P450 139-3 vapor 
diffusion crystallization was achieved by using solubility information derived from 
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formulator device experiments.  Crystallization of the remaining three proteins had been 
achieved in hanging drop format.   
 
Rho is a RNA/DNA helicase factor responsible for transcriptional termination in bacteria.  
Rho was first crystallized in vapor diffusion format through extensive screening (91) using 
conventional methods and then transferred directly to the screening device.  In the case of 
MscL successful vapor diffusion conditions were discovered and optimized prior to 
identifying conditions independently (including some novel conditions) using sparse matrix 
chip-based screening experiments.  The first crystallization conditions for DNA D/G/H 
were found using the screening device after extensive unsuccessful conventional screening.  
This condition was eventually used to achieve crystallization in vapor diffusion format by 
very refined systematic screening around the identified chip condition.  The results of 
crystallization trials for these three proteins are summarized in Table 2. 
 
 Protein  Vapor Diffusion Growth Chip    
 DNA B/C  NO   YES 
 Rho   YES   YES 
 hdTfR/HFE  NO   NO 
 P450 1-12G  NO   NO 
 P450 139-3  YES   YES 
 DNA D/G/H  YES   YES  
 MscL   YES   YES  
 
Table 2:  Transfer of crystallization conditions using growth device. 
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Screening around chip-based conditions was found to have a success rate that is 
comparable to growth chip experiments using the exact chip-based condition.  Since no 
additional chemical optimization was used in growth-chip experiments (although the 
kinetic variable was manipulated) this result supports the hypothesis that the slow diffusive 
equilibration between wells allows for more efficient sampling of crystallization phase-
space.  The overall success rate of the growth chip from this trial was 67 %.   
 
Consistent with the increased reaction volume, the size of crystals grown in the growth chip 
was generally larger than that of crystals grown in the screening device.  Figure 52 shows 
large crystals of DNA B/C, MscL, and P450 139-3 grown in a growth device.  The time 
required for crystal growth varied substantially, depending on the crystallization target.  
Crystals of MscL appeared after two days of incubation in growth device.  This incubation 
time is similar to that observed in the screening device (1 to 2 days).  In contrast, crystals of 
DNA B/C appeared after only 2 days of incubation in the screening device, but required 
greater than 14 days to appear in the growth device.   
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Figure 52:  Protein crystallization conditions successfully transported from screening 
device (≈ 10 nL) to growth device (≈ 300 nL).  (A) Large crystals of DNA B/C grown in 
condition identified in screening device (D).  (B)  Crystals of MscL grown in harvesting 
device using successful condition from screening device (E).  (C)  Large crystal of heme 
domain of P450 alkane hydroxylase, MUT 139-3.  Condition was discovered and 
optimized in screening device (F).  All scale bars are 100 µm. 
 
Another interesting observation was that some crystallization targets exhibited a clear 
dependence of crystal size and morphology on connecting channel length.  Crystals of 
DNA B/C grown by µFID in identical chemical conditions, at the same mixing ratio, but 
with different connecting channel lengths are shown in Figure 53.  This illustrates the 
importance of varying mixing kinetics as an optimization parameter.  In contrast, crystals 
of MSCL showed similar size and morphology at all connecting channel lengths.     
 
 
 139
 
Figure 53:  Dependence of crystal size and morphology on connecting channel 
geometry.  (A)  Crystals of DNA helicase B/C complex.  Mixing ratio of 2:1 
(protein:precipitant).  Precipitant is 2.0 M (NH4)2SO4, 0.1 M CAPS pH 10.5, 0.2 M 
Li2SO4.  Connecting channel length: 2000 µm.  (B)  Crystals of DNA helicase B/C 
complex grown in same conditions as (A).  Connecting channel length: 250 µm.  (C)  
Crystals of DNA helicase B/C complex.  Mixing ratio of 4:1 (protein:precipitant).  
Precipitant is 2.0 M (NH4)2SO4.  Connecting channel length: 500 µm.  (D)  Crystals of 
DNA helicase B/C complex grown in same conditions as (C).  Connecting channel 
length: 2000 µm.  All scale bars are 100 µm. 
 
 
 140
Harvesting from the Growth Device  
The protocol for extracting crystals from growth chip devices is similar to that used for 
extraction from screening devices.  The device is flipped upside down and a scalpel is used 
to cut around the periphery of the well containing the crystals creating a “patch” of 
elastomer that may be removed to expose the well.  A drop of cryo-protectant solution into 
which the crystals will be transferred is dispensed near the edge of the patch.  Peeling the 
patch from the rest of the device draws the cryo-protectant onto the exposed well, covering 
the crystals.  The crystals may then be removed using standard cryo-loops and flash-frozen 
in liquid nitrogen.  Although cumbersome, this general method (with slight variations) has 
allowed for the extraction of crystals for diffraction studies.  In the case of robust model 
proteins (eg. lysosyme, glucose isomerase, ferritin) high-resolution diffraction data has 
been collected using growth chip grown crystals.  Additionally, crystals extracted from 
growth chips have been used to collect high-resolution data from drug target proteins with 
previously unknown structures (personal communication with Fluidigm). 
 
Attempts to harvest more fragile crystals from growth devices have produced varied 
results, exhibiting diffracting power equal or inferior to crystals grown and harvested by 
conventional techniques.  Chip-grown crystals of DNA D/G/H diffracted to 5.5 Ǻ 
resolution.  This result is comparable to crystals grown and harvested from hanging drop 
formats, indicating that the low resolution may be attributed to the large unit cell, small 
size, incorrect cryo-protectant, or poor order of the crystal.  In another instance (Rho) 
crystals showed evidence of damage during harvesting from chip.  Crystals of Rho 
extracted from the growth chip diffracted to approximately 4 Ǻ resolution, while crystals 
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grown from the same condition in hanging drop format diffracted to 3 Ǻ resolution but 
displayed increased mosaicity.   
 
Harvesting crystals of DNA B/C from the growth device has been particularly problematic.  
A large number of crystals of DNA B/C (approximately 50) harvested from growth chips 
showed very poor diffraction, varying between 25 Ǻ and 8 Ǻ.  By comparison a very small 
(~1000 µm3) single crystal of DNA B/C (that could not be reproduced), grown after 
approximately 3 months of incubation in hanging drop format, diffracted to 3 Ǻ and 
exhibited the same space group as chip-grown crystals; suggesting that the poor diffraction 
of chip-grown DNA B/C crystals is due to damage during harvesting.    
 
Diffraction Device: Membrane-Mediated Vapor Diffusion 
The straightforward scaling up of µFID reactions in the form of a growth device has been 
successful in producing large diffraction-quality crystals.  This strategy has however not 
proven to be generally applicable in either the transport of successful conditions to larger-
volume formats or the harvesting of diffraction-quality crystals.  These shortcomings are 
attributable to dehydration/hydration effects resulting from the permeation of water vapor 
through the bulk silicone elastomer.  To realize a high correspondence method of scaling 
up crystallization conditions and provide clear path to structure the following criteria must 
be met.  
 
1.  In order to achieve high correspondence with µFID screening reactions, the device must 
preserve the kinetics of microfluidic mixing while providing larger reaction volumes. 
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2.  In order to achieve high correspondence with µFID screening reactions, the device must 
provide control over permeability effects and must allow for different rates of 
hydration/dehydration to be screened. 
3.  To avoid damaging fragile crystals, the device must allow for harvesting and mounting 
with minimal crystals manipulations. 
4.  In order to asses the quality of crystals independent of any cryo-protectant addition or 
freezing process, it is necessary that the device allow for facile room temperature 
diffraction studies. 
5.  The device must allow for the controlled addition of cryo-protectant to the crystal wells. 
6.  The device must allow for the facile screening of a broad range of cryo-protectants in 
order to quickly asses optimal freezing conditions. 
7.  The method of crystal harvesting and automation should be amenable to high-
throughput automation and therefore must eliminate the need for delicate crystal 
manipulations (i.e., “looping”). 
8.  To ensure that crystals are harvested at the optimal time the device must allow for the 
harvesting of crystals from selective wells without disturbing adjacent reactions.  
9.  To facilitate alignment of crystals within the X-ray beam the mounting format should 
provide minimal optical aberration. 
10.  The mounting format must allow for the collection of high-quality diffraction data over 
a wide range of angles with acceptable background scatter and attenuation. 
 
A diffraction device designed to simultaneously preserve the successful mixing kinetics of 
the µFID reactors and allow for precise control over dehydration/hydration effects is shown 
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in Figure 54.  The device integrates 20 reaction sites, each containing 5 separate µFID 
reactors (inset).  Each of the 100 reactors is designed to have a total reaction volume of 200 
nL, thereby scaling up the volume of the screening device by a factor of 20.  All reaction 
sites are connected in parallel to a single protein inlet and a single precipitant inlet.  The 
connecting channel between the chambers is designed to have lateral dimensions of 150 µm 
x 18 µm resulting in a cross sectional area that is approximately 3 fold larger than that of 
connecting channels in the screening device.   
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Figure 54:  Diffraction chip for scaling up crystallization conditions and harvesting 
protein crystals.  Protein sample and crystallizing agents are mixed at 20 separate reaction 
sites (inset) featuring 5 µFID reactors. 
 
In order to increase the probability of successfully scaling up conditions, different versions 
of the device were designed to screen the effect of mixing ratio and channel length.  A 
layout of a diffraction device designed to allow for optimization of both the mixing ratio 
and mixing rate in the initial transport of crystallization conditions to larger volume formats 
is shown in Figure 55.  Each reaction site has 5 reactors at one of the mixing ratios used in 
the screening device (4:1, 2:1, 1:1, 1:2, 1:4).  Additionally the connecting channel length is 
varied across the device from 200 µm to 1200 µm.  Once the optimal reactor geometry is 
determined by an initial diffraction chip experiment the condition is repeated on a separate 
device that reproduces only this geometry over the 100 reactors.  This redundancy allows 
for the production of a large number of crystals from identical conditions to be used in 
optimizing cryo-protection and freezing protocols. 
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Figure 55:  Layout of diffraction device.  Two control lines (red) actuate all interface and 
containment valves in parallel.  Flow structure at each reaction site defines a unique 
combination of mixing ratio and connecting channel geometry (blue).  150 µL reagent 
reservoirs (black circles) allow for control over rate and extent of dehydration. 
 
In addition to preserving the mixing kinetics of the screening device, the diffraction device 
further allows for control over the extent and rate of dehydration/hydration.  The key 
distinction between the diffraction device and the growth device is that each of the 20 
reaction sites is embedded in a 250 µm thick silicone membrane located at the bottom of 
separate 150 µL reagent reservoir.  A cross section of this membrane showing the enclosed 
fluidic structure is shown Figure 56.   
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Figure 56:  Optical micrograph of cross section of elastomer membrane containing µFID 
reactors.  142 µm high reaction wells are enclosed at the top and bottom by two 50 µm 
thick elastomer membranes.  The image is inverted so that the membrane containing the 
constricted connecting channel (in plane), valve membrane, and control channel (cross 
section) are visible at the top of the structure.   
 
Efficient vapor transport through the thin membrane may be exploited to exercise control 
over the rate and extent of evaporation.   The 150 µL wells overlaying each reaction site are 
filled with a fluid chosen to control the rate or extent of hydration/dehydration from the 
reactors.  For example an “osmotic bath protocol” may be used in which a solution of 
known concentration may is added to the reservoir and sealed with clear adhesive tape.  
During the course of an experiment this solution will equilibrate with the contents of the 
reactor through membrane-mediated vapor diffusion, and therefore defines an osmotic bath 
that may be used to precisely control the final extent of dehydration from the reactor 
(Figure 57).  The volume of the osmotic bath is much larger than that of the reactor so the 
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final state is independent of the contents of the well.  In order to ensure the reactor 
equilibrates to the same osmotic strength as the osmotic bath it is necessary that a low 
vapor pressure control fluid (eg. fluorinated silicone oil) be used in the control lines.  
Additionally, since slow dehydration through the elastomer may occur (over several weeks) 
the osmotic bath solution should be periodically replenished to ensure a well-defined final 
state.   
 
 
 
Figure 57:  Schematic of diffraction device reaction site illustrating combined 
equilibration resulting from µFID reaction and membrane-mediated vapor diffusion. 
 
Control over reagent dehydration provides an additional parameter that may be used in 
crystal optimization.  Since the 20 reaction sites of the device may be manipulated 
independently using different osmotic bath conditions the final level of 
dehydration/hydration to be screened across the device.  This is useful both in scaling up 
crystallization conditions and in optimizing crystal quality.  Figure 58 shows a gallery of 
lysosyme crystallization trials using identical chemical conditions and different 
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concentrations of osmotic bath solution.  The ease with which the osmotic bath conditions 
can be exchanged makes it straight forward to manipulate the concentration of 
crystallization reagents over time.  This added level of control may be used to transiently 
increase the supersaturation for a well-defined time as a means for controlling crystal 
nucleation.  Additionally, once crystals are formed, the osmotic bath may be exchanged for 
progressively more dilute solutions in order to investigate the solubility of crystals - 
information which is extremely valuable in crystal optimization, harvesting, and seeding 
experiments.   
 
 
 
Figure 58:  Influence of osmotic bath solution on crystallization of Lysosyme.  Mixing 
ratio 2:1 (protein:precipitant).  Precipitant is 2 M NaCl, 0.1 M Sodium Acetate, pH 5.2.  
Osmotic baths are 0 M NaCl (A), 1.0 M NaCl (B), 2.0 M NaCl (C), and 4.0 M NaCl (D).  
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Concentrated osmotic bath (D) shows pronounced shrinking of wells and coexistence of 
tetragonal (second from right) and orthorhombic crystal forms (thin needles).  All scale 
bars are 800 µm. 
 
Membrane-mediated vapor diffusion may also be used to modify the pH or chemistry of 
the reactors over time.  Volatile chemicals added to the reagent reservoir will cross the 
membrane in vapor phase.  This is particularly useful for the addition of volatile cryo-
protectants (eg. isopropyl alcohol, ethanol), cross-linking agents (eg. gluteraldehyde, 
fomaldahyde), or volatile ligands (eg. ethane).  Finally, in cases were crystals grow in the 
presence of a modest concentration of cryo-protectant (eg. glycerol, low molecular weight 
PEG, MPD, lithium sulfate), the osmotic bath may be used to concentrate these agents 
sufficiently so that they freeze into an amorphous glass.   
 
Crystallization Using “Osmotic Bath” Protocol 
Initial experiments using the “osmotic bath protocol” described above were successful in 
the crystallization of proteins lysosyme, ferritin, glucose isomerase, and MscL.  However, 
subsequent trials using hdTfR/HFE, DNA B/C and P450 1-12G failed to produce crystals 
despite extensive exploration of the final reaction state.  Experiments with DNA B/C 
further showed evidence of convective transport between the two wells visible as a plume 
of protein precipitation.  The cause of this convection was determined to be osmotic 
differences between the sample and the reagent well during the initial stages of 
equilibration.  The time constant for equilibration between the osmotic bath and a reaction 
chamber may be approximated as 
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where w is the membrane thickness, V is the reactor volume, ρliq is the mass density of 
water, ∆Pvap is the difference in vapor pressure between osmotic bath and the reagents, KP 
is the permeability of the silicone rubber, A is the area of the membrane, and , ρgas is the 
mass density of the water vapor.  Assuming an initial concentration difference of one molar 
(∆Pvap ≈ 3.5 cmHg), a permeability to water vapor similar to that for CO2 (KP ≈ 5*10-7 
cm3·cm/cm2·s·cmHg) (30), a ratio of densities ρliq/ρgas ≈ 1000, and given the reactor and 
membrane geometries used in the diffraction chip, this time constant is approximately 12 
hours.  In comparison the time constant for diffusive equilibration of a salt (D ≈ 1000 
µm2/s) between two chambers of 100 nL volume connected by a 500 µm long connecting 
channel of 2250 µm2 cross section is on the order of 5 hours.  These two timescales are 
comparable resulting in an osmotic pumping effect between the coupled wells which 
destroys the desired diffusive mixing.  In order to preserve diffusive mixing between the 
wells the use of the “osmotic bath” protocol was abandoned during the initial diffusive 
equilibration phase.  The use of an osmotic bath in manipulating the final amount of 
dehydration after initial diffusive mixing is however complete is very useful in establishing 
a reaction of well-defined chemistry.   
 
Crystallization Using “Permeation Barrier” Protocol 
An alternative “permeation barrier” protocol was devised in which permeable oil (FMS oil) 
is introduced into the reagent reservoirs overlaying the reaction chambers.  Since the oil is 
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immiscible in water it does not induce an osmotic pumping effect between the wells so that 
the desired equilibration by diffusion is preserved.  The oil creates a barrier to vapor 
permeation and therefore allows for the rate of dehydration to be modulated.  By varying 
the level/amount of oil in each chamber the rate of dehydration may be controlled and 
screened across the device, mimicking the permeability effects that are realized in the 
screening device.    The effectiveness of this protocol was evaluated in crystallization trials 
using the 6 of the 7 protein models that had previously been tested using the growth chip 
(P450 139-3 was not tested).  All 6 of the model proteins were successfully crystallize on 
the first attempt, thereby showing this protocol to be a high correspondence method of 
scaling up crystallization conditions identified in the screening device.  Figure 59 shows 
crystals of Rho grown using this protocol. 
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Figure 59:  Crystals of Rho grown in diffraction device.  1:1 mixing ratio of protein 
sample (Rho 10 mg/mL, excess RNA (CU)4, 75 mM NaCl, 10 mM TRIS·HCl pH 7.5) to 
precipitant (5% w/v PEG 8000, 40% v/v glycerol, 75 mM NaCl).  Scale bar is 300 µm. 
 
Diffraction Device: In Silicone Diffraction Studies 
Complementary to novel technologies for high-throughput screening and crystal growth is 
the need to develop general methods for quickly harvesting and mounting protein crystals.  
Traditional techniques for manually mounting crystals by “looping” the crystal out of a 
drop of mother liquor require significant skill on the part of the technician and are not 
amenable to automation.  Furthermore, since the vast majority of diffraction studies are 
performed at cryogenic temperatures, harvesting requires the selection and addition of 
cryoprotectant.  The choice of cryoprotectant, the concentration of cryoprotectant, and the 
rate of cryoprotectant addition are parameters that must be optimized to achieve the 
maximal diffracting power of the crystal: poorly optimized freezing conditions can result in 
greatly reduced crystal diffraction.   
 
In cases where diffraction is poor it can be difficult to ascertain whether the crystal was 
inherently disordered or damaged during the mounting and freezing process.  Room-
temperature diffraction studies can be used as a diagnostic to evaluate the inherent order of 
a crystal form prior to screening freezing parameters.  In practice room temperature mounts 
in capillaries are difficult to implement, can mechanically damage crystals, and are rarely 
used for all but a last resort.  Easy methods for performing in situ diffraction studies of 
crystals that do not require mechanical manipulations or the exchange of mother liquor are 
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therefore of great value in evaluating the quality of crystals.  The extension of these 
methods to allow the automated harvesting of crystals, facile cryoprotectant screening, and 
low background diffraction studies at cryogenic temperatures will relieve a major obstacle 
in the structure determination process.            
  
Beyond allowing for control over dehydration during crystallization, the thin membranes of 
the diffraction device allow for direct in silicone diffraction studies.  Once a specific 
reaction site is selected for harvesting, a thin membrane disk containing the crystals may be 
extracted from the device.  A punch tool is inserted through the open face of the reagent 
reservoirs and used to cut around the periphery of the membrane, creating a “crystal disk”.  
Since the reagent reservoirs are located near the center of the membrane there is no risk of 
damaging the crystals during this process.  The punch tool is designed to fit the orifice of 
the reagent reservoir so that it is inherently self-aligning.  Crystals may be extracted 
without the need for delicate manipulations under magnifying optics so that the extraction 
procedure is readily amenable to automation.  Furthemore, many crystals within a disk may 
be harvested simultaneously in a single procedure, thereby greatly increasing the 
throughput of extraction.   
 
After the crystal disk is cut from the surrounding elastomer it is lifted from the reagent 
reservoir and mounted using a standard magnetic cap fitted with a small alligator clip 
(Figure 60A).  Once the crystal disk is positioned in the x-ray beam the crystals may be 
easily visualized through the thin transparent membrane.  The crystals may then be 
interrogated one by one to asses their quality and to generate statistics on the quality of 
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crystals grown in a given condition.  A large savings in time is achieved by eliminating the 
need for the separate mounting of each crystal screened.  Alpha-numeric indices on each 
well allow for easy cataloguing of conditions.   
 
 
 
Figure 60:  (A)  250 µm thick crystal disk mounted on a cryo-cap fitted with a micro-
alligator clip.  Diameter of disk is ¼ inch.  (B)  Diffraction pattern from a single MscL 
crystal showing highest-order reflections at approximately 11.5 Å.  Crystals were grown 
at 4 °C by µFID at a 1:1 mixing ratio with precipitant (40 % v.v PEG MME 750, 100 mM 
nickel chloride, 100 mM imidazole pH 8.0).  Image taken at 4 °C with 20 minute 
exposure on R-AXIS II home source with 1° oscillation.  Characteristic ring diffraction 
pattern of the silicone elastomer is visible at approximately 7 Ǻ. 
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This technique was used to evaluate the intrinsic order of crystals of MscL grown in 
diffraction devices.  Approximately 10 crystals were subject to diffraction studies at room 
temperature on a Rigaku R-AXIS II home source.  Exposure times of 10 to 30 minutes 
were taken with 1 ° oscillation at an angle normal to the face of the crystal disks.  Of the 10 
crystals studied the highest-order reflections were observed at 9 Ǻ resolution.   
Representative diffraction data from a crystal of MscL collected in silicone at room 
temperature is shown in Figure 60B.  The low resolution data collected from these crystals 
suggests that the crystals are inherently disordered. 
 
The flash freezing of crystals to cryogenic temperatures (typically -195 °C) is used to 
reduce x-ray radiation damage and hence increase the amount of data that can be collected 
from a single crystal.  The correct choice and controlled addition of cryo-protectant is a 
crucial step in achieving the full diffraction potential of a crystal.  The diffraction device 
allows for both the parallel screening of different cryo-protectants, and the controlled 
addition of these agents by free interface diffusion.  To introduce cryo-protectant to a µFID 
reactor the osmotic bath solution is first replaced with a solution containing the desired 
cryo-protectant.  The membrane covering the well opposite to the well containing crystals 
is then perforated using a micro-knife bringing it into fluidic contact with reservoir 
solution.  This allows for the cryo-protectant to slowly diffuse into the crystal well over 
time.  For the current well volume and channel geometry the required time for cryo-
protectant addition is approximately 24 hours.  The parallel screening of 20 different cryo-
protectants is accomplished on a single device having identical reaction sites.  Once the 
equilibration of cryo-protectant is complete the crystal disks are extracted as described 
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above and flash frozen by immersion in a cryogen (liquid nitrogen).  As an alternative to 
introduction directly from the reagent reservoir the cryo-protectant could be introduced to 
the µFID reactors using a separate microfluidic inlet.  This arrangement would further 
allow for addition of other solutions such as ligands, heavy metals, or fresh protein stock. 
 
Cryogenic in silicone diffraction studies were performed on crystals of 3 crystallization 
standards (lysozyme, glucose isomerase, ferritin), and MscL using a variety of 
cryoprotectants.  6 crystal disks containing crystals of MscL grown from the same 
precipitant (40 % v.v PEG MME 750, 100 mM nickel chloride, 100 mM imidazole pH 8.0) 
were harvested from a single device.  These disks were frozen in a variety of cryo-
protectants (15% PEG 300, 35% PEG 300, 25% propane diol, 20% PEG 300, 28% xylatol, 
20 % glycerol).  A single oscillation frame was taken of approximately 40 crystals from 
these disks.  All crystals showed comparable diffracting power with the average resolution 
of typically less than 10 Å.  The highest-order reflections observed were at approximately 9 
Å.  This result is consistent with diffraction studies conducted at room temperature and 
supports the hypothesis that these crystals are intrinsically poorly ordered. 
 
In contrast, diffraction studies using the three crystallization standards showed very high-
resolution diffraction.  Three-dimensional glucose isomerase crystals having a 
characteristic dimension of 100 µm diffracted to 1.4 Å resolution and exhibited low 
mosaicity (0.3).  Similarily, ferritin crystals diffracted to 1.6 Å resolution with mosaicity of 
0.2.  Crystals of lysozyme shot through the crystal disk diffracted to 1.2 Å resolution.  This 
resolution is very high, particularly in light of the fact that a five-month-old stock of 
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lysozyme was used with no optimization of crystallization or harvesting conditions.  By 
comparison, of the 884 structures of lysozyme deposited in the protein data bank all but 10 
are of lower resolution.   
 
Three diffraction patterns from a crystal disk containing a 150 µm x 100 µm x 100 µm 
lysozyme crystal taken at -195 °C is shown in  
Figure 61.  The patterns are taken at 0°, 45°, and 90° from normal to the plane of the disk.  
Rotation of the crystal disk changes the thickness of elastomer through which incident and 
diffracted x-rays must travel, changing both the attenuation of reflections and the amount of 
background scatter.  The signal to noise of reflections is still high at a disk angle of 45° to 
normal so that data may be collected over a 90° angle.  At 90° to normal the incident and 
diffracted x-rays must pass through a large amount of elastomer, resulting in the 
elimination of all but the strongest reflections and a large and asymmetric background 
scatter.   
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Figure 61:  In silicone diffraction studies of lysozyme.  (A)  Diffraction pattern take at 0° 
from normal to plane of disk: 20 minute exposure with 1° oscillation, detector distance of 
250 mm.  (B)  Diffraction pattern take at 45° from normal to plane of disk: 20 minute 
exposure with 1° oscillation, detector distance of 250 mm.  (C)  Diffraction pattern take 
at 90° from normal to plane of disk: 20 minute exposure with 1° oscillation, detector 
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distance of 250 mm.  (D)  Clean reflections at 1.6 Å resolution: 30 minute exposure with 
1° oscillation, detector distance of 100 mm.  All data taken on R-AXIS IV home source. 
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C h a p t e r  9  
PRACTICAL CONSIDERATIONS: FABRICATION AND OPERATION 
Introduction 
Since the first reports of microfluidics for use in analytical chemistry and the biological 
sciences, major efforts have focused on achieving highly integrated lab-on-chip devices.  
Despite the compelling promise of chip-based fluid-handling and measurement systems, 
technical obstacles have until recently made this goal largely unrealized.  The fabrication of 
true sealing microvalves, a long-standing problem in the field, was addressed by Unger et 
al. in the development of Multilayer Soft Lithography.  This elegant work represented a 
major breakthrough in microfluidics, allowing for the robust and inexpensive integration of 
valves in a monolithic silicone elastomer device.   
 
Realizing the potential of MSL in achieving dense integration and high levels of 
functionality required that technical problems related to fabrication and device operation to 
be overcome.  One major advance, the development of a technique for filling elastomeric 
microfluidic devices called Pressurized Outgas Priming (POP), is described in Chapter 2.  
This technique is the basis for a robust geometric metering scheme, allows for the 
suppression of bubble formation, and enables the practical realization of complex large-
scale fluidic networks.  The first section in this Chapter introduces the technique of 
multilayer soft lithography (MSL).  The remaining sections outline the author’s 
contribution to the development and refinement of techniques for device priming, substrate 
bonding, and layer-layer alignment.  Additionally, other fabrication issues and techniques 
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for creating multilevel flow structures, and alternate valve geometries are discussed.  It is 
the author’s intention that this Chapter will provide a useful introduction to several 
important considerations for researchers who are interested in MSL technology.  
 
Multilayer Soft Lithography: Background 
Multilayer Soft Lithography (MSL), which is an extension of Soft Lithography (26, 92), 
enables the facile and inexpensive large-scale integration of valves on chip (13, 27).  MSL 
describes a process by which consecutive micro-molding and layer bonding steps are used 
to generate complex multilayer fluidic devices with active mechanical valves, pumps, 
mixers, and flow control logic.  Both replica molding from microfabricated masters and the 
use of elastomer membranes for actuation of microfluidic valves predates the multilayer 
soft lithography.  MSL technology seamlessly integrates these ideas in an elegant and 
simple fabrication process.  The enormous success of this technique can be largely 
attributed to a method developed by Unger et al. for covalently bonding successive layers 
of silicone elastomer.   
 
Due to their excellent optical properties, low surface energy (22 mJ/m2), and low Young’s 
modulus, silicone rubbers have become the most popular material for multi-layer soft 
lithography.  Silicone rubbers are typically formed from the combination of two liquid 
components that cross-link into a flexible solid upon curing.  One such example polymer is 
General Electric RTV 615.  Part A of this compound consists polydimethylsiloxane 
polymers that have been functionalized with vinyl groups.  Part B contains silicon hydride 
(Si-H) groups that covalently bond to the vinyl groups of part A, cross-linking the 
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polymers.  In the presence of a platinum catalyst the silicon hydride groups become 
covalently bonded through a direct addition reaction to the vinyl groups, thereby 
solidifying the mixture through a cross-linking process (Figure 62).  The low curing 
shrinkage and absence of gaseous byproducts makes this system ideal for the high-fidelity 
reproduction of microfabricated features.   
 
When mixed at the stoichiometric ratio of 10:1 (A:B) there is an equal number of vinyl and 
silicon hydride groups, so that all reactive groups are incorporated into a covalent bond.  
However, when combined at a different ratio, there remain active groups that do not 
participate in a covalent bond, and which instead may be used to permanently bond two 
surfaces together, creating a monolithic device (Figure 62).   
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Figure 62:  MSL bonding process.  Cross-linking of polymer through direct addition 
reaction of silicon hydride and vinyl groups (top).  Off-ratio mixing of silicone results in 
excess reactive surface groups for covalent layer-layer bonding.  
 
A process flow diagram illustrating the steps in MSL is shown in Figure 63.  Two negative 
molds, one defining the flow structure, and the other defining the control structure of 
valves, are first patterned on a silicon wafer using conventional photolithography, leaving 
10 µm raised features of photo-resist.  The flow layer master is then annealed so that the 
photo-resist is allowed to re-flow, creating rounded flow channels.  Masters are reproduced 
by replica molding in silicone rubber.  A 30:1 ratio of (A:B) silicone rubber, having excess 
vinyl groups, is spun onto the flow mold to a final thickness of 30 µm.  A 3:1 silicone 
rubber layer, containing excess silicon hydride groups, is cast over the control mold to a 
thickness of approximately 7 mm.  Once both layers are heated and allowed to partially 
cure, the structures solidify.  The control layer is then peeled from the mold, punched to 
create valve access ports, and aligned to the flow structure.  The entire device is then heated 
once again, causing the excess vinyl and silicon hydride groups to covalently bond.  The 
resulting monolithic device is peeled from the flow mold, and channel access ports are 
punched into it prior to sealing the multilayer polymer to a glass substrate.  The substrate 
itself may additionally have structural features, such as microwells that may be accessed 
through the molded channels, thus providing larger localized volumes for reactions to 
occur.  
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Figure 63:  Flow diagram illustration technique of multilayer soft lithography. 
 
When a control channel crosses over a flow channel, only a thin square membrane of 
elastomer separates the two, forming a valve (Figure 64A).  By pneumatic or hydraulic 
pressurization of the control channel, the membrane may be deflected down into the flow 
channel, causing it to seal against the glass substrate (Figure 64B).  Due to the compliance 
of the membrane, a hermetic seal may be easily achieved at moderate actuation pressures 
even in the presence of particulates or imperfections.  The low Young’s modulus of the 
elastomer ( ~1 MPa vrs ~100 GPa  for crystalline silicon) allows for closing of valves 
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having areas as small as 100 µm2, so that many thousands of active valves may be 
integrated on a chip smaller then a credit card (27).  Just as the transistor is the fundamental 
component in modern electronic circuitry, higher level fluidic toolbox of components may 
be built up from combinations of valves.   
 
 
 
Figure 64:  MSL valves.  (A) Micrograph of an open valve showing control (horizontal) 
and flow (vertical) structures.  (B) Closed valve.  Application of pressure to control 
structure deflects membrane and pinches off flow structure, creating a fluidic seal.  
 
Unger et al. described the serial combination of three separately addressable valves along a 
channel to form a peristaltic pump (Figure 65).  When operated in the linear regime (below 
the cutoff frequency) sequential actuation of these valves through a designated peristaltic 
cycle of states moves a fixed volume of fluid across the pump.  This pump allows for the 
flow direction to be reversed through reversal of the peristaltic sequence.  The Navier-
Stokes equations, which describe the flow of a Newtonian fluid at low Reynolds number 
are time-reversible so that reversal of the peristaltic sequence causes an exact time-reversal 
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of the unsteady flow field due to forward pumping, regardless of symmetry breaking in the 
flow structure upstream and downstream of the pump.  Interestingly, the cycling of two 
valves is sufficient for producing a directional flow if symmetry is broken through the time 
sequence (personal communication with Jian Liu).  Below the pump cutoff frequency the 
flow rate is proportional to the peristaltic cycling rate, thereby allowing for programmable 
control of the mass flux. 
 
 
 
Figure 65:  Peristaltic pump. 
 
Chu et al. described a rotary mixer which features the integration of a peristaltic pump in a 
contained circular flow structure to accelerate the mixing of reagents.  Batch mixing is 
achieved through the dispersion of the reagents within the flow structure as they circulate 
through the ring.  Using this method the time required for the mixing of two solutions was 
reduced from many hours to minutes.  Chapter 5 describes the incorporation of this mixing 
structure as a key element in achieving true combinatorial mixing on chip.  An analysis of 
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the scaling laws that govern the mixing speed, numerical simulations of mixing, and the 
optimization of this element for ultra-fast mixing are presented in Chapter 6.   
 
The actuation pressure required to close a valve is dependent on the geometry of the valve 
junction and the material properties of the elastomer.  For elastomer membranes fabricated 
from 20:1 GE RTV bonded to 5:1 GE RTV, and a standard geometry of a 10 µm high flow 
channel, a 20 µm thick membrane, and a 100 µm x 100 µm valve, the required actuation 
pressure is approximately 6 psi.  The strong dependence of actuation pressure on the 
channel and valve geometry may be exploited to engineer bridges (valves with very high 
actuation pressure) by simply tapering the thickness of a control channel in the vicinity of a 
flow channel that is not to be closed.  By applying an intermediate actuation pressure, a 
single control channel may be used to close a plurality of selected flow channels without 
significantly impeding flow in adjacent lines.   
 
Chou proposed the use of bridges in realizing a microfluidic multiplexing element.  This 
element uses an array of complementary valve pairs organized in binary-tree architecture to 
selecting 1 of N flow lines using 2log2N control lines (Figure 66).  This element enables the 
realization of increasingly complex fluidic structures with only a modest rise in control 
complexity.  The straightforward implementation of this design was first demonstrated in 
early protein crystallization designs.  More complex multiplexing structures have been 
instrumental in realizing large-scale fluidic integration (27), and on-chip combinatorial 
mixing.   
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Figure 66:  Parallel-channel multiplexing structure.  Each pair of complementary valves 
comprises a bit.  
 
Elastomer Shrinkage 
The polymerization of poly(dimethyl-siloxane) does not require the removal of a solvent, 
and does not produce bi-products.  These properties ensure that very little elastomer 
shrinkage occurs during curing when compared to other elastomer systems (typically with 
volume shrinkage on the order of 10% - 30%).  Nevertheless, even slight intrinsic 
deformation of a molded structure, when integrated over the full length of a device, can 
result in unacceptable feature registration errors.  Although this problem was tolerated in 
early MSL devices (cell and DNA sorters), by maintaining small active device areas 
(approximately 10 mm2), few valves (less than 10), and large registration tolerances, it 
placed unacceptable constraints on early screening device designs that necessitated larger 
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areas (10 cm2) and higher levels of integration (approximately 200 valves).  A linear 
shrinkage of 1% over the typical length of a device results in misalignment between 
features that is large (300 µm) compared to the feature dimensions (100 µm).   
 
Initial curing of the elastomer layers prior to bonding results the isotropic shrinkage of the 
structures.  Since both layers are supported by a silicon substrate during curing, this 
shrinkage is manifested as an expansive strain in the thick layer (7 mm) and thin film 
(approx 25 µ).  Release of the thick layer prior to alignment releaves this strain causing a 
compression of the molded features.  This compression was found to be reproducible and 
can therefore be compensated for by a complementary expansion of the mold features.  A 
systematic study of a silicone elastomer system (GE 615 RTV) was carried out to 
determine the degree of shrinkage during polymerization.  A microfabricated ruler 
consisting of an array of lines spaced at 100 µm intervals was fabricated for the 
measurement of elastomer shrinkage.  The elastomer was mixed at a ratio of 5 part A : 1 
part B, cast to approximately 7 mm, degassed, and cured at 80 °C for 1.25 hours.  The 3 cm 
molded elastomer part was aligned at one end to the original mold and inspected using an 
optical microscope.  The total shrinkage of the molded part over the 3 cm pattern was 
determined to be 450 ± 50 microns, corresponding to a linear compression of 
approximately 1.5 %.  The molded part was subsequently cured overnight (approximately 
20 hours) and compared to the master once more.  The final shrinkage after full curing was 
determined to be approximately 2.5 %.  Correct registration of features over 3 cm with 10 
µm alignment tolerances was achieved by the compensatory expansion of appropriate 
master molds by these factors.           
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Layer-Layer Registration 
As the complexity of devices has increased techniques for the precise alignment of 
complex molded elastomer parts have been developed in parallel by many members of our 
lab, most notably by Todd Thorsen, Sebastian Maerkl, Jian Liu, and myself.  This 
discussion is intended to elucidate the process by which micromolded structures can be 
manually aligned to micron precision over a large active area; a task that will seem unlikely 
to readers with little experience in this area. 
 
Ignoring leveling considerations, correct alignment of part to a substrate requires the 
simultaneous control of two translational degrees of freedom and one rotational degree of 
freedom.  Techniques for the alignment of hard planar substrates for wafer bonding 
applications are well established and can achieve alignment tolerances below 1 µm.  In 
contrast, soft structures present a nontrivial alignment problem due to curing shrinkage, 
elastic deformation, and unlevel cast parts.  This problem is accentuated in the manual 
alignment of large compliant parts where physical manipulations invariably introduce 
mechanical deformations which are large compared to the feature sizes.  Furthermore, the 
precision with which an average person can perform manipulations is limited to several 
tens of microns.   
 
Nevertheless a technique of iterative alignment and mechanical force-motion transduction 
enables the manual alignment of features over a large working area with micron-scale 
precision.  The part is first aligned to the substrate as precisely as possible, creating a 
reversible bond.  Typically this will result mechanical deformations of the piece (warping), 
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translational misalignment errors of approximately 100 µm, and rotational errors on the 
order of a few degrees.  One side of the part is then peeled from the substrate and, with the 
opposite side fixed to the substrate, is realigned by pushing or pulling the piece.  During 
this process the elastomer part acts as a force-motion transducer.  The strain imparted to the 
elastomer is distributed evenly over the length of the unsupported elastomer.  This results 
in a large mechanical reduction so that a 100 µm translation at the end of a 1 cm 
unsupported section produces a 1 µm translation of features located 100 µm from the fixed 
point.  Slowly advancing the contact front and iterating this process allows for micron scale 
alignment to be achieved over a large working area.  The use of elastic materials for force 
transduction and mechanical reduction may find applications in other areas where 
inexpensive micromanipulations are required.     
 
Substrate Adhesion 
Glass-elastomer hybrid flow structures eliminate the need for an additional elastomer 
bonding step and allow for the incorporation substrate features such as electrodes or 
microwells.  Additionally, hybrid structures may exploit the plethora of well-characterized 
surface modifications and functionalization protocols for glass.  Crucial to the operation of 
these devices is the ability to create a strong silicone-glass bond.  Early hybrid devices 
relied exclusively on Vanderwhaals interactions between the glass and the elastomer for 
device sealing.  This resulted in a weak bond that could not withstand fluid pressures in 
excess of approximately 3 psi, and that was easily compromised by mechanical strain 
during the insertion of fluidic input/ouput connectors.  The limited operation pressure of 
these devices necessitated the use of surface modification protocols to increase 
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hydrophillicity and facilitate filling (98). Using this bonding protocol it was found that 
delamination was the overwhelming device failure mode, ultimately resulting in the failure 
of approximately 50% of tested devices.   
 
A method for achieving high-strength silicone-glass bonds by oxygen plasma treatment of 
silicone has been previously described (99).  It is thought that oxygen plasma treatment 
produces reactive groups on the suface that can then covalently bond to the glass substrate.  
Contact angle measurements of oxygen plasma treated silicone give clear evidence of a 
chemical modification that makes the elastomer more hydrophilic.  Efforts to reproduce 
this work in our lab using GE 615 RTV elastomer have resulted in inconsistent and 
incomplete bonding over large surface areas.  Although inconsistent with the proposed 
bonding mechanism, bonding appears to be dependent upon the material system (personal 
communication R. Ismagilov); reported results use Silgard silicone rubbers.  Results with 
Silgard are apparently also inconsistent with variations attributed to contaminants 
introduced in the plasma chamber (personal communication R. Ismagilov).  Another 
practical consideration that makes this technique less attractive is that the surface 
modification is temporary so that bonding must be done shortly after plasma treatment.  
This requirement places impractical time constraints on device alignment and assembly.  
Finally, the bonding is instantaneous so that “one-touch” alignment of devices to substrate 
features is required.      
 
In order to resolve this fundamental problem a new bonding protocol was developed for 
reversible and robust bonding of Silgard and GE silicone rubber to glass substrates.  To 
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achieve a strong reversible bond the device and substrate are rinsed with ethanol, dried 
under a stream of nitrogen, and aligned to one another.  The assembled device is then 
baked overnight at 80 °C.  It was found that this procedure reliably produced seals that 
could withstand greater than 10 psi flow pressures with some seals holding in excess of 30 
psi.  The bonding procedure was shown to work with both Silgard and GE silicones, and 
was compatible with borosilicate crown, soda lime and quartz substrates.  Robust bonding 
with epoxy and BSA functionalized slides has also been achieved (personal communication 
with S. Maerkl).  The mechanism for this bonding is unclear and has not been thoroughly 
investigated.  It is however probable that the ethanol does not participate directly in the 
glass-silicone bonding interaction and that other organic solvents would be equally 
effective.  Limited investigation has showed that ethanol was necessary for bonding, and 
that bond strength increased with bake time.  Furthermore, fully cured elastomers appear to 
bond as well as partially cured elastomers.  Since this technique has been instrumental in 
improving device yield, and has been universally accepted in our lab as a standard protocol, 
the mechanism of bonding warrants further investigation.   
 
Robust Multilayer Bonding 
Multiple elastomer bonding steps are required for the fabrication of MSL devices that do 
not use hybrid glass-elastomer channels, use push-up valve geometries, or that incorporate 
two control layers (see below).  The original protocol for bonding successive elastomer 
layers utilizes alternating mixing ratio compositions of 3:1 and 30:1 (13).  This protocol 
works well for the bonding of thick layers but produces weak bonds for the thin layers that 
are used to create channel and valve structures.  This poor bonding can be attributed to the 
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diffusion of reactive species through the polymer during curing steps (in personal 
communication with Mark Unger).  FTIR studies of cross sections of bonded silicone 
elastomer suggest that as a thick elastomer layer containing excess vinyl groups is bonded 
to a thin silicon hydride-rich layer the short silicon hydride chains can diffuse up into the 
bulk material (personal communication K. Self).  The final material properties of the thin 
film are therefore dominated by the thicker elastomer layer, resulting in a chemical 
composition on the bottom surface that resembles 5:1 silicone.  A strong second bond can 
be formed between a thin film of 20:1 elastomer and a thin film of 20:1 elastomer 
previously bonded to a thick 5:1 layer.  Although this protocol works well for the 
successive bonding of two thin layers, it fails if the thickness of the first bonded film is 
large (greater than 50 µm).  This failure is likely due to incomplete diffusion of the silicon 
hydride groups from the bottom surface of the first layer.      
 
Bubble Formation 
Early MSL devices relied exclusively on pneumatic actuation for implementing valve 
control.  This actuation scheme created problems due to bubble formation resulting from 
permeation of gas across the elastomer membrane.  This mechanism is particularly 
problematic in applications where valves must be operated at high pressures, or actuated for 
prolonged periods of time.  In principal, since the control lines must necessarily be 
maintained at a pressure higher than the working fluid bubble formation can appear 
instantaneously.  In practice surface tension at the channel wall suppressed this process 
until a nucleation event occurs.  The onset of this nucleation can be postponed by initially 
priming the device at high pressure (to ensure no nucleation sites remain).  Once a 
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nucleation event occurs the bubble continues to grow, filling the entirety of the channel or 
breaking off into a string of satellite bubbles.  This phenomena severely limits reliability 
and performance in pneumatically actuated devices. 
 
As an alternative to pneumatics, hydraulic actuation may be used to completely eliminate 
the problem of bubble formation.  The POP technique allows for control structures to be 
“dead-end” filled with a hydraulic fluid without any modification of control channel 
design.  Due to the high gas permeability of silicone and the generally large surface to 
volume ratios of control structures, complete filling of control lines can be achieved in less 
than a minute at modest filling pressures (10 psi).  The choice of hydraulic fluid will be 
application specific, and will be governed by the fluid properties.  The use of dionized 
water as a control fluid has become standard in applications involving aqueous chemistry.   
 
Controlling Reagent Dehydration 
The use of water as hydraulic fluid has the added advantage of reducing reagent 
dehydration issues.  The high permeability of silicone rubber to water vapor implies that 
reagents are constantly subject to dehydration through the bulk material.  This effect is 
pronounced in applications that require long incubation times and can result in complete 
drying of the flow structure.  The rate of dehydration depends on the relative vapor pressure 
of the reagent solution, and hence on it’s composition, and on the partial vapor pressure in 
the surrounding polymer matrix.  The presence of a water-filled control structure in close 
proximity to the reagent line mediates this effect by elevating the partial pressure of water 
vapor near the channels.  At short times this acts to dramatically reduce the rate of 
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dehydration.  This effect has been exploited to reduce dehydration in numerous 
applications including cell-screening arrays (27), PCR devices (32), and protein 
crystallization (29).  At long times a state of dynamic equilibrium is achieved in which the 
rates of vapor transport to and from the reagents are equal.  This equilibrium depends on a 
number of factors including the osmotic strength of the reagents, the proximity and density 
of the control structure, and the ambient temperature and humidity.  The complicated 
interplay of these effects makes the long time dehydration of reagents a difficult parameter 
to control.  This issue is further discussed in Chapter 8 along with methods for controlling 
dehydration.  
 
In some applications it may be advantageous to use alternative control fluids.  In such cases 
material compatibility issues must be considered.  Many common organic solvents such as 
toluene, isopropyl alcohol, and acetone will quickly swell the elastomer, constricting 
control channels.  Other volatile organic solvents such as alcohol will quickly diffuse in gas 
phase through the bulk material and contaminate reagents.  This may be used to advantage 
as a means of slowly introducing chemical species into a reaction; for example in inducing 
cells with ethanol.  Oils may be used as control fluids if no transport of vapor from the 
control lines is desired.  Many oils, including paraffin oil and poly(dimethyl-siloxane) are 
incompatible with silicone rubber and will quickly swell channels.  Highly fluorinated 
silicone oils (FluoroguardTM Dupont, FMS oil Hampton Research) are however compatible 
with silicone rubber and can be used for prolonged periods without detrimental effects.  
Many of these compounds have very high viscosity (approximately 1000 cP), and are 
therefore not suitable for applications requiring fast control response.    
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Push-up Valves 
In the original valve configuration described by Unger et al. the control structure is bonded 
on top of a membrane that is deflected down into a hybrid silicon-glass flow channel 
structure.  In this push-down geometry the membrane is not of constant thickness since the 
flow channel has a rounded cross section.  The difference in valve membrane thickness 
between the center and the edge of the flow channel is equal to the channel height.  The 
added thickness increases the flexural rigidity of the valve.  This increased stiffness results 
in a faster valve recovery time but limits the maximum channel height that can be closed at 
achievable actuation pressures.    
 
The lack of a robust technique for fabricating inter-layer vias implies that all valves must 
connected to a planar continuous control structure terminating at a control input port.  In 
some applications this constraint creates routing problems that are fundamentally 
unavoidable (topologically entangled).  One example of this is the design of a microfluidic 
matrix form combinatorial polymerase chain reactions in which every flow junction must 
be controlled by three separately addressable valves.  The integration of valve structures 
both on the top and the bottom of a flow structure allows for crossing control lines, thereby 
obviating the routing constraints imposed by planar structures.   
 
To this end, an alternative valve-geometry was investigated in which a membrane of 
constant cross section is deflected up into the flow structure.  This push-up geometry is 
more optimal in that a membrane is deflected into a curved shape that matches that of the 
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top of the flow structure.  Push up valves 50, 100, and 200 µm thickness where fabricated 
and tested in the closing of a 10 µm high and 100 µm thick flow channel.  The membrane 
thickness was designed to be approximately 30 µm.  It was confirmed that these valves 
closed at lower actuation pressures than push-down valves of equal lateral dimensions and 
similar minimum membrane thickness.  This solution to the routing problem was ultimately 
abandoned for a planar solution using designed differential actuation pressures (discussed 
below).  Nevertheless, the push-up geometry has been used for the fabrication of valves in 
high channel structures (100), alleviating routing problems (F. Balagadde, personal 
communication) (32), and for the integration of multilevel fluidic flow structures (in 
review, PNAS).  The closure of a 40 µm high flow channel by 200 µm x 200 µm push-up 
valves is shown in Figure 67. 
 
 
 
Figure 67:  Integrated push-up valves for the closure of tall (40 µm) channel structures. 
Figure courtesy of J. Marcus.  One vertex of the matrix is shown in the inset. 
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Variable Pressure Valves 
If control valves have a consistent logical relationship during operation it may be still be 
possible to implement planar control structures despite fundamental routing problems due 
to topological entanglement.  In the case of the microfluidic matrix structure shown in 
Figure 68 operation requires that valve X always be actuated when valve Y is actuated.  In 
this case both valves may be controlled by a single pressure source if the valves are 
designed to have differential actuation pressure thresholds.  The strong dependence of the 
threshold actuation pressure of a valve on valve width may be exploited to tune valve 
actuation pressures, thereby allowing for the selective actuation of certain valves at 
intermediate pressures.  Application of 110 KPa psi pressure causes the closure of valve X 
(width 270 microns) while valve Y (width 96 microns) remains open.  At pressures above 
260 KPa both valves are closed.  This design was used to implement an N by N 
combinatorial PCR microfluidic matrix that amortizes a single slug of polymerase reagent 
over N2 reactions.       
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Figure 68:  Microfluidic matrix structure using variable pressure valves to eliminate 
wiring constraints.   
 
Multilevel Molds 
The ability to combine channel structures having varying height into a single fluidic 
network greatly increases design control and flexibility.  For instance, tall channels can be 
used to create a low-impedance fluidic bus, or to increase flow through long i/o 
connections.  Tall reaction wells can be used to increased reaction volumes while 
minimizing diffusion lengths and surface to volume ratios (see below).  Additionally, 
vertically constricted channel sections can be used as size-specific filters for bead and cell 
capture or column stacking. 
 
The incorporation of valves into multilevel mold structures imposes additional design 
constraints that must be adhered to.  Regardless of whether a push-up or push-down valve 
geometry is used, achieving a good seal requires that the flow channel have a rounded cross 
section.  The fabrication of molds having a rounded flow structure is achieved by thermal 
re-flow of the patterned photo-resist.  Negative photo-resists such as SU8 rely on thermal 
polymerization of UV-exposed regions, and therefore can not be reflowed.  In order to be 
compatible with membrane valves, flow channel sections must therefore be defined using a 
positive photoresist such as Shipley 5740.     
 
For features that do not require rounded cross sections negative photoresists such as the 
SU8 series are superior to positive resists in that they are more mechanically robust, allow a 
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broad range of channel heights (100 nm to 1000 µm), and can achieve very high aspect 
ratios (up to 50:1).    For these reasons SU8 resists are preferable for the fabrication of 
control structures molds.  The higher achievable channel heights result in a dramatic 
decrease in the fluidic impedance of the control structure network, thereby allowing for 
faster valve response (6).  Furthermore, SU8 resist allow for molding/curing temperatures 
up to approximately 200 °C compared to approximately 90 °C for 5740.  A negative master 
of a control structure patterned in a 25 µm high SU8 2025 film is shown Figure 69. 
 
 
 
Figure 69:  Negative master of 25 µm high control features fabricated in SU8 2025.  
 
Furthermore, in some applications such as the fabrication of removable filters (see below) 
and observation windows for absorbance and fluorescence measurements, it may be desired 
to maintain a rectangular channel cross section in specific locations within the flow 
structure.  Multiple lithography steps can be used to create hybrid SU8-5740 molds.  If SU8 
features are shorter than 5740 features this process is straightforward.  Features are first 
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defined in SU8 by conventional processing.  The wafer is then coated with 5740 photoresist 
and processed in the conventional way.  Initial soft-baking of the 5740 planarizes the film 
so that height perturbations due to spin-coating over the SU8 features are minimized.  Since 
SU8 features as small as 1 µm in height are easily visible through 10 µm of 5740, 
alignment is easily achieved.  Once the 5740 features have been developed they are 
thermally annealed to generate a rounded profile amenable to the integration of valves.  A 
molded replica of a mixing ring featuring a 10 µm high observation window of rectangular 
cross section incorporated in a 13 µm high section of channel having rounded cross section 
is shown in Figure 70.     
 
 
 
Figure 70:  Optical micrograph of mixing ring structure molded from hybrid 5740-SU8 
master.  10 µm high observation windows of rectangular cross section allow for precise 
absorption measurements. 
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SU8 resists are the most practical option if feature heights in excess of 40 µm are needed in 
combination with relatively thin (10 µm - 20 µm) valve-compatible channels.  In such cases 
the SU8 features must be added after 5740 processing is complete since the spin-coating of 
5740 onto the high SU8 features would result in a poor quality film of uneven thickness.  
The requirement that the SU8 be added after the 5740 presents a non-trivial technical 
problem in that the SU8 processing is incompatible with 5740 photo-resist; SU8 developer 
quickly dissolves 5740 features.  After considerable investigation it was found that a 
standard reflow of 5740 features followed by hard-baking at temperatures above 180 °C for 
1 hour resulted in a permanent chemical change to the 5740 photo-resist.  Films baked at 
this elevated temperature exhibit a pronounced change in color, going from dark red to 
black, but remain optically smooth.  Provided that a sufficiently long reflow bake (120 °C 
for 1.5 hrs) is done prior to hard baking no significant deformation of features is observed. 
 
Hard-baked films were not damaged by SU8 processing, and were further found to be 
extremely resistant to a variety of solvents including acetone, isopropyl alcohol, and cyclo-
benzene; in fact a solvent was not discovered that would remove the film.  The elevated 
bake temperature is crucial to the success of this process.  Hard-baking overnight at 150 °C, 
the first protection protocol that was tried, did not produce chemically resilient films.  An 
important point is that thick SU8 films are highly stressed and are prone to cracking so that 
thermal shock due to rapid heating or cooling should be avoided.  In practice this is easily 
achieved by temperature ramping protocols or by simply using the thermal mass of the 
oven/hot-plate to achieve gradual temperature changes.  A microfabricated mold featuring 
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and array of 50 µm high SU8 channels joined to rounded 13 µm high 5740 channels is 
shown in Figure 71.   
 
 
 
Figure 71:  Hybrid 5740-SU8 negative master with 50 µm tall SU8 features fabricated on 
top of rounded 13 µm high 5740. 
 
Microfluidic Filters 
Many applications require the capture of beads or cells during buffer exchange steps or 
column stacking.  This may be achieved by a simple size filter formed by a section of 
channel that is constricted in height or width.  Since beads may be less than 1 µm in radius, 
very high-resolution lithography is required to implement filters based on lateral 
constrictions.  Alternatively, vertical constrictions may be easily implemented using 
multilevel molds as described above.  A significant consideration in the design and 
fabrication of features that are highly constricted in the vertical dimension is the possibility 
of channel collapse during MSL processing.  It was found that channel structures having 
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aspect ratios of 1:10 and heights of 10 µm spontaneously collapsed during alignment of 
elastomer layers. This process was observed to nucleate in a section of channel and then 
propagate along the channel length, “zipping up” the channel feature.  This problem was 
eventually overcome by increasing the channel aspect ratio and by optimizing elastomer 
curing times. 
 
Vertical constrictions due to multilevel mold features are “hard-wired” into a device, 
creating permanent filters.  Removable filters are useful in many applications, such as 
buffer exchange or cell capture, that only require particles to be impeded intermittently.  
Such a filter can be easily realized by the partial actuation of a membrane valve.  Precise 
control of the pressure applied to a valve may be used to sufficiently constrict but not close 
a channel so that particles may not pass.  Tuning the actuation pressure of such a filter 
allows for the filter cutoff size to be dynamically controlled.  This strategy has been 
implemented in the capture of cells for CDNA analysis (31).  A major disadvantage to this 
scheme is that the filter cutoff size is very sensitive to the actuation pressure, making it 
inconvenient and difficult to automate.  Furthermore, perturbations to the pressure in the 
flow or control structure arising from peripheral valve actuations can result in the escape of 
trapped particles.  
 
To circumvent these limitations removable filters that are insensitive to actuation pressure 
can be formed by membrane actuators located in sections of channel with rectangular cross 
section.  Deflection of a membrane into a square channel results in incomplete closure of 
the channel with small gaps remaining at the channel corners.  Sub-micron gaps are easily 
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achieved in these structures over a broad range of actuation pressures so that no analogue 
control of the actuation pressure is required.  These filters may be molded from masters 
made using multi-step lithography to include sections of channel made from SU8 (Figure 
72).  These filters have been used for column stacking in applications including on-chip 
chemical synthesis and single cell CDNA analysis (J. Marcus in personal communication).    
 
 
 
Figure 72:  Section of a microfluidic device designed for mRNA capture.  Removable 
filter (blue) is used to stack functionalized beads for affinity capture (inset).  Figure 
courtesy of J. Marcus.     
   
Microwell Fabrication 
The integration of microwell structures with increased feature heights allows for reaction 
volumes to be increased while maintaining small component footprint and minimizing 
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diffusion times.  Tall microwell structures also allow for improved sensitivity in 
fluorescence and absorbance measurements by providing increased optical path length.  
Multilevel molds may be used in conjunction with push-up valves to fabricate channel and 
well structures in a single molding step.  An optical micrograph of a multilevel mold 
having an array of 65 µm high microwells connected by 13 µm high flow channels is 
shown in Figure 73.  The incorporation of microwells or other tall features in the flow 
channel mold implies that only the push-up valve geometry may be used since a silicone 
film thick enough to cover the features will result in membranes that are too thick for 
actuation at reasonable pressures. 
 
 
 
Figure 73:  Negative master with 65 µm high microwells fabricated in SU8 2075 resist 
on top of 10 µm high rounded 5740 channels.  
 
The simultaneous molding of microwells and channel structures has the advantage that no 
subsequent elastomer alignment step of the channels to the wells is required.  Alternatively, 
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the flow structure may be aligned and bonded to a substrate in which microwells have been 
separately fabricated.  This scheme allows for push-down valve geometry to be used and 
has the advantage that a reversible substrate bond can be formed that allows for access to 
the microwells for the recovery of reaction products.  In particular, a robust reversible bond 
can be formed between an elastomer flow structure and a glass substrate with etched 
microwells.  An important advantage of this geometry is that the reagents are in direct 
contact with the substrate, allowing for the straightforward integration of sensing elements 
including electrodes, waveguides, ligands, and metallized films for surface plasmon 
resonance.   
 
A procedure was developed for etching microwells in soda lime and borosilicate crown 
microscope slides.  The glass slides are patterned with photoresist (Shipley SJR 5740) 
using a negative high-resolution transparency film as a mask.  The back of the slides are 
then masked with an additional layer of photo-resist and hard-baked at 125 °C for 20 
minutes to protect them during etching.  Etching is performed at 25 °C with propeller 
agitation in equal parts of dionized water, 1 N hydrochloric acid, and buffered oxide 
etchant (6 ammonium fluoride: 1 hydrofluoric acid, Transene Company).  The addition of 
hydrochloric acid prevents the re-deposition of insoluble fluoride salts formed by impurity 
elements in the soda lime and borosilicate crown glass substrates (101).  Figure 74:  Optical 
micrographs of features etched in soda lime glass.  (A)  Rough etch surface due to the 
formation of insoluble fluoride salts.  (B)  Addition of 1 N HCl to etchant results in smooth 
etch. shows a comparison between borosilicate crown glass slides etched with straight 
buffered oxide etchant and in the presence of 1 N hydrocholoric acid.  Etching for 90 
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minutes at 25 °C yields a maximum well depth of approximately 80 µm.  The slides are 
then washed in acetone to remove the photoresist, and then cleaned in an acid bath 
(NanoStripTM Cyantek Corp.).  
 
 
 
Figure 74:  Optical micrographs of features etched in soda lime glass.  (A)  Rough etch 
surface due to the formation of insoluble fluoride salts.  (B)  Addition of 1 N HCl to 
etchant results in smooth etch. 
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APPENDIX A: FABRICATION PROTOCOLS 
 
Fabrication Protocol: Screening Device  
3” silicon wafer substrate 
 
Mold Fabrication: 
 
I. Flow Mold  
 
Priming:   HDMS vapor 1 min in tuperware container (STP) 
 
Spin 5740:   2000 rpm x 60 s / 15 s ramp 
    Film thickness = 11 microns 
 
Soft Bake:   contact bake hotplate 
    110 C x 90 s 
 
Expose Wafer:  define channel structure 
    45 at 7 mW/cm2 
 
Develop:   5:1 dilution of Shipley 2401 developer 
    rinse DI H2O  
    dry under nitrogen 
 
Reflow:   contact hotplate 
    110 C x 40 min 
 
Hard Bake:  in oven  
    ramp 120 C to 180 C 
    hold 1 hr 
    ramp 180 C to 120 C 
 
Spin SU8 50:  500 rpm x 15 s / 15 s ramp  
    2000 rpm x 40 s / 15 s ramp 
    Film thickness =  60 microns 
 
Pre-Exposure Bake: contact bake hotplate 
    5 min x 65 C / 20 min x 95 C 
 
Expose Wafer:  define microwells and low impendence i/o  
50 s at 7 mW/cm2 
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Post-Exposure Bake:  1 min x 65 C / 12 min x 95 C / 1 min x 65 C 
 
Develop:   100 % Shipley Nanodeveloper 
    rinse with fresh developer 
    dry under nitrogen 
 
II. Control Mold 
 
Spin SU8 2025:  3000 rpm x 45 s / 15 second ramp up  
     film thickness = 13 microns 
 
Pre-Exposure Bake: contact bake hotplate 
    1 min x 65 C / 5 min x 95 C 
 
Expose Wafer:  define control structure 
    25 s at 7 mW/cm2 
 
Post-Exposure Bake: 1 min x 65 C / 5 min x 95 C 
 
Develop:   100 % Shipley Nanodeveloper 
    rinse with fresh developer 
    dry under nitrogen 
 
Hard Bake:  contact hotplate 
150 C x 60 min 
 
MSL Fabrication 
 
Priming:   all molds  
    TMCS vapor 1 min in tuperware container (STP) 
 
Cast Flow Layer:  combine 5:1 GE 615 RTV (30 g A: 6 g B) 
mix hybrid mixer: 2 min mix / 2 min degas 
30 g onto flow mold (petri dish lined with Al foil) 
 
Degas Flow Layer: pull vacuum in bell jar (approx 30 minutes) 
 
Spin Control Layer: combine 20:1 GE 615 RTV (40 g A: 2 g B) 
mix hybrid mixer: 2 min mix / 2 min degas 
    dispense 5 mL on control layer 
    1800 rpm x 60 s / 15 s ramp* 
    film thickness = 28 microns 
 
Spin Blank Layer:    combine 20:1 GE 615 RTV (40 g A: 2 g B) 
mix hybrid mixer: 2 min mix / 2 min degas 
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    dispense 5 mL on blank wafer 
    2000 rpm x 60 s / 15 s ramp 
    film thickness = 30 microns 
 
1st Cure Flow Layer: convection oven 
    80 C x 60 min 
 
1st Cure Control Layer: convection oven 
    80 C x 40 min 
 
1st Cure Blank Layer: convection oven 
    80 C x 40 min 
 
Control/Flow Bonding: peel flow layer from mold 
    align to control layer 
    bake in convection oven 
    80 C x 90 min 
 
Puncing I/O Ports: peel bonded device from control mold 
    punch all flow and control ports  
 
Blank/Control Bonding:   place control/flow structure on blank 
    ensure no air bubbles 
    ensure no collapsed valves 
    bake in convection oven 
    80 C x 3 hours 
 
Dicing:   cut around periphery of thick layer 
    peel from substrate 
    dice into separate devices 
 
Substrate Mounting: rinse bottom of devices with ethanol 
    dry under nitrogen 
rinse glass slides with ethanol 
    dry under nitrogen 
    put device on slide 
    ensure no air bubbles 
    bake in convection oven 
    80 C x 12 hours 
 
 
 
 
 
 
* spin parameters need to be optimized for each batch. 
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Fabrication Protocol: Formulator Device  
3” silicon wafer substrate 
 
Mold Fabrication: 
 
I. Flow Mold  
 
Spin SU8 2015:  3000 rpm x 70 s / 15 second ramp up  
     film thickness = 13 microns 
 
Pre-Exposure Bake: contact bake hotplate 
    1 min x 65 C / 3 min x 95 C 
 
Expose Wafer:  define observation windows 
    25 s at 7 mW/cm2 
 
Post-Exposure Bake: 1 min x 65 C / 4 min x 95 C 
 
Develop:   100 % Shipley Nanodeveloper 
    rinse with fresh developer 
    dry under nitrogen 
 
Wash:   spin and rinse with acetone and isopropyl alcohol 
 
Hard Bake:  contact bake hotplate 
    150 C x 60 min  
 
Priming:   HDMS vapor 1 min in tuperware container (STP) 
 
Spin 5740:   1500 rpm x 60 s / 15 s ramp 
    Film thickness = 12.5 microns 
 
Soft Bake:   contact bake hotplate 
    110 C x 90 s 
Expose Wafer:  define channel structure 
    45 at 7 mW/cm2 
 
Develop:   5:1 dilution of Shipley 2401 developer 
    rinse DI H2O  
    dry under nitrogen 
 
Reflow:   contact hotplate 
    110 C x 40 min 
 
Hard Bake:  in oven  
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    ramp 120 C to 180 C 
    hold 1 hr 
    ramp 180 C to 120 C 
 
Spin SU8 50:  500 rpm x 15 s / 15 s ramp  
    3000 rpm x 40 s / 15 s ramp 
    Film thickness = 42 microns 
 
Pre-Exposure Bake: contact bake hotplate 
    5 min x 65 C / 15 min x 95 C 
 
Expose Wafer:  define low impendence i/o    
50 s at 7 mW/cm2 
 
Post-Exposure Bake:  1 min x 65 C / 7 min x 95 C / 1 min x 65 C 
 
Develop:   100 % Shipley Nanodeveloper 
    rinse with fresh developer 
    dry under nitrogen 
 
II. Control Mold 
 
Spin SU8 2025:  3000 rpm x 45 s / 15 second ramp up  
     film thickness = 13 microns 
 
Pre-Exposure Bake: contact bake hotplate 
    1 min x 65 C / 5 min x 95 C 
 
Expose Wafer:  define control structure 
    25 s at 7 mW/cm2 
 
Post-Exposure Bake: 1 min x 65 C / 5 min x 95 C 
 
Develop:   100 % Shipley Nanodeveloper 
    rinse with fresh developer 
    dry under nitrogen 
Hard Bake:  contact hotplate 
150 C x 60 min 
 
MSL Fabrication 
 
Priming:   all molds  
    TMCS vapor 1 min in tuperware container (STP) 
 
Cast Flow Layer:  combine 5:1 GE 615 RTV (30 g A: 6 g B) 
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mix hybrid mixer: 2 min mix / 2 min degas 
30 g onto flow mold (petri dish lined with Al foil) 
 
Degas Flow Layer: pull vacuum in bell jar (approx 30 minutes) 
 
Spin Control Layer: combine 20:1 GE 615 RTV (40 g A: 2 g B) 
mix hybrid mixer: 2 min mix / 2 min degas 
    dispense 5 mL on control layer 
    1800 rpm x 60 s / 15 s ramp* 
    film thickness = 28 microns 
 
Spin Blank Layer:    combine 20:1 GE 615 RTV (40 g A: 2 g B) 
mix hybrid mixer: 2 min mix / 2 min degas 
    dispense 5 mL on blank wafer 
    2000 rpm x 60 s / 15 s ramp 
    film thickness = 30 microns 
 
1st Cure Flow Layer: convection oven 
    80 C x 60 min 
 
1st Cure Control Layer: convection oven 
    80 C x 40 min 
 
1st Cure Blank Layer: convection oven 
    80 C x 40 min 
 
Control/Flow Bonding: peel flow layer from mold 
    align to control layer 
    bake in convection oven 
    80 C x 90 min 
 
Puncing I/O Ports: peel bonded device from control mold 
    punch all flow and control ports  
 
Blank/Control Bonding:   place control/flow structure on blank 
    ensure no air bubbles 
    ensure no collapsed valves 
    bake in convection oven 
    80 C x 3 hours 
 
Dicing:   cut around periphery of thick layer 
    peel from substrate 
    dice into separate devices 
 
Substrate Mounting: rinse bottom of devices with ethanol 
    dry under nitrogen 
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rinse glass slides with ethanol 
    dry under nitrogen 
    put device on slide 
    ensure no air bubbles 
    bake in convection oven 
    80 C x 12 hours 
 
 
* spin parameters need to be optimized for each batch. 
 
 
     
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 197
Fabrication Protocol: Diffraction Device  
3” silicon wafer substrate 
 
Mold Fabrication: 
 
I. Reservoir Molds   
 
Spin SU8 2025:  3000 rpm x 45 s / 15 second ramp up  
     film thickness = 13 microns 
 
Pre-Exposure Bake: contact bake hotplate 
    1 min x 65 C / 5 min x 95 C 
 
Expose Wafer:  define reservoirs 
    25 s at 7 mW/cm2 
 
Post-Exposure Bake: 1 min x 65 C / 5 min x 95 C 
 
Develop:   100 % Shipley Nanodeveloper 
    rinse with fresh developer 
    dry under nitrogen 
  
II. Flow Mold  
 
Priming:   HDMS vapor 1 min in tuperware container (STP) 
 
Spin 5740:   900 rpm x 50 s / 5 s ramp 
    Film thickness = 16 microns 
 
Soft Bake:   contact bake hotplate 
    110 C x 100 s 
 
Expose Wafer:  define channel structure 
    70 at 7 mW/cm2 
 
Develop:   7:1 dilution of Shipley 2401 developer 
    rinse DI H2O  
    dry under nitrogen 
 
Reflow:   contact hotplate 
    115 C x 25 min 
 
Hard Bake:  in oven  
    ramp 120 C to 180 C 
    hold 1 hr 
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    ramp 180 C to 120 C 
 
Spin SU8 100:  1500 rpm x 60 s / 15 s ramp  
    Film thickness = 150 microns 
    sit for 15 minutes on flat level surface 
 
Pre-Exposure Bake: contact bake on level hotplate 
    5 min x 65 C / 30 min x 95 C / 1 min 65 C 
    cool to room temperature 
 
Expose Wafer:  define microwells and high i/o   
130 s at 7 mW/cm2 
 
Post-Exposure Bake:  2 min x 65 C / 12 min x 95 C / 1 min x 65 C 
 
Develop:   100 % Shipley Nanodeveloper 
    rinse with fresh developer 
    dry under nitrogen 
 
III. Control Mold 
 
Spin SU8 2025:  3000 rpm x 45 s / 15 second ramp up  
     film thickness = 13 microns 
 
Pre-Exposure Bake: contact bake hotplate 
    1 min x 65 C / 5 min x 95 C 
 
Expose Wafer:  define control structure 
    25 s at 7 mW/cm2 
 
Post-Exposure Bake: 1 min x 65 C / 5 min x 95 C 
 
Develop:   100 % Shipley Nanodeveloper 
    rinse with fresh developer 
    dry under nitrogen 
 
Hard Bake:  contact hotplate 
150 C x 60 min 
 
MSL Fabrication 
 
Priming:   all molds  
    TMCS vapor 5 min in tuperware container (STP) 
 
Cast Through Layer: combine 5:1 GE 615 RTV (36 g A: 7 g B) 
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mix hybrid mixer: 2 min mix / 2 min degas 
36 g onto flow mold (petri dish lined with Al foil) 
 
Degas Through Layer: pull vacuum in bell jar (approx 30 minutes) 
 
Spin Flow Layer 1: combine 5:1 GE 615 RTV (30 g A: 6 g B) 
mix hybrid mixer: 2 min mix / 2 min degas 
    dispense 5 mL on flow layer 
    350 rpm x 60 s / 10 s ramp* 
    film thickness = 180 microns 
 
Degas Flow Layer: pull vacuum in bell jar (approx 30 minutes) 
 
Spin Control Layer: combine 20:1 GE 615 RTV (40 g A: 2 g B) 
mix hybrid mixer: 2 min mix / 2 min degas 
    dispense 5 mL on control layer 
    1800 rpm x 60 s / 15 s ramp* 
    film thickness = 28 microns 
 
Spin Blank Layer:    combine 20:1 GE 615 RTV (40 g A: 2 g B) 
mix hybrid mixer: 2 min mix / 2 min degas 
    dispense 5 mL on blank wafer 
    2000 rpm x 60 s / 15 s ramp 
    film thickness = 30 microns 
 
1st Cure Through Layer: convection oven 
    80 C x 80 min 
 
1st Cure Flow Layer: convection oven 
    80 C x 60 min 
 
Spin Flow Layer 2: combine 20:1 GE 615 RTV (40 g A: 2 g B) 
mix hybrid mixer: 2 min mix / 2 min degas 
    dispense 5 mL on blank wafer 
    2000 rpm x 60 s / 15 s ramp 
    film thickness = 30 microns 
 
2nd Cure Control Layer: convection oven 
    80 C x 20 min 
 
Punching Reservoirs: peel through layer from mold 
    punch reservoir through holes  
 
Through/Flow Bonding: peel through layer from mold 
    align to flow layer 
    bake in convection oven 
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    80 C x 60 min 
 
1st Cure Control Layer: convection oven 
    80 C x 40 min 
 
Control/Flow Bonding: peel flow layer from mold 
    take care to not rip membranes 
    align to control layer 
    ensure no air bubbles under membranes 
    ensure no collapsed valves 
    bake in convection oven 
    80 C x 70 min 
 
1st Cure Blank Layer: convection oven 
    80 C x 40 min 
 
Puncing I/O Ports: peel bonded device from control mold 
    punch all flow and control ports  
 
Blank/Control Bonding:   place control/flow structure on blank 
    pull vacuum to ensure no air bubbles 
    ensure no collapsed valves 
    bake in convection oven 
    80 C x 12 hours 
 
Dicing:   cut around periphery of thick layer 
    peel from substrate 
    cut device to shape 
 
Substrate Mounting: rinse bottom of device with ethanol 
    dry under nitrogen 
rinse glass slides with ethanol 
    dry under nitrogen 
    put device on slide 
    pull vacuum to ensure no air bubbles 
    bake in convection oven 
    80 C x 12 hours 
 
 
 
 
 
 
 
 
* spin parameters need to be optimized for each batch. 
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APPENDIX B: MATLAB SCRIPT FOR MIXING SIMULATIONS 
%  Program for simulating dispersion in tube or rotary mixer for a %
 given flow    % velocity profile. 
 
%    data input 
 
filename = input('enter function filename: ','s'); 
fid = fopen(filename, 'w'); % open functionfile 
 
dif = input('diffusion constant(um*um/s): '); 
fprintf(fid, 'Diffusion constant (um*um/s): %6f\n', dif); 
 
inic = input('initial concetration: '); 
fprintf(fid, 'Initial concentration: %6f\n', inic); 
 
vel = input('max velocity(um/s): ');  
fprintf(fid, 'Max velocity (um/s): %6f\n', vel); 
 
xl = input('length of tube (nodes): '); 
fprintf(fid, 'Number of nodes in x-dir: %6f\n', xl); 
 
yl = input('width of tube (nodes): '); 
fprintf(fid, 'Number of nodes in y-dir: %6f\n', yl); 
 
time = input('simulationb time: '); 
fprintf(fid, 'Simulation time (s): %6f\n', time); 
 
dx = input('um pr node x-dir: '); 
fprintf(fid, 'Spatial step size in x-dir (um/node): %6f\n', dx); 
 
dy = input('um pr node y-dir: '); 
fprintf(fid, 'Spatial step size in y-dir (um/node): %6f\n', dy); 
 
dt = input('timesteps (s): '); 
fprintf(fid, 'Time step (s) %6f\n', dt); 
 
slugl = input('slug length(nodes): '); 
fprintf(fid, 'Initial length of slug (x-dir nodes): %6f\n', slugl); 
 
numpic = input('number of pictures saved in matrix ct: '); 
fprintf(fid, 'Number of events saved (i.e. matrices below): %6f\n', 
numpic); 
 
 
inicond = (x1, y1, time,dx,dy,dt,slug); 
 
 
%  calculation of timeresolution and initial matrix 
 
 
stepcount = 1; 
lastcount = time/dt; 
 
 
channelnl = xl + 100; 
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c = zeros(channelnl,yl); 
inidom = (100+slugl); 
c(101:inidom,:) = ones; 
c = c*inic; 
ctemp = c; 
ct = zeros(channelnl,yl*10); 
 
%  discretize velocity profile 
 
 
v = zeros(yl,1); 
n = 1; 
while n <= yl 
 v(n,1) = -vel*(4/((yl-1)*(yl-1)))*((n-1)*(n-1) - (n-1)*(yl-1)); 
     n=n+1; 
end 
 
%  do calculations  
 
 
q=1; 
 
while stepcount <= lastcount 
 
 
%  lower noflux boundary y-1 = y+1 
    y = 1; 
    x = 2; 
    n = y; 
 while x < (xl + 97) 
  ctemp(x,y) = (dif*dt/(dx*dx))*(c(x+1,y) - 2*c(x,y)   
  + c(x-1,y)) + (dif*dt/(dy*dy))*(c(x,y+1) -2*c(x,y)   
  + c(x,y+1)) + (v(n,1)*dt/dx)*(-c(x,y) + c(x-1,y))   
  + c(x,y);    
  x = x+1; 
 end 
 
 
%  high noflux boundary y+1 = y-1 
    y = yl; 
    x = 2; 
    n = y; 
      while x < (xl + 98) 
  ctemp(x,y) = (dif*dt/(dx*dx))*(c(x+1,y) - 2*c(x,y)   
  + c(x-1,y)) + (dif*dt/(dy*dy))*(c(x,y-1) -2*c(x,y)   
  + c(x,y-1)) + (v(n,1)*dt/dx)*(-c(x,y) + c(x-1,y))   
  + c(x,y);    
  x = x+1; 
 end 
    y = 2; 
    n = 2; 
 while y < yl 
  x = 2; 
  while x < (xl + 98) 
   ctemp(x,y) = (dif*dt/(dx*dx))*(c(x+1,y) - 2*c(x,y)  
   + c(x-1,y)) + (dif*dt/(dy*dy))*(c(x,y+1) -2*c(x,y)  
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   + c(x,y-1)) + (v(n,1)*dt/dx)*(-c(x,y) + c(x-1,y))  
   + c(x,y);    
   x = x+1; 
  end 
       y = y+1; 
  n = y;  
 end  
    c = ctemp; 
 
    if stepcount > q*lastcount/numpic 
        ct(:,(q*yl-(yl-1)):q*yl)=c; 
        tau = dt*q*lastcount/numpic 
        x=1; 
        while x<=channelnl 
            y=1; 
            while y <=yl 
                fprintf(fid, '%6f\n', c(x,y)); 
                y=y+1; 
            end 
            x=x+1; 
        end 
        q = q+1; 
        fprintf(fid,'\n'); 
    end 
    stepcount = stepcount + 1 
     
        
     
end 
fclose(fid); 
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APPENDIX C: PHASE-SPACE DIAGRAMS 
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APPENDIX D: CRYSTALLIZATION RESULTS FOR OPTIMAL SCREENING 
Optimal Xylanase Crystallization Screen Based on Phase-space Mapping 
     
# Buffer  pH Conc Prec1  Conc Prec2  Conc  Prot. 
    M   M   M mg/mL 
1 NaCitrate 4.6 0.1 NaCitrate 0.65 none  N/A 7 
2 NaCitrate 4.6 0.1 NaCitrate 0.475 none  N/A 17 
3 Tris/HCL 6.5 0.1 NaCitrate 0.7 none  N/A 5 
4 Tris/HCL 6.5 0.1 NaCitrate 0.5 none  N/A 9 
5 Tris/HCL 8.45 0.1 NaCitrate 0.425 none  N/A 19 
6 Tris/HCL 8.45 0.1 NaCitrate 0.475 none  N/A 9.5 
7 NaCitrate 4.6 0.1 Na/K Tart 1.1 none  N/A 6.5 
8 NaCitrate 4.6 0.1 K2HPO4  0.8 none  N/A 9 
9 NaCitrate 4.6 0.1 K2HPO4  1.8 none  N/A 6.75 
10 Tris/HCL 6.5 0.1 K2HPO4  0.6 none  N/A 24.75 
11 Tris/HCL 6.5 0.1 Na/K Tart 0.75 none  N/A 21 
12 Tris/HCL 8.45 0.1 K2HPO4  2.8 none  N/A 6.75 
13 NaCitrate 4.6 0.1 (NH4)2SO4 1.08 none  N/A 9 
14 Tris/HCL 6.5 0.1 (NH4)2SO4 1.89 none  N/A 4.5 
15 Tris/HCL 8.45 0.1 (NH4)2SO4 0.81 none  N/A 24.75 
16 NaCitrate 4.6 0.1 K2HPO4  2.8 none  N/A 3.5 
17 NaCitrate 4.6 0.1 Na/K Tart 0.75 none  N/A 17 
18 Tris/HCL 8.45 0.1 K2HPO4  0.4 none  N/A 31.5 
19 NaCitrate 4.6 0.1 (NH4)2SO4 0.945 none  N/A 23.62 
20 Tris/HCL 6.5 0.1 Na/K Tart 1.4 none  N/A 4.5 
21 Tris/HCL 6.5 0.1 (NH4)2SO4 1.35 none  N/A 9 
22 Tris/HCL 8.45 0.1 Na/K Tart 0.9 none  N/A 6.75 
23 Tris/HCL 8.45 0.1 Na/K Tart 0.7 none  N/A 13.5 
24 Tris/HCL 8.45 0.1 (NH4)2SO4 1.755 none  N/A 4.5 
25 Tris/HCL 8.2 0.1 P8000  16 NaCl  0.1 42 
26 Tris/HCL 8.2 0.1 P8000  23 NaCl  0.1 21 
27 Tris/HCL 8.2 0.1 P8000  15 None  N/A 54 
28 Tris/HCL 8.2 0.1 P8000  24 None  N/A 30 
29 Tris/HCL 8.2 0.1 P8000  28 Am Aoc  0.1 18 
30 Tris/HCL 8.2 0.1 P8000  19 Am Aoc  0.1 33 
31 Tris/HCL 8.2 0.1 P8000  14 Am Aoc  0.1 60 
32 Tris/HCL 8.2 0.1 P8000  20 K Citrate 0.05 42 
33 Tris/HCL 8.2 0.1 P8000  14 K Citrate 0.05 60 
34 Tris/HCL 8.2 0.1 P8000  16 K Citrate 0.05 36 
35 Tris/HCL 8.2 0.1 P8000  24 (NH4)2SO4 .0675 18 
36 Tris/HCL 8.2 0.1 P8000  24 (NH4)2SO5 .0675 6 
37 Tris/HCL 8.2 0.1 P8000  10 MgSO4  0.05 66 
38 Tris/HCL 8.2 0.1 P8000  16 MgSO4  0.05 30 
39 Tris/HCL 8.2 0.1 P8000  18 MgSO4  0.05 36 
40 Tris/HCL 7.6 0.1 P8000  12 NaCl  0.1 66 
41 Tris/HCL 7.6 0.1 P8000  28 NaCl  0.1 18 
42 Tris/HCL 7.6 0.1 P8000  30 K2HPO4  0.1 12 
43 Tris/HCL 7.6 0.1 P8000  22 K2HPO5  0.1 12 
44 Tris/HCL 7.6 0.1 P8000  16 K2HPO6  0.1 42 
45 Tris/HCL 7.6 0.1 P8000  18 NH4AOc  0.1 36 
46 Tris/HCL 7.6 0.1 P8000  28 K Citrate 0.05 18 
47 Tris/HCL 7.6 0.1 P8000  16 (NH4)2SO4 .0675 54 
48 Tris/HCL 7.6 0.1 P8000  30 MgSO4  0.05 12 
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